{
    "gene_diseases": [
        {
            "diseaseId": "OMIM:265880",
            "phenodigmScore": 68.465,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0011001 Increased bone mineral density",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "59.23",
            "diseaseModelAvgRaw": "1.37",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.99",
            "diseaseModelMaxNorm": "77.7",
            "markerNumModels": "9",
            "diseaseTerm": "Pyknoachondrogenesis",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "OMIM:114065",
            "phenodigmScore": 50.14,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010702 Increased circulating antibody level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "35.87",
            "diseaseModelAvgRaw": "1.0",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.07",
            "diseaseModelMaxNorm": "64.41",
            "markerNumModels": "9",
            "diseaseTerm": "Calcific Aortic Disease With Immunologic Abnormalities, Familial",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:33110",
            "phenodigmScore": 59.925,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0100806 Sepsis,HP:0004432 Agammaglobulinemia,HP:0001875 Neutropenia,HP:0002110 Bronchiectasis,HP:0000389 Chronic otitis media,HP:0012115 Hepatitis,HP:0002719 Recurrent infections,HP:0001369 Arthritis,HP:0002754 Osteomyelitis,HP:0001287 Meningitis,HP:0001581 Recurrent skin infections,HP:0000988 Skin rash,HP:0002205 Recurrent respiratory infections,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "41.57",
            "diseaseModelAvgRaw": "0.92",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "78.28",
            "markerNumModels": "9",
            "diseaseTerm": "Autosomal Agammaglobulinemia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:667",
            "phenodigmScore": 41.345,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002716 Lymphadenopathy,HP:0002257 Chronic rhinitis,HP:0002148 Hypophosphatemia,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0000388 Otitis media,HP:0002901 Hypocalcemia,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.56",
            "diseaseModelAvgRaw": "0.42",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "64.13",
            "markerNumModels": "9",
            "diseaseTerm": "Autosomal Recessive Malignant Osteopetrosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:263300",
            "phenodigmScore": 46.364999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0001974 Leukocytosis,HP:0001898 Increased red blood cell mass,HP:0001744 Splenomegaly,HP:0001899 Increased hematocrit,HP:0001873 Thrombocytopenia,HP:0001900 Increased hemoglobin",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.38",
            "diseaseModelAvgRaw": "0.5",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "72.35",
            "markerNumModels": "9",
            "diseaseTerm": "Polycythemia Vera",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:603552",
            "phenodigmScore": 57.584999999999994,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001875 Neutropenia,HP:0002716 Lymphadenopathy,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0000952 Jaundice,HP:0003281 Increased circulating ferritin concentration,HP:0000988 Skin rash,HP:0002155 Hypertriglyceridemia,HP:0001873 Thrombocytopenia,HP:0012156 Hemophagocytosis,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "34.4",
            "diseaseModelAvgRaw": "0.74",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "80.77",
            "markerNumModels": "9",
            "diseaseTerm": "Hemophagocytic Lymphohistiocytosis, Familial, 4",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:91351",
            "phenodigmScore": 38.395,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001287 Meningitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "7.25",
            "diseaseModelAvgRaw": "0.16",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "69.54",
            "markerNumModels": "9",
            "diseaseTerm": "Pituitary Dermoid And Epidermoid Cysts",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:342",
            "phenodigmScore": 43.769999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001701 Pericarditis,HP:0001541 Ascites,HP:0002586 Peritonitis,HP:0002716 Lymphadenopathy,HP:0001369 Arthritis,HP:0001733 Pancreatitis,HP:0001744 Splenomegaly,HP:0001287 Meningitis,HP:0000988 Skin rash,HP:0100796 Orchitis,HP:0002758 Osteoarthritis,HP:0001055 Erysipelas",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.8",
            "diseaseModelAvgRaw": "0.45",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "67.74",
            "markerNumModels": "9",
            "diseaseTerm": "Familial Mediterranean Fever",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:540",
            "phenodigmScore": 70.99,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001875 Neutropenia,HP:0002716 Lymphadenopathy,HP:0004313 Decreased circulating antibody level,HP:0001744 Splenomegaly,HP:0003281 Increased circulating ferritin concentration,HP:0040186 Maculopapular exanthema,HP:0000952 Jaundice,HP:0011112 Abnormality of serum cytokine level,HP:0001019 Erythroderma,HP:0002383 Infectious encephalitis,HP:0012178 Reduced natural killer cell activity,HP:0000988 Skin rash,HP:0002155 Hypertriglyceridemia,HP:0003073 Hypoalbuminemia,HP:0030356 Increased serum interferon-gamma level,HP:0002240 Hepatomegaly,HP:0030783 Increased circulating interleukin 6,HP:0012156 Hemophagocytosis,HP:0011118 Abnormality of tumor necrosis factor secretion,HP:0001903 Anemia,HP:0002611 Cholestatic liver disease,HP:0001873 Thrombocytopenia,HP:0002583 Colitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "46.41",
            "diseaseModelAvgRaw": "1.04",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "95.57",
            "markerNumModels": "9",
            "diseaseTerm": "Familial Hemophagocytic Lymphohistiocytosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:125",
            "phenodigmScore": 53.465,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0006721 Acute lymphoblastic leukemia,HP:0032170 Severe varicella zoster infection,HP:0005353 Recurrent herpes,HP:0004313 Decreased circulating antibody level,HP:0002719 Recurrent infections,HP:0000554 Uveitis,HP:0002850 Decreased circulating total IgM,HP:0020105 Severe toxoplasmosis,HP:0100825 Cheilitis,HP:0000010 Recurrent urinary tract infections,HP:0004808 Acute myeloid leukemia,HP:0000988 Skin rash,HP:0011110 Recurrent tonsillitis,HP:0031393 Abnormal proportion of CD8-positive T cells,HP:0002090 Pneumonia,HP:0002720 Decreased circulating IgA level,HP:0012384 Rhinitis,HP:0025615 Abscess,HP:0000388 Otitis media,HP:0031123 Recurrent gastroenteritis,HP:0004315 Decreased circulating IgG level,HP:0032218 Decreased proportion of CD4-positive T cells",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "33.79",
            "diseaseModelAvgRaw": "0.7",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "73.14",
            "markerNumModels": "9",
            "diseaseTerm": "Bloom Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:77297",
            "phenodigmScore": 46.555,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0011123 Inflammatory abnormality of the skin,HP:0012647 Abnormal inflammatory response,HP:0001974 Leukocytosis,HP:0002240 Hepatomegaly,HP:0200039 Pustule,HP:0100769 Synovitis,HP:0004840 Hypochromic microcytic anemia,HP:0004810 Congenital hypoplastic anemia,HP:0001061 Acne,HP:0002754 Osteomyelitis,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.52",
            "diseaseModelAvgRaw": "0.45",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "71.59",
            "markerNumModels": "9",
            "diseaseTerm": "Majeed Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:308250",
            "phenodigmScore": 65.815,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002850 Decreased circulating total IgM",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "48.55",
            "diseaseModelAvgRaw": "1.2",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "83.08",
            "markerNumModels": "9",
            "diseaseTerm": "Immunoglobulin M, Level Of",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:271510",
            "phenodigmScore": 44.33,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004315 Decreased circulating IgG level,HP:0001875 Neutropenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.08",
            "diseaseModelAvgRaw": "0.39",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "70.58",
            "markerNumModels": "9",
            "diseaseTerm": "Spondyloepimetaphyseal Dysplasia, Sponastrime Type",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615758",
            "phenodigmScore": 47.165000000000006,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002205 Recurrent respiratory infections,HP:0012490 Panniculitis,HP:0005407 Decreased proportion of CD4-positive helper T cells",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "27.04",
            "diseaseModelAvgRaw": "0.6",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.15",
            "diseaseModelMaxNorm": "67.29",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 22",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615122",
            "phenodigmScore": 73.73,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0002240 Hepatomegaly,HP:0032170 Severe varicella zoster infection,HP:0001876 Pancytopenia,HP:0001541 Ascites,HP:0002716 Lymphadenopathy,HP:0004313 Decreased circulating antibody level,HP:0002719 Recurrent infections,HP:0031381 Decreased lymphocyte proliferation in response to mitogen,HP:0033509 EBV encephalitis,HP:0001744 Splenomegaly,HP:0001433 Hepatosplenomegaly,HP:0000554 Uveitis,HP:0006532 Recurrent pneumonia,HP:0033508 EBV meningitis,HP:0001915 Aplastic anemia,HP:0012156 Hemophagocytosis,HP:0020072 Persistent EBV viremia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "58.17",
            "diseaseModelAvgRaw": "1.24",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.58",
            "diseaseModelMaxNorm": "89.29",
            "markerNumModels": "9",
            "diseaseTerm": "Lymphoproliferative Syndrome 2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:226990",
            "phenodigmScore": 53.725,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0002090 Pneumonia,HP:0002110 Bronchiectasis,HP:0002719 Recurrent infections,HP:0001744 Splenomegaly,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "28.75",
            "diseaseModelAvgRaw": "0.66",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "78.7",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 32B",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:300635",
            "phenodigmScore": 67.23,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002037 Inflammation of the large intestine,HP:0025084 Folliculitis,HP:0012115 Hepatitis,HP:0004313 Decreased circulating antibody level,HP:0002719 Recurrent infections,HP:0001061 Acne,HP:0001744 Splenomegaly,HP:0003281 Increased circulating ferritin concentration,HP:0001915 Aplastic anemia,HP:0001581 Recurrent skin infections,HP:0002155 Hypertriglyceridemia,HP:0001876 Pancytopenia,HP:0002205 Recurrent respiratory infections,HP:0002583 Colitis,HP:0012156 Hemophagocytosis,HP:0012219 Erythema nodosum",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "54.67",
            "diseaseModelAvgRaw": "1.22",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "79.79",
            "markerNumModels": "9",
            "diseaseTerm": "Lymphoproliferative Syndrome, X-Linked, 2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:230900",
            "phenodigmScore": 48.185,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002100 Recurrent aspiration pneumonia,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0002059 Cerebral atrophy,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.37",
            "diseaseModelAvgRaw": "0.41",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "77.0",
            "markerNumModels": "9",
            "diseaseTerm": "Gaucher Disease, Type Ii",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618935",
            "phenodigmScore": 55.44,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000964 Eczema,HP:0002840 Lymphadenitis,HP:0002716 Lymphadenopathy,HP:0025615 Abscess,HP:0002719 Recurrent infections,HP:0012203 Onychomycosis,HP:0001744 Splenomegaly,HP:0032252 Granuloma,HP:0100280 Crohn's disease,HP:0009789 Perianal abscess,HP:0003203 Impaired oxidative burst,HP:0006532 Recurrent pneumonia,HP:0001735 Acute pancreatitis,HP:0001433 Hepatosplenomegaly,HP:0011110 Recurrent tonsillitis,HP:0001888 Lymphopenia,HP:0001878 Hemolytic anemia,HP:0100279 Ulcerative colitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "40.73",
            "diseaseModelAvgRaw": "0.92",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "70.15",
            "markerNumModels": "9",
            "diseaseTerm": "Granulomatous Disease, Chronic, Autosomal Recessive, 5",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:69126",
            "phenodigmScore": 56.97,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0200039 Pustule,HP:0100614 Myositis,HP:0002716 Lymphadenopathy,HP:0001061 Acne,HP:0001369 Arthritis,HP:0012649 Increased inflammatory response,HP:0100280 Crohn's disease,HP:0010702 Increased circulating antibody level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "37.49",
            "diseaseModelAvgRaw": "0.83",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "76.45",
            "markerNumModels": "9",
            "diseaseTerm": "Pyogenic Arthritis-Pyoderma Gangrenosum-Acne Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:723",
            "phenodigmScore": 54.095,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0006515 Interstitial pneumonitis,HP:0009098 Chronic oral candidiasis,HP:0010702 Increased circulating antibody level,HP:0011949 Acute infectious pneumonia,HP:0020102 Pneumocystis jirovecii pneumonia,HP:0011991 Abnormal neutrophil count",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "35.25",
            "diseaseModelAvgRaw": "0.77",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "72.94",
            "markerNumModels": "9",
            "diseaseTerm": "Pneumocystosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:54251",
            "phenodigmScore": 50.26,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0030049 Brain abscess,HP:0100763 Abnormality of the lymphatic system,HP:0001903 Anemia,HP:0002733 Abnormality of the lymph nodes,HP:0001732 Abnormality of the pancreas,HP:0011897 Neutrophilia,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0100523 Liver abscess",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "32.7",
            "diseaseModelAvgRaw": "0.66",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.13",
            "diseaseModelMaxNorm": "67.82",
            "markerNumModels": "9",
            "diseaseTerm": "Corticosteroid-Sensitive Aseptic Abscess Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:79312",
            "phenodigmScore": 49.62,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001875 Neutropenia,HP:0001903 Anemia,HP:0001733 Pancreatitis,HP:0001744 Splenomegaly,HP:0001987 Hyperammonemia,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.94",
            "diseaseModelAvgRaw": "0.47",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "77.3",
            "markerNumModels": "9",
            "diseaseTerm": "Vitamin B12-Unresponsive Methylmalonic Acidemia Type Mut-",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:610377",
            "phenodigmScore": 55.07,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0006268 Fluctuating splenomegaly,HP:0001974 Leukocytosis,HP:0410246 Increased circulating IgD level,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0001272 Cerebellar atrophy,HP:0004819 Normocytic hypoplastic anemia,HP:0003236 Elevated circulating creatine kinase concentration,HP:0002716 Lymphadenopathy,HP:0002719 Recurrent infections,HP:0001903 Anemia,HP:0006564 Fluctuating hepatomegaly,HP:0001433 Hepatosplenomegaly,HP:0000988 Skin rash,HP:0002059 Cerebral atrophy,HP:0001873 Thrombocytopenia,HP:0012282 Morbilliform rash",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "36.97",
            "diseaseModelAvgRaw": "0.77",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.2",
            "diseaseModelMaxNorm": "73.17",
            "markerNumModels": "9",
            "diseaseTerm": "Mevalonic Aciduria",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:91138",
            "phenodigmScore": 46.3,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001097 Keratoconjunctivitis sicca,HP:0002240 Hepatomegaly,HP:0100721 Mediastinal lymphadenopathy,HP:0100778 Cryoglobulinemia,HP:0001369 Arthritis,HP:0012224 Circulating immune complexes,HP:0001744 Splenomegaly,HP:0001392 Abnormality of the liver,HP:0006562 Viral hepatitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.15",
            "diseaseModelAvgRaw": "0.43",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "72.45",
            "markerNumModels": "9",
            "diseaseTerm": "Cryoglobulinemic Vasculitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:603903",
            "phenodigmScore": 45.285,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0001974 Leukocytosis,HP:0002240 Hepatomegaly,HP:0001640 Cardiomegaly,HP:0001081 Cholelithiasis,HP:0001744 Splenomegaly,HP:0008346 Increased red cell sickling tendency,HP:0001878 Hemolytic anemia,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "24.25",
            "diseaseModelAvgRaw": "0.57",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "66.32",
            "markerNumModels": "9",
            "diseaseTerm": "Sickle Cell Anemia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:242850",
            "phenodigmScore": 59.15,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0030151 Cholangitis,HP:0004429 Recurrent viral infections,HP:0004787 Fulminant hepatitis,HP:0002850 Decreased circulating total IgM",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "43.05",
            "diseaseModelAvgRaw": "1.06",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "75.25",
            "markerNumModels": "9",
            "diseaseTerm": "Immune Deficiency Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:185020",
            "phenodigmScore": 41.5,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004446 Stomatocytosis,HP:0001878 Hemolytic anemia,HP:0001923 Reticulocytosis,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "15.85",
            "diseaseModelAvgRaw": "0.43",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "67.15",
            "markerNumModels": "9",
            "diseaseTerm": "Cryohydrocytosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:614102",
            "phenodigmScore": 69.705,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010701 Abnormal immunoglobulin level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "49.91",
            "diseaseModelAvgRaw": "1.09",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.1",
            "diseaseModelMaxNorm": "89.5",
            "markerNumModels": "9",
            "diseaseTerm": "Immunoglobulin Kappa Light Chain Deficiency",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:420741",
            "phenodigmScore": 50.71,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002090 Pneumonia,HP:0002720 Decreased circulating IgA level,HP:0004315 Decreased circulating IgG level,HP:0011109 Chronic sinusitis,HP:0004429 Recurrent viral infections,HP:0001369 Arthritis,HP:0008940 Generalized lymphadenopathy,HP:0000388 Otitis media,HP:0006532 Recurrent pneumonia,HP:0006254 Elevated alpha-fetoprotein,HP:0002850 Decreased circulating total IgM,HP:0011108 Recurrent sinusitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "30.01",
            "diseaseModelAvgRaw": "0.67",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "71.41",
            "markerNumModels": "9",
            "diseaseTerm": "Riddle Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:331235",
            "phenodigmScore": 70.125,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0032170 Severe varicella zoster infection,HP:0033430 Non-infectious meningitis,HP:0005353 Recurrent herpes,HP:0001904 Neutropenia in presence of anti-neutropil antibodies,HP:0002716 Lymphadenopathy,HP:0100537 Fasciitis,HP:0002719 Recurrent infections,HP:0032261 Nontuberculous mycobacterial pulmonary infection,HP:0045080 Decreased proportion of CD3-positive T cells,HP:0100280 Crohn's disease,HP:0007499 Recurrent staphylococcal infections,HP:0002850 Decreased circulating total IgM,HP:0002205 Recurrent respiratory infections,HP:0003193 Allergic rhinitis,HP:0032262 Pulmonary tuberculosis,HP:0002840 Lymphadenitis,HP:0011109 Chronic sinusitis,HP:0012203 Onychomycosis,HP:0000010 Recurrent urinary tract infections,HP:0001973 Autoimmune thrombocytopenia,HP:0006532 Recurrent pneumonia,HP:0005415 Decreased proportion of CD8-positive T cells,HP:0001047 Atopic dermatitis,HP:0009098 Chronic oral candidiasis,HP:0000388 Otitis media,HP:0032275 Recurrent shingles,HP:0032169 Severe infection,HP:0012204 Recurrent vulvovaginal candidiasis,HP:0004798 Recurrent infection of the gastrointestinal tract,HP:0032140 Decreased specific antibody response to vaccination,HP:0002110 Bronchiectasis,HP:0002837 Recurrent bronchitis,HP:0030380 Decreased proportion of transitional B cells,HP:0000491 Keratitis,HP:0001287 Meningitis,HP:0002788 Recurrent upper respiratory tract infections,HP:0031047 Paraproteinemia,HP:0001370 Rheumatoid arthritis,HP:0011370 Recurrent cutaneous fungal infections,HP:0031691 Severe viral infection,HP:0032218 Decreased proportion of CD4-positive T cells,HP:0000872 Hashimoto thyroiditis,HP:0030757 Tooth abscess,HP:0011108 Recurrent sinusitis,HP:0031292 Cutaneous abscess",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "54.46",
            "diseaseModelAvgRaw": "1.13",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.65",
            "diseaseModelMaxNorm": "85.79",
            "markerNumModels": "9",
            "diseaseTerm": "Selective Igm Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:209004",
            "phenodigmScore": 68.83,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0005508 Monoclonal immunoglobulin M proteinemia,HP:0025346 Increased circulating beta-2-microglobulin level,HP:0100778 Cryoglobulinemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "37.66",
            "diseaseModelAvgRaw": "0.62",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.47",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Axonal Polyneuropathy Associated With Igg/Igm/Iga Monoclonal Gammopathy",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:37748",
            "phenodigmScore": 69.635,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0002240 Hepatomegaly,HP:0002716 Lymphadenopathy,HP:0001903 Anemia,HP:0001369 Arthritis,HP:0001744 Splenomegaly,HP:0003496 Increased circulating IgM level,HP:0000988 Skin rash",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "42.62",
            "diseaseModelAvgRaw": "0.88",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "96.65",
            "markerNumModels": "9",
            "diseaseTerm": "Schnitzler Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:79277",
            "phenodigmScore": 43.455,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001878 Hemolytic anemia,HP:0020181 Reduced haptoglobin level,HP:0500046 Seborrhoeic blepharitis,HP:0008282 Unconjugated hyperbilirubinemia,HP:0001882 Leukopenia,HP:0012132 Erythroid hyperplasia,HP:0001744 Splenomegaly,HP:0011273 Anisocytosis,HP:0005406 Recurrent bacterial skin infections,HP:0100532 Scleritis,HP:0004447 Poikilocytosis,HP:0001923 Reticulocytosis,HP:0001873 Thrombocytopenia,HP:0012187 Increased erythrocyte protoporphyrin concentration,HP:0001096 Keratoconjunctivitis,HP:0010472 Abnormal circulating porphyrin concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "22.34",
            "diseaseModelAvgRaw": "0.51",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "64.57",
            "markerNumModels": "9",
            "diseaseTerm": "Congenital Erythropoietic Porphyria",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:619472",
            "phenodigmScore": 43.519999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001047 Atopic dermatitis,HP:0000964 Eczema,HP:0002720 Decreased circulating IgA level,HP:0001667 Right ventricular hypertrophy,HP:0003237 Increased circulating IgG level,HP:0005231 Chronic gastritis,HP:0003212 Increased circulating IgE level,HP:0032061 Hypereosinophilia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "10.8",
            "diseaseModelAvgRaw": "0.25",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.6",
            "diseaseModelMaxNorm": "76.24",
            "markerNumModels": "9",
            "diseaseTerm": "Viss Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:267700",
            "phenodigmScore": 64.895,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002902 Hyponatremia,HP:0003075 Hypoproteinemia,HP:0003233 Decreased HDL cholesterol concentration,HP:0002383 Infectious encephalitis,HP:0002240 Hepatomegaly,HP:0001882 Leukopenia,HP:0003141 Increased LDL cholesterol concentration,HP:0002716 Lymphadenopathy,HP:0003362 Increased VLDL cholesterol concentration,HP:0001903 Anemia,HP:0003573 Increased total bilirubin,HP:0001744 Splenomegaly,HP:0001287 Meningitis,HP:0003281 Increased circulating ferritin concentration,HP:0002155 Hypertriglyceridemia,HP:0003073 Hypoalbuminemia,HP:0001873 Thrombocytopenia,HP:0012156 Hemophagocytosis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "37.01",
            "diseaseModelAvgRaw": "0.81",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "92.78",
            "markerNumModels": "9",
            "diseaseTerm": "Hemophagocytic Lymphohistiocytosis, Familial, 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:224100",
            "phenodigmScore": 45.745,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010972 Anemia of inadequate production,HP:0001081 Cholelithiasis,HP:0001744 Splenomegaly,HP:0001923 Reticulocytosis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "16.72",
            "diseaseModelAvgRaw": "0.41",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "74.77",
            "markerNumModels": "9",
            "diseaseTerm": "Anemia, Congenital Dyserythropoietic, Type Ii",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:235500",
            "phenodigmScore": 64.17,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002720 Decreased circulating IgA level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "47.29",
            "diseaseModelAvgRaw": "1.31",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "81.05",
            "markerNumModels": "9",
            "diseaseTerm": "Hemosiderosis, Pulmonary, With Deficiency Of Gamma-A Globulin",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:238600",
            "phenodigmScore": 44.25,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003077 Hyperlipidemia,HP:0001733 Pancreatitis,HP:0031028 Lactescent serum,HP:0001744 Splenomegaly,HP:0003124 Hypercholesterolemia,HP:0000952 Jaundice,HP:0001433 Hepatosplenomegaly,HP:0012238 Increased circulating chylomicron concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "25.94",
            "diseaseModelAvgRaw": "0.61",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "62.56",
            "markerNumModels": "9",
            "diseaseTerm": "Hyperlipoproteinemia, Type I",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:257200",
            "phenodigmScore": 46.17,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001541 Ascites,HP:0002716 Lymphadenopathy,HP:0004333 Bone-marrow foam cells,HP:0001744 Splenomegaly,HP:0001935 Microcytic anemia,HP:0006579 Prolonged neonatal jaundice,HP:0002205 Recurrent respiratory infections,HP:0001982 Sea-blue histiocytosis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.8",
            "diseaseModelAvgRaw": "0.41",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "73.54",
            "markerNumModels": "9",
            "diseaseTerm": "Niemann-Pick Disease, Type A",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:166700",
            "phenodigmScore": 67.205,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001387 Joint stiffness,HP:0010739 Osteopoikilosis,HP:0001371 Flexion contracture",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "56.53",
            "diseaseModelAvgRaw": "1.06",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.93",
            "diseaseModelMaxNorm": "77.88",
            "markerNumModels": "9",
            "diseaseTerm": "Buschke-Ollendorff Syndrome",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "ORPHA:84064",
            "phenodigmScore": 47.9,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0011031 Abnormality of iron homeostasis,HP:0011877 Increased mean platelet volume,HP:0001894 Thrombocytosis,HP:0001395 Hepatic fibrosis,HP:0000778 Hypoplasia of the thymus,HP:0002719 Recurrent infections,HP:0002884 Hepatoblastoma,HP:0001744 Splenomegaly,HP:0005263 Gastritis,HP:0001394 Cirrhosis,HP:0001392 Abnormality of the liver,HP:0003139 Panhypogammaglobulinemia,HP:0001888 Lymphopenia,HP:0002583 Colitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "28.2",
            "diseaseModelAvgRaw": "0.66",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "67.6",
            "markerNumModels": "9",
            "diseaseTerm": "Syndromic Diarrhea",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:610798",
            "phenodigmScore": 66.42,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0006538 Recurrent bronchopulmonary infections,HP:0001875 Neutropenia,HP:0002850 Decreased circulating total IgM",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "47.41",
            "diseaseModelAvgRaw": "1.01",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "85.43",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency Due To Defect In Mapbp-Interacting Protein",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618982",
            "phenodigmScore": 83.09,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012302 Herpes simplex encephalitis,HP:0005404 Increased B cell count,HP:0032184 Increased proportion of memory T cells,HP:0002110 Bronchiectasis,HP:0002716 Lymphadenopathy,HP:0000403 Recurrent otitis media,HP:0002719 Recurrent infections,HP:0003237 Increased circulating IgG level,HP:0003212 Increased circulating IgE level,HP:0001433 Hepatosplenomegaly,HP:0032163 Molluscum contagiosum",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "68.06",
            "diseaseModelAvgRaw": "1.54",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.7",
            "diseaseModelMaxNorm": "98.12",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 72 With Autoinflammation",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618963",
            "phenodigmScore": 60.129999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0001974 Leukocytosis,HP:0020087 BCGosis,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0003281 Increased circulating ferritin concentration,HP:0001433 Hepatosplenomegaly,HP:0000988 Skin rash,HP:0001876 Pancytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "43.18",
            "diseaseModelAvgRaw": "0.92",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "77.08",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 69",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613313",
            "phenodigmScore": 52.144999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003452 Increased serum iron,HP:0002240 Hepatomegaly,HP:0001395 Hepatic fibrosis,HP:0001903 Anemia,HP:0012463 Elevated transferrin saturation,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0003281 Increased circulating ferritin concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "24.18",
            "diseaseModelAvgRaw": "0.56",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "80.11",
            "markerNumModels": "9",
            "diseaseTerm": "Hemochromatosis, Type 2B",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618048",
            "phenodigmScore": 63.56,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002716 Lymphadenopathy,HP:0002719 Recurrent infections,HP:0010702 Increased circulating antibody level,HP:0000988 Skin rash,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "47.08",
            "diseaseModelAvgRaw": "1.0",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "80.04",
            "markerNumModels": "9",
            "diseaseTerm": "Proteasome-Associated Autoinflammatory Syndrome 2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:731",
            "phenodigmScore": 42.985,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0011040 Abnormality of the intrahepatic bile duct,HP:0030151 Cholangitis,HP:0030153 Cholangiocarcinoma,HP:0001744 Splenomegaly,HP:0006560 Biliary hyperplasia,HP:0001433 Hepatosplenomegaly,HP:0001971 Hypersplenism,HP:0001409 Portal hypertension,HP:0000952 Jaundice,HP:0002902 Hyponatremia,HP:0001395 Hepatic fibrosis,HP:0002612 Congenital hepatic fibrosis,HP:0000010 Recurrent urinary tract infections,HP:0006532 Recurrent pneumonia,HP:0001396 Cholestasis,HP:0001405 Periportal fibrosis,HP:0001737 Pancreatic cysts,HP:0012202 Increased serum bile acid concentration,HP:0001541 Ascites,HP:0002884 Hepatoblastoma,HP:0001873 Thrombocytopenia,HP:0000105 Enlarged kidney",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.0",
            "diseaseModelAvgRaw": "0.51",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "64.97",
            "markerNumModels": "9",
            "diseaseTerm": "Autosomal Recessive Polycystic Kidney Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:602450",
            "phenodigmScore": 54.375,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0030813 Absent tonsils,HP:0002090 Pneumonia,HP:0002732 Lymph node hypoplasia,HP:0005359 Aplasia of the thymus,HP:0002788 Recurrent upper respiratory tract infections,HP:0000388 Otitis media,HP:0003139 Panhypogammaglobulinemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "47.08",
            "diseaseModelAvgRaw": "0.99",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "1.98",
            "diseaseModelMaxNorm": "61.67",
            "markerNumModels": "9",
            "diseaseTerm": "Severe Combined Immunodeficiency With Sensitivity To Ionizing Radiation",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:31204",
            "phenodigmScore": 54.809999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0030049 Brain abscess,HP:0100806 Sepsis,HP:0002383 Infectious encephalitis,HP:0001701 Pericarditis,HP:0002090 Pneumonia,HP:0100584 Endocarditis,HP:0002840 Lymphadenitis,HP:0002586 Peritonitis,HP:0002754 Osteomyelitis,HP:0000491 Keratitis,HP:0001287 Meningitis,HP:0100523 Liver abscess,HP:0100646 Thyroiditis,HP:0100532 Scleritis,HP:0011450 Unusual CNS infection,HP:0032169 Severe infection,HP:0031292 Cutaneous abscess,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "24.99",
            "diseaseModelAvgRaw": "0.56",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "84.63",
            "markerNumModels": "9",
            "diseaseTerm": "Nocardiosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:2177",
            "phenodigmScore": 37.905,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001287 Meningitis,HP:0002120 Cerebral cortical atrophy",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "8.76",
            "diseaseModelAvgRaw": "0.19",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0003224 neuron degeneration,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "67.05",
            "markerNumModels": "9",
            "diseaseTerm": "Hydranencephaly",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:250500",
            "phenodigmScore": 69.89,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0011001 Increased bone mineral density",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "62.08",
            "diseaseModelAvgRaw": "1.37",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.99",
            "diseaseModelMaxNorm": "77.7",
            "markerNumModels": "9",
            "diseaseTerm": "Metaphyseal Modeling Abnormality, Skin Lesions, And Spastic Paraplegia",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "ORPHA:331206",
            "phenodigmScore": 65.485,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010975 Abnormal B cell count,HP:0004313 Decreased circulating antibody level,HP:0200117 Recurrent upper and lower respiratory tract infections,HP:0031402 Reduced antigen-specific T cell proliferation,HP:0045080 Decreased proportion of CD3-positive T cells,HP:0001433 Hepatosplenomegaly,HP:0011839 Abnormal T cell count,HP:0002850 Decreased circulating total IgM,HP:0001880 Eosinophilia,HP:0001890 Autoimmune hemolytic anemia,HP:0002840 Lymphadenitis,HP:0002841 Recurrent fungal infections,HP:0000988 Skin rash,HP:0001888 Lymphopenia,HP:0002240 Hepatomegaly,HP:0002720 Decreased circulating IgA level,HP:0031381 Decreased lymphocyte proliferation in response to mitogen,HP:0002743 Recurrent enteroviral infections,HP:0002718 Recurrent bacterial infections,HP:0004315 Decreased circulating IgG level,HP:0004429 Recurrent viral infections,HP:0001873 Thrombocytopenia,HP:0040089 Abnormal natural killer cell count",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "56.52",
            "diseaseModelAvgRaw": "1.28",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "74.45",
            "markerNumModels": "9",
            "diseaseTerm": "Severe Combined Immunodeficiency Due To Complete Rag1/2 Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:241520",
            "phenodigmScore": 58.36,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001363 Craniosynostosis,HP:0011001 Increased bone mineral density,HP:0004912 Hypophosphatemic rickets,HP:0002748 Rickets",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "48.46",
            "diseaseModelAvgRaw": "1.24",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.99",
            "diseaseModelMaxNorm": "68.26",
            "markerNumModels": "9",
            "diseaseTerm": "Hypophosphatemic Rickets, Autosomal Recessive, 1",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "ORPHA:100026",
            "phenodigmScore": 48.125,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002716 Lymphadenopathy,HP:0004332 Abnormal lymphocyte morphology,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0001973 Autoimmune thrombocytopenia,HP:0001370 Rheumatoid arthritis,HP:0000988 Skin rash,HP:0001873 Thrombocytopenia,HP:0002205 Recurrent respiratory infections,HP:0001890 Autoimmune hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "27.98",
            "diseaseModelAvgRaw": "0.63",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "68.27",
            "markerNumModels": "9",
            "diseaseTerm": "Gamma-Heavy Chain Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:31205",
            "phenodigmScore": 47.535000000000004,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0100806 Sepsis,HP:0001701 Pericarditis,HP:0200039 Pustule,HP:0100584 Endocarditis,HP:0002840 Lymphadenitis,HP:0040313 Oligoarthritis,HP:0001903 Anemia,HP:0001369 Arthritis,HP:0003095 Septic arthritis,HP:0011850 Parotitis,HP:0001733 Pancreatitis,HP:0001287 Meningitis,HP:0025181 Abdominal aseptic abscess,HP:0040186 Maculopapular exanthema,HP:0000988 Skin rash,HP:0012282 Morbilliform rash,HP:0012219 Erythema nodosum",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "27.01",
            "diseaseModelAvgRaw": "0.6",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "68.06",
            "markerNumModels": "9",
            "diseaseTerm": "Rat-Bite Fever",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:2571",
            "phenodigmScore": 58.2,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002205 Recurrent respiratory infections,HP:0008348 Decreased circulating IgG2 level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "32.42",
            "diseaseModelAvgRaw": "0.69",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "83.98",
            "markerNumModels": "9",
            "diseaseTerm": "X-Linked Immunoneurologic Disorder",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:608106",
            "phenodigmScore": 75.68,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0002720 Decreased circulating IgA level,HP:0002716 Lymphadenopathy,HP:0004315 Decreased circulating IgG level,HP:0000031 Epididymitis,HP:0200117 Recurrent upper and lower respiratory tract infections,HP:0003496 Increased circulating IgM level,HP:0002959 Impaired Ig class switch recombination",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "54.33",
            "diseaseModelAvgRaw": "1.25",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "97.03",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency With Hyper-Igm, Type 5",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:215250",
            "phenodigmScore": 54.49,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002720 Decreased circulating IgA level,HP:0002843 Abnormal T cell morphology",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "36.25",
            "diseaseModelAvgRaw": "0.83",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "72.73",
            "markerNumModels": "9",
            "diseaseTerm": "Chondroitin-6-Sulfaturia, Defective Cellular Immunity, Nephrotic Syndrome",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:616050",
            "phenodigmScore": 61.345,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia,HP:0012178 Reduced natural killer cell activity,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0001287 Meningitis,HP:0003281 Increased circulating ferritin concentration,HP:0040218 Reduced natural killer cell count,HP:0000988 Skin rash,HP:0004387 Enterocolitis,HP:0001876 Pancytopenia,HP:0001873 Thrombocytopenia,HP:0011227 Elevated circulating C-reactive protein concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "43.47",
            "diseaseModelAvgRaw": "0.93",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "79.22",
            "markerNumModels": "9",
            "diseaseTerm": "Autoinflammation With Infantile Enterocolitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613796",
            "phenodigmScore": 62.74,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012302 Herpes simplex encephalitis,HP:0004429 Recurrent viral infections,HP:0011274 Recurrent mycobacterial infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "25.48",
            "diseaseModelAvgRaw": "0.59",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0006082 CNS inflammation",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.7",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 31B",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:288",
            "phenodigmScore": 45.35,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004804 Congenital hemolytic anemia,HP:0003265 Neonatal hyperbilirubinemia,HP:0004446 Stomatocytosis,HP:0002904 Hyperbilirubinemia,HP:0001081 Cholelithiasis,HP:0001744 Splenomegaly,HP:0000952 Jaundice,HP:0004447 Poikilocytosis,HP:0001923 Reticulocytosis,HP:0006579 Prolonged neonatal jaundice,HP:0001877 Abnormal erythrocyte morphology,HP:0001878 Hemolytic anemia,HP:0004445 Elliptocytosis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.55",
            "diseaseModelAvgRaw": "0.56",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "67.15",
            "markerNumModels": "9",
            "diseaseTerm": "Hereditary Elliptocytosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:90039",
            "phenodigmScore": 51.98,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0011907 Reduced alpha/beta synthesis ratio,HP:0005560 Imbalanced hemoglobin synthesis,HP:0030058 Sickled erythrocytes,HP:0001903 Anemia,HP:0011902 Abnormal hemoglobin,HP:0001744 Splenomegaly,HP:0011906 Reduced beta/alpha synthesis ratio,HP:0045047 HbS hemoglobin,HP:0011905 Reduced hemoglobin A,HP:0025066 Decreased mean corpuscular volume,HP:0025547 Decreased mean corpuscular hemoglobin concentration,HP:0045048 Increased HbA2 hemoglobin",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.89",
            "diseaseModelAvgRaw": "0.5",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "82.07",
            "markerNumModels": "9",
            "diseaseTerm": "Hemoglobin D Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615615",
            "phenodigmScore": 74.44,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0030253 Defective T cell proliferation,HP:0000403 Recurrent otitis media,HP:0045080 Decreased proportion of CD3-positive T cells,HP:0001888 Lymphopenia,HP:0002205 Recurrent respiratory infections,HP:0031123 Recurrent gastroenteritis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "54.67",
            "diseaseModelAvgRaw": "1.06",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.07",
            "diseaseModelMaxNorm": "94.21",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 18",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:153600",
            "phenodigmScore": 73.45,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001909 Leukemia,HP:0005508 Monoclonal immunoglobulin M proteinemia,HP:0003347 Impaired lymphocyte transformation with phytohemagglutinin,HP:0003459 Polyclonal elevation of IgM",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "47.99",
            "diseaseModelAvgRaw": "1.06",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.64",
            "diseaseModelMaxNorm": "98.91",
            "markerNumModels": "9",
            "diseaseTerm": "Macroglobulinemia, Waldenstrom, Susceptibility To, 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:602390",
            "phenodigmScore": 51.405,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003452 Increased serum iron,HP:0002240 Hepatomegaly,HP:0001369 Arthritis,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0003281 Increased circulating ferritin concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "22.7",
            "diseaseModelAvgRaw": "0.53",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "80.11",
            "markerNumModels": "9",
            "diseaseTerm": "Hemochromatosis, Type 2A",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:277",
            "phenodigmScore": 68.735,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0011123 Inflammatory abnormality of the skin,HP:0010976 B lymphocytopenia,HP:0030813 Absent tonsils,HP:0005354 Lack of T cell function,HP:0005390 Recurrent opportunistic infections,HP:0000403 Recurrent otitis media,HP:0002849 Absence of lymph node germinal center,HP:0003212 Increased circulating IgE level,HP:0002788 Recurrent upper respiratory tract infections,HP:0006532 Recurrent pneumonia,HP:0001888 Lymphopenia,HP:0005403 T lymphocytopenia,HP:0005368 Abnormality of humoral immunity",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "56.19",
            "diseaseModelAvgRaw": "1.19",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "81.28",
            "markerNumModels": "9",
            "diseaseTerm": "Severe Combined Immunodeficiency Due To Adenosine Deaminase Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:248500",
            "phenodigmScore": 49.92,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0002240 Hepatomegaly,HP:0001272 Cerebellar atrophy,HP:0001922 Vacuolated lymphocytes,HP:0004313 Decreased circulating antibody level,HP:0001744 Splenomegaly,HP:0007371 Corpus callosum atrophy,HP:0002120 Cerebral cortical atrophy",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "27.15",
            "diseaseModelAvgRaw": "0.55",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "72.69",
            "markerNumModels": "9",
            "diseaseTerm": "Mannosidosis, Alpha B, Lysosomal",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:300861",
            "phenodigmScore": 58.12,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002720 Decreased circulating IgA level,HP:0004315 Decreased circulating IgG level,HP:0002850 Decreased circulating total IgM",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "35.19",
            "diseaseModelAvgRaw": "0.75",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "81.05",
            "markerNumModels": "9",
            "diseaseTerm": "Mental Retardation, X-Linked, Syndromic, Chudley-Schwartz Type",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:610163",
            "phenodigmScore": 73.75,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001019 Erythroderma,HP:0005353 Recurrent herpes,HP:0410295 Complete or near-complete absence of specific antibody response to tetanus vaccine,HP:0003261 Increased circulating IgA level,HP:0003237 Increased circulating IgG level,HP:0003212 Increased circulating IgE level,HP:0003496 Increased circulating IgM level,HP:0005401 Recurrent candida infections,HP:0006532 Recurrent pneumonia,HP:0001880 Eosinophilia,HP:0005403 T lymphocytopenia,HP:0008348 Decreased circulating IgG2 level,HP:0001890 Autoimmune hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "57.38",
            "diseaseModelAvgRaw": "1.38",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "90.12",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 25",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:610539",
            "phenodigmScore": 53.445,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0003146 Hypocholesterolemia,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0001971 Hypersplenism,HP:0001873 Thrombocytopenia,HP:0011813 Increased cerebral lipofuscin",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.99",
            "diseaseModelAvgRaw": "0.49",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "82.9",
            "markerNumModels": "9",
            "diseaseTerm": "Gaucher Disease, Atypical, Due To Saposin C Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:240500",
            "phenodigmScore": 68.32,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0002240 Hepatomegaly,HP:0002729 Follicular hyperplasia,HP:0005435 Impaired T cell function,HP:0002720 Decreased circulating IgA level,HP:0002110 Bronchiectasis,HP:0004315 Decreased circulating IgG level,HP:0002837 Recurrent bronchitis,HP:0000403 Recurrent otitis media,HP:0002716 Lymphadenopathy,HP:0001744 Splenomegaly,HP:0001287 Meningitis,HP:0410301 Partial absence of specific antibody response to unconjugated pneumococcus vaccine,HP:0006532 Recurrent pneumonia,HP:0011108 Recurrent sinusitis,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "53.8",
            "diseaseModelAvgRaw": "1.2",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "82.84",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency, Common Variable, 2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:178500",
            "phenodigmScore": 53.335,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001394 Cirrhosis,HP:0010702 Increased circulating antibody level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "25.8",
            "diseaseModelAvgRaw": "0.56",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "80.87",
            "markerNumModels": "9",
            "diseaseTerm": "Interstitial Lung Disease 2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:617394",
            "phenodigmScore": 43.665,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0001396 Cholestasis,HP:0002613 Biliary cirrhosis,HP:0001409 Portal hypertension,HP:0030991 Sclerosing cholangitis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.8",
            "diseaseModelAvgRaw": "0.47",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "68.53",
            "markerNumModels": "9",
            "diseaseTerm": "Sclerosing Cholangitis, Neonatal",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:439232",
            "phenodigmScore": 44.18000000000001,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003259 Elevated circulating creatinine concentration,HP:0031047 Paraproteinemia,HP:0003077 Hyperlipidemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "17.35",
            "diseaseModelAvgRaw": "0.39",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "71.01",
            "markerNumModels": "9",
            "diseaseTerm": "Aapoaiv Amyloidosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615607",
            "phenodigmScore": 67.86,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000964 Eczema,HP:0000403 Recurrent otitis media,HP:0005415 Decreased proportion of CD8-positive T cells,HP:0002205 Recurrent respiratory infections,HP:0031123 Recurrent gastroenteritis,HP:0001890 Autoimmune hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "35.72",
            "diseaseModelAvgRaw": "0.74",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.65",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 17",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615816",
            "phenodigmScore": 64.265,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000964 Eczema,HP:0032170 Severe varicella zoster infection,HP:0003193 Allergic rhinitis,HP:0001875 Neutropenia,HP:0001880 Eosinophilia,HP:0002110 Bronchiectasis,HP:0025615 Abscess,HP:0003237 Increased circulating IgG level,HP:0002728 Chronic mucocutaneous candidiasis,HP:0003212 Increased circulating IgE level,HP:0007499 Recurrent staphylococcal infections,HP:0003496 Increased circulating IgM level,HP:0001888 Lymphopenia,HP:0000793 Membranoproliferative glomerulonephritis,HP:0032163 Molluscum contagiosum,HP:0002205 Recurrent respiratory infections,HP:0001878 Hemolytic anemia,HP:0002726 Recurrent Staphylococcus aureus infections,HP:0020072 Persistent EBV viremia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "40.64",
            "diseaseModelAvgRaw": "0.91",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "87.89",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 23",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:567983",
            "phenodigmScore": 46.21,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001395 Hepatic fibrosis,HP:0003077 Hyperlipidemia,HP:0004359 Abnormal circulating fatty-acid concentration,HP:0011113 Abnormality of cytokine secretion,HP:0001081 Cholelithiasis,HP:0001744 Splenomegaly,HP:0006560 Biliary hyperplasia,HP:0001394 Cirrhosis,HP:0001397 Hepatic steatosis,HP:0002908 Conjugated hyperbilirubinemia,HP:0001409 Portal hypertension,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "27.45",
            "diseaseModelAvgRaw": "0.65",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "64.97",
            "markerNumModels": "9",
            "diseaseTerm": "Parenteral Nutrition-Associated Cholestasis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:126250",
            "phenodigmScore": 63.644999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0005464 Craniofacial osteosclerosis,HP:0100774 Hyperostosis,HP:0003034 Diaphyseal sclerosis",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "68.88",
            "diseaseModelAvgRaw": "1.63",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.67",
            "diseaseModelMaxNorm": "58.41",
            "markerNumModels": "9",
            "diseaseTerm": "Distal Osteosclerosis",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "ORPHA:163596",
            "phenodigmScore": 45.18,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001701 Pericarditis,HP:0001903 Anemia,HP:0011902 Abnormal hemoglobin,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "16.92",
            "diseaseModelAvgRaw": "0.41",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "73.44",
            "markerNumModels": "9",
            "diseaseTerm": "Hb Bart'S Hydrops Fetalis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:603553",
            "phenodigmScore": 67.2,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002902 Hyponatremia,HP:0003075 Hypoproteinemia,HP:0002240 Hepatomegaly,HP:0002383 Infectious encephalitis,HP:0001882 Leukopenia,HP:0002716 Lymphadenopathy,HP:0012178 Reduced natural killer cell activity,HP:0001903 Anemia,HP:0003573 Increased total bilirubin,HP:0001744 Splenomegaly,HP:0001287 Meningitis,HP:0003281 Increased circulating ferritin concentration,HP:0001433 Hepatosplenomegaly,HP:0000988 Skin rash,HP:0002155 Hypertriglyceridemia,HP:0003073 Hypoalbuminemia,HP:0001876 Pancytopenia,HP:0001873 Thrombocytopenia,HP:0012156 Hemophagocytosis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "41.62",
            "diseaseModelAvgRaw": "0.92",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "92.78",
            "markerNumModels": "9",
            "diseaseTerm": "Hemophagocytic Lymphohistiocytosis, Familial, 2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:1600",
            "phenodigmScore": 41.285000000000004,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002720 Decreased circulating IgA level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "9.37",
            "diseaseModelAvgRaw": "0.2",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "73.2",
            "markerNumModels": "9",
            "diseaseTerm": "Monosomy 18Q",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:824",
            "phenodigmScore": 46.754999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0002240 Hepatomegaly,HP:0001894 Thrombocytosis,HP:0002716 Lymphadenopathy,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0001433 Hepatosplenomegaly,HP:0004447 Poikilocytosis,HP:0001978 Extramedullary hematopoiesis,HP:0001876 Pancytopenia,HP:0001873 Thrombocytopenia,HP:0001409 Portal hypertension",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.88",
            "diseaseModelAvgRaw": "0.44",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "73.63",
            "markerNumModels": "9",
            "diseaseTerm": "Primary Myelofibrosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618108",
            "phenodigmScore": 60.5,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010976 B lymphocytopenia,HP:0002037 Inflammation of the large intestine,HP:0002110 Bronchiectasis,HP:0004313 Decreased circulating antibody level,HP:0005263 Gastritis,HP:0009789 Perianal abscess,HP:0040218 Reduced natural killer cell count,HP:0000988 Skin rash,HP:0410297 Partial absence of specific antibody response to tetanus vaccine,HP:0002205 Recurrent respiratory infections,HP:0005403 T lymphocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "51.66",
            "diseaseModelAvgRaw": "1.19",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.08",
            "diseaseModelMaxNorm": "69.34",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 57 With Autoinflammation",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:508533",
            "phenodigmScore": 55.525,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0004315 Decreased circulating IgG level,HP:0031381 Decreased lymphocyte proliferation in response to mitogen,HP:0004313 Decreased circulating antibody level,HP:0003212 Increased circulating IgE level,HP:0032061 Hypereosinophilia,HP:0006532 Recurrent pneumonia,HP:0001888 Lymphopenia,HP:0002850 Decreased circulating total IgM,HP:0005415 Decreased proportion of CD8-positive T cells,HP:0005407 Decreased proportion of CD4-positive helper T cells,HP:0005403 T lymphocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "22.3",
            "diseaseModelAvgRaw": "0.46",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.65",
            "diseaseModelMaxNorm": "88.75",
            "markerNumModels": "9",
            "diseaseTerm": "Skeletal Dysplasia-T-Cell Immunodeficiency-Developmental Delay Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:224120",
            "phenodigmScore": 46.69,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012132 Erythroid hyperplasia,HP:0001744 Splenomegaly,HP:0011273 Anisocytosis,HP:0004447 Poikilocytosis,HP:0001923 Reticulocytosis,HP:0006579 Prolonged neonatal jaundice,HP:0005532 Macrocytic dyserythropoietic anemia,HP:0010972 Anemia of inadequate production",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "17.6",
            "diseaseModelAvgRaw": "0.42",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "75.78",
            "markerNumModels": "9",
            "diseaseTerm": "Anemia, Congenital Dyserythropoietic, Type Ia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615207",
            "phenodigmScore": 53.83,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004798 Recurrent infection of the gastrointestinal tract,HP:0030151 Cholangitis,HP:0002110 Bronchiectasis,HP:0000403 Recurrent otitis media,HP:0002719 Recurrent infections,HP:0001394 Cirrhosis,HP:0003139 Panhypogammaglobulinemia,HP:0006532 Recurrent pneumonia,HP:0020102 Pneumocystis jirovecii pneumonia,HP:0200124 Chronic hepatitis due to cryptosporidium infection,HP:0002205 Recurrent respiratory infections,HP:0011108 Recurrent sinusitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "43.0",
            "diseaseModelAvgRaw": "0.99",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "1.98",
            "diseaseModelMaxNorm": "64.66",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 56",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:133180",
            "phenodigmScore": 49.595,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0012132 Erythroid hyperplasia,HP:0001909 Leukemia,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0004808 Acute myeloid leukemia,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.91",
            "diseaseModelAvgRaw": "0.49",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "77.28",
            "markerNumModels": "9",
            "diseaseTerm": "Erythroleukemia, Familial, Susceptibility To",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:170100",
            "phenodigmScore": 56.135,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0000964 Eczema,HP:0001873 Thrombocytopenia,HP:0002719 Recurrent infections,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0010702 Increased circulating antibody level,HP:0006532 Recurrent pneumonia,HP:0006579 Prolonged neonatal jaundice,HP:0007473 Crusting erythematous dermatitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "35.53",
            "diseaseModelAvgRaw": "0.76",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "76.74",
            "markerNumModels": "9",
            "diseaseTerm": "Prolidase Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:269600",
            "phenodigmScore": 50.42,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001394 Cirrhosis,HP:0001873 Thrombocytopenia,HP:0001982 Sea-blue histiocytosis,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.73",
            "diseaseModelAvgRaw": "0.46",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "80.11",
            "markerNumModels": "9",
            "diseaseTerm": "Sea-Blue Histiocyte Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:611943",
            "phenodigmScore": 54.675,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004315 Decreased circulating IgG level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "27.49",
            "diseaseModelAvgRaw": "0.59",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "81.86",
            "markerNumModels": "9",
            "diseaseTerm": "Riddle Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:608957",
            "phenodigmScore": 64.54,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0002110 Bronchiectasis,HP:0004429 Recurrent viral infections,HP:0005422 Absence of CD8-positive T cells,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "34.18",
            "diseaseModelAvgRaw": "0.8",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.61",
            "diseaseModelMaxNorm": "94.9",
            "markerNumModels": "9",
            "diseaseTerm": "Cd8 Deficiency, Familial",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:611881",
            "phenodigmScore": 43.665000000000006,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001897 Normocytic anemia,HP:0001895 Normochromic anemia,HP:0001081 Cholelithiasis,HP:0001744 Splenomegaly,HP:0001930 Nonspherocytic hemolytic anemia,HP:0001082 Cholecystitis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.04",
            "diseaseModelAvgRaw": "0.41",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "69.29",
            "markerNumModels": "9",
            "diseaseTerm": "Glycogen Storage Disease Xii",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615559",
            "phenodigmScore": 67.85,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002716 Lymphadenopathy,HP:0002719 Recurrent infections,HP:0001744 Splenomegaly,HP:0033207 Increased proportion autoreactive unresponsive CD21-/low B cells,HP:0001433 Hepatosplenomegaly,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0020072 Persistent EBV viremia,HP:0001890 Autoimmune hemolytic anemia,HP:0410293 Absent isohemagglutinin level,HP:0030388 Decreased proportion of class-switched memory B cells,HP:0012178 Reduced natural killer cell activity,HP:0002783 Recurrent lower respiratory tract infections,HP:0000010 Recurrent urinary tract infections,HP:0001973 Autoimmune thrombocytopenia,HP:0030374 Decreased proportion of memory B cells,HP:0002729 Follicular hyperplasia,HP:0002240 Hepatomegaly,HP:0100721 Mediastinal lymphadenopathy,HP:0012578 Membranous nephropathy,HP:0001369 Arthritis,HP:0008940 Generalized lymphadenopathy,HP:0005404 Increased B cell count,HP:0045042 Decreased serum complement C4,HP:0000403 Recurrent otitis media,HP:0010702 Increased circulating antibody level,HP:0002788 Recurrent upper respiratory tract infections,HP:0005421 Decreased serum complement C3,HP:0011108 Recurrent sinusitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "52.39",
            "diseaseModelAvgRaw": "1.09",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "83.31",
            "markerNumModels": "9",
            "diseaseTerm": "Autoimmune Lymphoproliferative Syndrome, Type Iii",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:319251",
            "phenodigmScore": 60.17,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002383 Infectious encephalitis,HP:0012115 Hepatitis,HP:0001903 Anemia,HP:0003237 Increased circulating IgG level,HP:0000554 Uveitis,HP:0003496 Increased circulating IgM level,HP:0000988 Skin rash,HP:0031691 Severe viral infection,HP:0001873 Thrombocytopenia,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "32.36",
            "diseaseModelAvgRaw": "0.7",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "87.98",
            "markerNumModels": "9",
            "diseaseTerm": "Rift Valley Fever",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:214500",
            "phenodigmScore": 51.505,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001875 Neutropenia,HP:0001882 Leukopenia,HP:0002716 Lymphadenopathy,HP:0002180 Neurodegeneration,HP:0002719 Recurrent infections,HP:0012484 Abnormal dense granules,HP:0032499 Giant neutrophil granules,HP:0001744 Splenomegaly,HP:0000704 Periodontitis,HP:0001903 Anemia,HP:0005406 Recurrent bacterial skin infections,HP:0011993 Impaired neutrophil bactericidal activity,HP:0005429 Recurrent systemic pyogenic infections,HP:0001873 Thrombocytopenia,HP:0012156 Hemophagocytosis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "32.72",
            "diseaseModelAvgRaw": "0.74",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "70.29",
            "markerNumModels": "9",
            "diseaseTerm": "Chediak-Higashi Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:247630",
            "phenodigmScore": 74.66499999999999,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002843 Abnormal T cell morphology,HP:0004315 Decreased circulating IgG level,HP:0001888 Lymphopenia,HP:0002850 Decreased circulating total IgM",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "66.25",
            "diseaseModelAvgRaw": "1.53",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "83.08",
            "markerNumModels": "9",
            "diseaseTerm": "Lymphoid System Deterioration, Progressive",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:242870",
            "phenodigmScore": 76.65,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0004315 Decreased circulating IgG level,HP:0005403 T lymphocytopenia,HP:0005401 Recurrent candida infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "58.77",
            "diseaseModelAvgRaw": "1.3",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "94.53",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency, Partial Combined, With Absence Of Hla Determinants And Beta-2-Microglobulin From Lymphocytes",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615934",
            "phenodigmScore": 64.37,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0200039 Pustule,HP:0001882 Leukopenia,HP:0100614 Myositis,HP:0003261 Increased circulating IgA level,HP:0033280 Paratracheal lymphadenopathy,HP:0002719 Recurrent infections,HP:0003237 Increased circulating IgG level,HP:0001903 Anemia,HP:0025300 Malar rash,HP:0000988 Skin rash,HP:0033605 Pustular rash,HP:0001888 Lymphopenia,HP:0002205 Recurrent respiratory infections,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0002729 Follicular hyperplasia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "40.88",
            "diseaseModelAvgRaw": "0.9",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.6",
            "diseaseModelMaxNorm": "87.86",
            "markerNumModels": "9",
            "diseaseTerm": "Sting-Associated Vasculopathy, Infantile-Onset",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:166740",
            "phenodigmScore": 53.6,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0005791 Cortical thickening of long bone diaphyses,HP:0002757 Recurrent fractures,HP:0011001 Increased bone mineral density",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "39.42",
            "diseaseModelAvgRaw": "0.98",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.99",
            "diseaseModelMaxNorm": "67.78",
            "markerNumModels": "9",
            "diseaseTerm": "Osteosclerosis With Ichthyosis And Fractures",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "ORPHA:37042",
            "phenodigmScore": 56.11,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0000964 Eczema,HP:0031085 Decreased prealbumin level,HP:0001970 Tubulointerstitial nephritis,HP:0001875 Neutropenia,HP:0001904 Neutropenia in presence of anti-neutropil antibodies,HP:0002716 Lymphadenopathy,HP:0012115 Hepatitis,HP:0002719 Recurrent infections,HP:0001744 Splenomegaly,HP:0005263 Gastritis,HP:0002205 Recurrent respiratory infections,HP:0003111 Abnormal blood ion concentration,HP:0011123 Inflammatory abnormality of the skin,HP:0001890 Autoimmune hemolytic anemia,HP:0002754 Osteomyelitis,HP:0001973 Autoimmune thrombocytopenia,HP:0003073 Hypoalbuminemia,HP:0002090 Pneumonia,HP:0001891 Iron deficiency anemia,HP:0012578 Membranous nephropathy,HP:0002917 Hypomagnesemia,HP:0002901 Hypocalcemia,HP:0031401 Reduced proportion of CD4-negative\\, CD8-negative\\, alpha-beta regulatory T cells,HP:0007473 Crusting erythematous dermatitis,HP:0031123 Recurrent gastroenteritis,HP:0000976 Eczematoid dermatitis,HP:0003765 Psoriasiform dermatitis,HP:0006515 Interstitial pneumonitis,HP:0100614 Myositis,HP:0003212 Increased circulating IgE level,HP:0001287 Meningitis,HP:0001581 Recurrent skin infections,HP:0100646 Thyroiditis,HP:0002583 Colitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "40.0",
            "diseaseModelAvgRaw": "0.95",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "72.22",
            "markerNumModels": "9",
            "diseaseTerm": "Immune Dysregulation-Polyendocrinopathy-Enteropathy-X-Linked Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:369837",
            "phenodigmScore": 44.135,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003072 Hypercalcemia,HP:0001272 Cerebellar atrophy,HP:0002720 Decreased circulating IgA level,HP:0002283 Global brain atrophy,HP:0002155 Hypertriglyceridemia,HP:0002850 Decreased circulating total IgM",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "12.41",
            "diseaseModelAvgRaw": "0.27",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "75.86",
            "markerNumModels": "9",
            "diseaseTerm": "Intellectual Disability-Seizures-Hypophosphatasia-Ophthalmic-Skeletal Anomalies Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:278000",
            "phenodigmScore": 48.255,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0003233 Decreased HDL cholesterol concentration,HP:0031141 Increased hepatic echogenicity,HP:0001395 Hepatic fibrosis,HP:0001882 Leukopenia,HP:0003141 Increased LDL cholesterol concentration,HP:0004333 Bone-marrow foam cells,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0003124 Hypercholesterolemia,HP:0001394 Cirrhosis,HP:0001433 Hepatosplenomegaly,HP:0001971 Hypersplenism,HP:0001397 Hepatic steatosis,HP:0002155 Hypertriglyceridemia,HP:0012852 Hepatic bridging fibrosis,HP:0001873 Thrombocytopenia,HP:0001409 Portal hypertension,HP:0001405 Periportal fibrosis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.84",
            "diseaseModelAvgRaw": "0.55",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "72.67",
            "markerNumModels": "9",
            "diseaseTerm": "Lysosomal Acid Lipase Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:330015",
            "phenodigmScore": 47.445,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002843 Abnormal T cell morphology,HP:0005560 Imbalanced hemoglobin synthesis,HP:0003233 Decreased HDL cholesterol concentration,HP:0001970 Tubulointerstitial nephritis,HP:0003141 Increased LDL cholesterol concentration,HP:0001903 Anemia,HP:0003212 Increased circulating IgE level,HP:0000988 Skin rash,HP:0005368 Abnormality of humoral immunity",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.47",
            "diseaseModelAvgRaw": "0.43",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "74.42",
            "markerNumModels": "9",
            "diseaseTerm": "Lead Poisoning",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:1117",
            "phenodigmScore": 43.620000000000005,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001287 Meningitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "10.81",
            "diseaseModelAvgRaw": "0.23",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "76.43",
            "markerNumModels": "9",
            "diseaseTerm": "Aplasia Cutis-Myopia Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:545",
            "phenodigmScore": 51.30500000000001,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100721 Mediastinal lymphadenopathy,HP:0002716 Lymphadenopathy,HP:0002585 Abnormality of the peritoneum,HP:0001744 Splenomegaly,HP:0001287 Meningitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "22.85",
            "diseaseModelAvgRaw": "0.49",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "79.76",
            "markerNumModels": "9",
            "diseaseTerm": "Follicular Lymphoma",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:32960",
            "phenodigmScore": 47.435,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0001701 Pericarditis,HP:0002586 Peritonitis,HP:0100614 Myositis,HP:0002716 Lymphadenopathy,HP:0100537 Fasciitis,HP:0001369 Arthritis,HP:0001744 Splenomegaly,HP:0000554 Uveitis,HP:0000988 Skin rash,HP:0100776 Recurrent pharyngitis,HP:0100796 Orchitis,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0001055 Erysipelas,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "29.23",
            "diseaseModelAvgRaw": "0.63",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "65.64",
            "markerNumModels": "9",
            "diseaseTerm": "Tumor Necrosis Factor Receptor 1 Associated Periodic Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:233650",
            "phenodigmScore": 70.65,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010976 B lymphocytopenia,HP:0004315 Decreased circulating IgG level,HP:0002205 Recurrent respiratory infections,HP:0005403 T lymphocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "57.29",
            "diseaseModelAvgRaw": "1.29",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "84.01",
            "markerNumModels": "9",
            "diseaseTerm": "Combined Cellular And Humoral Immune Defects With Granulomas",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:2133",
            "phenodigmScore": 45.215,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0032231 Hypochromia,HP:0004840 Hypochromic microcytic anemia,HP:0020059 Increased red blood cell count,HP:0011902 Abnormal hemoglobin,HP:0001744 Splenomegaly,HP:0011905 Reduced hemoglobin A,HP:0025066 Decreased mean corpuscular volume,HP:0004817 Drug-sensitive hemolytic anemia,HP:0010972 Anemia of inadequate production",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.84",
            "diseaseModelAvgRaw": "0.44",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "71.59",
            "markerNumModels": "9",
            "diseaseTerm": "Hemoglobin E Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:2348",
            "phenodigmScore": 46.115,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0005339 Abnormality of complement system,HP:0001733 Pancreatitis,HP:0001744 Splenomegaly,HP:0001397 Hepatic steatosis,HP:0002155 Hypertriglyceridemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "17.61",
            "diseaseModelAvgRaw": "0.39",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "74.62",
            "markerNumModels": "9",
            "diseaseTerm": "Familial Partial Lipodystrophy, Dunnigan Type",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615592",
            "phenodigmScore": 61.56,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004313 Decreased circulating antibody level,HP:0004432 Agammaglobulinemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "49.6",
            "diseaseModelAvgRaw": "1.07",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.07",
            "diseaseModelMaxNorm": "73.52",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 15B",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:260470",
            "phenodigmScore": 58.315,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002383 Infectious encephalitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "16.63",
            "diseaseModelAvgRaw": "0.47",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0006082 CNS inflammation",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Subacute Sclerosing Panencephalitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:607594",
            "phenodigmScore": 70.1,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0010976 B lymphocytopenia,HP:0002240 Hepatomegaly,HP:0030388 Decreased proportion of class-switched memory B cells,HP:0002090 Pneumonia,HP:0005435 Impaired T cell function,HP:0002720 Decreased circulating IgA level,HP:0002110 Bronchiectasis,HP:0004315 Decreased circulating IgG level,HP:0002837 Recurrent bronchitis,HP:0000403 Recurrent otitis media,HP:0001904 Neutropenia in presence of anti-neutropil antibodies,HP:0002716 Lymphadenopathy,HP:0001744 Splenomegaly,HP:0006532 Recurrent pneumonia,HP:0002850 Decreased circulating total IgM,HP:0011108 Recurrent sinusitis,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "56.87",
            "diseaseModelAvgRaw": "1.33",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "83.33",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency, Common Variable, 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:79314",
            "phenodigmScore": 59.235,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002383 Infectious encephalitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.47",
            "diseaseModelAvgRaw": "0.35",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0006082 CNS inflammation",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "L-2-Hydroxyglutaric Aciduria",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:231401",
            "phenodigmScore": 47.465,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001875 Neutropenia,HP:0002488 Acute leukemia,HP:0001744 Splenomegaly,HP:0001935 Microcytic anemia,HP:0001873 Thrombocytopenia,HP:0011903 HbH hemoglobin",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.04",
            "diseaseModelAvgRaw": "0.43",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "75.89",
            "markerNumModels": "9",
            "diseaseTerm": "Alpha-Thalassemia-Myelodysplastic Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:223370",
            "phenodigmScore": 47.45,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000964 Eczema,HP:0006721 Acute lymphoblastic leukemia,HP:0002720 Decreased circulating IgA level,HP:0004315 Decreased circulating IgG level,HP:0002719 Recurrent infections,HP:0000388 Otitis media,HP:0001915 Aplastic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.11",
            "diseaseModelAvgRaw": "0.45",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "73.79",
            "markerNumModels": "9",
            "diseaseTerm": "Dubowitz Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:241600",
            "phenodigmScore": 58.214999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia,HP:0002110 Bronchiectasis,HP:0004315 Decreased circulating IgG level,HP:0003073 Hypoalbuminemia,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "39.72",
            "diseaseModelAvgRaw": "1.03",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "76.71",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 43",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:169105",
            "phenodigmScore": 52.83,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0100721 Mediastinal lymphadenopathy,HP:0002110 Bronchiectasis,HP:0004313 Decreased circulating antibody level,HP:0001903 Anemia,HP:0000010 Recurrent urinary tract infections,HP:0001581 Recurrent skin infections,HP:0100522 Thymoma,HP:0010515 Aplasia/Hypoplasia of the thymus,HP:0001873 Thrombocytopenia,HP:0002205 Recurrent respiratory infections,HP:0001881 Abnormal leukocyte morphology",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "44.34",
            "diseaseModelAvgRaw": "0.99",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.01",
            "diseaseModelMaxNorm": "61.32",
            "markerNumModels": "9",
            "diseaseTerm": "Good Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:73",
            "phenodigmScore": 44.495000000000005,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001287 Meningitis,HP:0100764 Lymphangioma,HP:0002754 Osteomyelitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "10.71",
            "diseaseModelAvgRaw": "0.22",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "78.28",
            "markerNumModels": "9",
            "diseaseTerm": "Gorham-Stout Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:449395",
            "phenodigmScore": 56.995000000000005,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001970 Tubulointerstitial nephritis,HP:0002716 Lymphadenopathy,HP:0001880 Eosinophilia,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0032298 Increased circulating IgG1 level,HP:0011123 Inflammatory abnormality of the skin,HP:0001701 Pericarditis,HP:0002840 Lymphadenitis,HP:0005200 Retroperitoneal fibrosis,HP:0011109 Chronic sinusitis,HP:0012089 Arteritis,HP:0001082 Cholecystitis,HP:0100577 Urinary bladder inflammation,HP:0012578 Membranous nephropathy,HP:0030991 Sclerosing cholangitis,HP:0100016 Abnormality of mesentery morphology,HP:0006515 Interstitial pneumonitis,HP:0000024 Prostatitis,HP:0045042 Decreased serum complement C4,HP:0003259 Elevated circulating creatinine concentration,HP:0032300 Increased circulating IgG4 level,HP:0003237 Increased circulating IgG level,HP:0001733 Pancreatitis,HP:0004431 Complement deficiency,HP:0003212 Increased circulating IgE level,HP:0001287 Meningitis,HP:0100646 Thyroiditis,HP:0005421 Decreased serum complement C3,HP:0031032 Decreased retinol-binding protein level,HP:0000105 Enlarged kidney",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "34.93",
            "diseaseModelAvgRaw": "0.84",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.6",
            "diseaseModelMaxNorm": "79.06",
            "markerNumModels": "9",
            "diseaseTerm": "Igg4-Related Kidney Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:300853",
            "phenodigmScore": 72.065,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0032204 Chronic active Epstein-Barr virus infection,HP:0032170 Severe varicella zoster infection,HP:0100721 Mediastinal lymphadenopathy,HP:0031268 Decreased CD69 upregulation upon TCR activation,HP:0002110 Bronchiectasis,HP:0002837 Recurrent bronchitis,HP:0002716 Lymphadenopathy,HP:0004429 Recurrent viral infections,HP:0000403 Recurrent otitis media,HP:0002848 Decreased specific anti-polysaccharide antibody level,HP:0001744 Splenomegaly,HP:0001973 Autoimmune thrombocytopenia,HP:0005419 Decreased T cell activation,HP:0032247 Persistent CMV viremia,HP:0005407 Decreased proportion of CD4-positive helper T cells,HP:0032218 Decreased proportion of CD4-positive T cells,HP:0033222 Decreased CD4:CD8 ratio,HP:0002205 Recurrent respiratory infections,HP:0011108 Recurrent sinusitis,HP:0020072 Persistent EBV viremia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "65.43",
            "diseaseModelAvgRaw": "1.25",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "78.7",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency, X-Linked, With Magnesium Defect, Epstein-Barr Virus Infection, And Neoplasia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:79330",
            "phenodigmScore": 49.53,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002720 Decreased circulating IgA level,HP:0004315 Decreased circulating IgG level,HP:0004313 Decreased circulating antibody level,HP:0001640 Cardiomegaly,HP:0001712 Left ventricular hypertrophy,HP:0001433 Hepatosplenomegaly,HP:0002850 Decreased circulating total IgM,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.92",
            "diseaseModelAvgRaw": "0.53",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "75.14",
            "markerNumModels": "9",
            "diseaseTerm": "Mogs-Cdg",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:617780",
            "phenodigmScore": 58.145,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0000964 Eczema,HP:0001972 Macrocytic anemia,HP:0004313 Decreased circulating antibody level,HP:0002719 Recurrent infections,HP:0001889 Megaloblastic anemia,HP:0003095 Septic arthritis,HP:0006532 Recurrent pneumonia,HP:0001888 Lymphopenia,HP:0001876 Pancytopenia,HP:0010972 Anemia of inadequate production",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "46.06",
            "diseaseModelAvgRaw": "1.04",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.01",
            "diseaseModelMaxNorm": "70.23",
            "markerNumModels": "9",
            "diseaseTerm": "Combined Immunodeficiency And Megaloblastic Anemia With Or Without Hyperhomocysteinemia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:89843",
            "phenodigmScore": 52.095,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003212 Increased circulating IgE level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "22.91",
            "diseaseModelAvgRaw": "0.46",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "81.28",
            "markerNumModels": "9",
            "diseaseTerm": "Dystrophic Epidermolysis Bullosa Pruriginosa",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:79078",
            "phenodigmScore": 52.335,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001097 Keratoconjunctivitis sicca,HP:0001970 Tubulointerstitial nephritis,HP:0100614 Myositis,HP:0003261 Increased circulating IgA level,HP:0002716 Lymphadenopathy,HP:0005200 Retroperitoneal fibrosis,HP:0032300 Increased circulating IgG4 level,HP:0100646 Thyroiditis,HP:0003496 Increased circulating IgM level,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "26.66",
            "diseaseModelAvgRaw": "0.67",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "78.01",
            "markerNumModels": "9",
            "diseaseTerm": "Igg4-Related Dacryoadenitis And Sialadenitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618969",
            "phenodigmScore": 65.66,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010976 B lymphocytopenia,HP:0003460 Decreased circulating total IgA,HP:0032132 Decreased circulating total IgG,HP:0004313 Decreased circulating antibody level,HP:0020083 Furuncle,HP:0005407 Decreased proportion of CD4-positive helper T cells,HP:0002850 Decreased circulating total IgM,HP:0002583 Colitis,HP:0011108 Recurrent sinusitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "49.95",
            "diseaseModelAvgRaw": "1.1",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "81.37",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 70",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:134750",
            "phenodigmScore": 45.58,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001370 Rheumatoid arthritis,HP:0001875 Neutropenia,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.57",
            "diseaseModelAvgRaw": "0.53",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "70.59",
            "markerNumModels": "9",
            "diseaseTerm": "Felty Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:209920",
            "phenodigmScore": 74.805,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0030151 Cholangitis,HP:0004432 Agammaglobulinemia,HP:0002383 Infectious encephalitis,HP:0005386 Recurrent protozoan infections,HP:0001875 Neutropenia,HP:0001080 Biliary tract abnormality,HP:0002841 Recurrent fungal infections,HP:0002965 Cutaneous anergy,HP:0007041 Chronic lymphocytic meningitis,HP:0004429 Recurrent viral infections,HP:0002783 Recurrent lower respiratory tract infections,HP:0002728 Chronic mucocutaneous candidiasis,HP:0000010 Recurrent urinary tract infections,HP:0002788 Recurrent upper respiratory tract infections,HP:0003139 Panhypogammaglobulinemia,HP:0006562 Viral hepatitis,HP:0002583 Colitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "56.68",
            "diseaseModelAvgRaw": "1.27",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "92.93",
            "markerNumModels": "9",
            "diseaseTerm": "Bare Lymphocyte Syndrome, Type Ii",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:781",
            "phenodigmScore": 64.16499999999999,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0002716 Lymphadenopathy,HP:0012115 Hepatitis,HP:0001744 Splenomegaly,HP:0001433 Hepatosplenomegaly,HP:0040186 Maculopapular exanthema,HP:0001701 Pericarditis,HP:0002383 Infectious encephalitis,HP:0100778 Cryoglobulinemia,HP:0002754 Osteomyelitis,HP:0001082 Cholecystitis,HP:0002240 Hepatomegaly,HP:0002090 Pneumonia,HP:0100584 Endocarditis,HP:0032101 Unusual infection,HP:0001392 Abnormality of the liver,HP:0001903 Anemia,HP:0001287 Meningitis,HP:0010702 Increased circulating antibody level,HP:0032252 Granuloma,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "37.51",
            "diseaseModelAvgRaw": "0.84",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "90.82",
            "markerNumModels": "9",
            "diseaseTerm": "Q Fever",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:619381",
            "phenodigmScore": 54.28,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003228 Hypernatremia,HP:0002716 Lymphadenopathy,HP:0012115 Hepatitis,HP:0002719 Recurrent infections,HP:0001744 Splenomegaly,HP:0005263 Gastritis,HP:0100280 Crohn's disease,HP:0002850 Decreased circulating total IgM,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0010976 B lymphocytopenia,HP:0002754 Osteomyelitis,HP:0040218 Reduced natural killer cell count,HP:0002722 Recurrent abscess formation,HP:0000988 Skin rash,HP:0003073 Hypoalbuminemia,HP:0005403 T lymphocytopenia,HP:0002729 Follicular hyperplasia,HP:0031397 Decreased proportion of naive T cells,HP:0003460 Decreased circulating total IgA,HP:0002090 Pneumonia,HP:0031381 Decreased lymphocyte proliferation in response to mitogen,HP:0001369 Arthritis,HP:0032132 Decreased circulating total IgG,HP:0002110 Bronchiectasis,HP:0000403 Recurrent otitis media,HP:0001903 Anemia,HP:0001581 Recurrent skin infections,HP:0033605 Pustular rash,HP:0002583 Colitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "43.74",
            "diseaseModelAvgRaw": "1.03",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "64.82",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 82 With Systemic Inflammation",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:601705",
            "phenodigmScore": 50.835,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0005403 T lymphocytopenia,HP:0008165 Decreased helper T cell proportion",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.22",
            "diseaseModelAvgRaw": "0.41",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.21",
            "diseaseModelMaxNorm": "83.45",
            "markerNumModels": "9",
            "diseaseTerm": "T-Cell Immunodeficiency, Congenital Alopecia, And Nail Dystrophy",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:617388",
            "phenodigmScore": 63.06,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001097 Keratoconjunctivitis sicca,HP:0002240 Hepatomegaly,HP:0003261 Increased circulating IgA level,HP:0003237 Increased circulating IgG level,HP:0011859 Punctate keratitis,HP:0001744 Splenomegaly,HP:0000554 Uveitis,HP:0100646 Thyroiditis,HP:0032061 Hypereosinophilia,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0001890 Autoimmune hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "39.61",
            "diseaseModelAvgRaw": "0.91",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.6",
            "diseaseModelMaxNorm": "86.51",
            "markerNumModels": "9",
            "diseaseTerm": "Autoinflammation With Arthritis And Dyskeratosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:232900",
            "phenodigmScore": 55.61,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001997 Gout,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.94",
            "diseaseModelAvgRaw": "0.43",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "92.28",
            "markerNumModels": "9",
            "diseaseTerm": "Glycoprotein Storage Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:470",
            "phenodigmScore": 50.425,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001970 Tubulointerstitial nephritis,HP:0004313 Decreased circulating antibody level,HP:0002154 Hyperglycinemia,HP:0001987 Hyperammonemia,HP:0003281 Increased circulating ferritin concentration,HP:0001433 Hepatosplenomegaly,HP:0011424 Increased serum zinc,HP:0003233 Decreased HDL cholesterol concentration,HP:0003141 Increased LDL cholesterol concentration,HP:0008358 Hyperprolinemia,HP:0001394 Cirrhosis,HP:0002155 Hypertriglyceridemia,HP:0002240 Hepatomegaly,HP:0003217 Hyperglutaminemia,HP:0012578 Membranous nephropathy,HP:0012156 Hemophagocytosis,HP:0005368 Abnormality of humoral immunity,HP:0002718 Recurrent bacterial infections,HP:0012278 Abnormal circulating serine concentration,HP:0000099 Glomerulonephritis,HP:0001882 Leukopenia,HP:0001903 Anemia,HP:0001733 Pancreatitis,HP:0003348 Hyperalaninemia,HP:0004431 Complement deficiency,HP:0003124 Hypercholesterolemia,HP:0010702 Increased circulating antibody level,HP:0012280 Hepatic amyloidosis,HP:0001873 Thrombocytopenia,HP:0011966 Elevated plasma citrulline,HP:0006517 Intraalveolar phospholipid accumulation",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "32.75",
            "diseaseModelAvgRaw": "0.74",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "68.1",
            "markerNumModels": "9",
            "diseaseTerm": "Lysinuric Protein Intolerance",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:229717",
            "phenodigmScore": 56.78,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0100806 Sepsis,HP:0002090 Pneumonia,HP:0100838 Recurrent cutaneous abscess formation,HP:0100763 Abnormality of the lymphatic system,HP:0004332 Abnormal lymphocyte morphology,HP:0001903 Anemia,HP:0001369 Arthritis,HP:0100765 Abnormality of the tonsils,HP:0001287 Meningitis,HP:0000388 Otitis media,HP:0100533 Inflammatory abnormality of the eye,HP:0000988 Skin rash,HP:0001873 Thrombocytopenia,HP:0002205 Recurrent respiratory infections,HP:0001874 Abnormality of neutrophils",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "32.35",
            "diseaseModelAvgRaw": "0.68",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "81.21",
            "markerNumModels": "9",
            "diseaseTerm": "Isolated Agammaglobulinemia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613790",
            "phenodigmScore": 62.375,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001287 Meningitis,HP:0004434 Decreased serum complement C8",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "24.75",
            "diseaseModelAvgRaw": "0.46",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0002494 increased IgM level,MP:0002493 increased IgG level,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Complement Component 8 Deficiency, Type I",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:616649",
            "phenodigmScore": 45.865,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001878 Hemolytic anemia,HP:0001927 Acanthocytosis,HP:0002904 Hyperbilirubinemia,HP:0001744 Splenomegaly,HP:0001923 Reticulocytosis,HP:0004444 Spherocytosis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.0",
            "diseaseModelAvgRaw": "0.62",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "68.73",
            "markerNumModels": "9",
            "diseaseTerm": "Spherocytosis, Type 2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:83600",
            "phenodigmScore": 47.464999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010702 Increased circulating antibody level,HP:0004429 Recurrent viral infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "22.69",
            "diseaseModelAvgRaw": "0.47",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "72.24",
            "markerNumModels": "9",
            "diseaseTerm": "Encephalitis Lethargica",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613494",
            "phenodigmScore": 67.33500000000001,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0004315 Decreased circulating IgG level,HP:0006532 Recurrent pneumonia,HP:0002850 Decreased circulating total IgM,HP:0410300 Complete or near-complete absence of specific antibody response to unconjugated pneumococcus vaccine,HP:0011108 Recurrent sinusitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "49.24",
            "diseaseModelAvgRaw": "1.13",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "85.43",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency, Common Variable, 4",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:193670",
            "phenodigmScore": 65.915,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0001875 Neutropenia,HP:0002110 Bronchiectasis,HP:0004315 Decreased circulating IgG level,HP:0004313 Decreased circulating antibody level,HP:0002788 Recurrent upper respiratory tract infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "48.79",
            "diseaseModelAvgRaw": "1.03",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "83.04",
            "markerNumModels": "9",
            "diseaseTerm": "Whim Syndrome 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618042",
            "phenodigmScore": 54.870000000000005,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004313 Decreased circulating antibody level,HP:0006517 Intraalveolar phospholipid accumulation",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "46.04",
            "diseaseModelAvgRaw": "1.07",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.07",
            "diseaseModelMaxNorm": "63.7",
            "markerNumModels": "9",
            "diseaseTerm": "Pulmonary Alveolar Proteinosis With Hypogammaglobulinemia",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:86816",
            "phenodigmScore": 50.92999999999999,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia,HP:0003077 Hyperlipidemia,HP:0002783 Recurrent lower respiratory tract infections,HP:0003124 Hypercholesterolemia,HP:0010702 Increased circulating antibody level,HP:0003073 Hypoalbuminemia,HP:0005413 Increased alpha-globulin",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "32.26",
            "diseaseModelAvgRaw": "0.77",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "69.6",
            "markerNumModels": "9",
            "diseaseTerm": "Congenital Analbuminemia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:617765",
            "phenodigmScore": 63.875,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0030388 Decreased proportion of class-switched memory B cells,HP:0032140 Decreased specific antibody response to vaccination,HP:0002720 Decreased circulating IgA level,HP:0005357 Defective B cell differentiation,HP:0004315 Decreased circulating IgG level,HP:0002850 Decreased circulating total IgM",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "53.32",
            "diseaseModelAvgRaw": "1.32",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "74.43",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency, Common Variable, 14",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:609529",
            "phenodigmScore": 67.16,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002720 Decreased circulating IgA level,HP:0004332 Abnormal lymphocyte morphology",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "53.27",
            "diseaseModelAvgRaw": "1.14",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "81.05",
            "markerNumModels": "9",
            "diseaseTerm": "Immunoglobulin A Deficiency 2",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:354",
            "phenodigmScore": 55.4,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002383 Infectious encephalitis,HP:0001744 Splenomegaly,HP:0001433 Hepatosplenomegaly,HP:0002205 Recurrent respiratory infections,HP:0011951 Aspiration pneumonia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "10.8",
            "diseaseModelAvgRaw": "0.22",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Gm1 Gangliosidosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:308240",
            "phenodigmScore": 80.67,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002383 Infectious encephalitis,HP:0001875 Neutropenia,HP:0001876 Pancytopenia,HP:0002716 Lymphadenopathy,HP:0012178 Reduced natural killer cell activity,HP:0004313 Decreased circulating antibody level,HP:0004315 Decreased circulating IgG level,HP:0004787 Fulminant hepatitis,HP:0001744 Splenomegaly,HP:0002961 Dysgammaglobulinemia,HP:0001287 Meningitis,HP:0031693 Severe Epstein Barr virus infection,HP:0003496 Increased circulating IgM level,HP:0100827 Lymphocytosis,HP:0100776 Recurrent pharyngitis,HP:0001873 Thrombocytopenia,HP:0002205 Recurrent respiratory infections,HP:0001915 Aplastic anemia,HP:0012156 Hemophagocytosis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "61.34",
            "diseaseModelAvgRaw": "1.38",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Lymphoproliferative Syndrome, X-Linked, 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:607115",
            "phenodigmScore": 56.96,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0002716 Lymphadenopathy,HP:0001903 Anemia,HP:0001369 Arthritis,HP:0001287 Meningitis,HP:0001433 Hepatosplenomegaly,HP:0000554 Uveitis,HP:0000988 Skin rash,HP:0001880 Eosinophilia,HP:0011227 Elevated circulating C-reactive protein concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "36.58",
            "diseaseModelAvgRaw": "0.78",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "77.34",
            "markerNumModels": "9",
            "diseaseTerm": "Cinca Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:35078",
            "phenodigmScore": 63.52,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004798 Recurrent infection of the gastrointestinal tract,HP:0010976 B lymphocytopenia,HP:0003347 Impaired lymphocyte transformation with phytohemagglutinin,HP:0200039 Pustule,HP:0005354 Lack of T cell function,HP:0005390 Recurrent opportunistic infections,HP:0005403 T lymphocytopenia,HP:0004315 Decreased circulating IgG level,HP:0011837 Partial IgA deficiency,HP:0031381 Decreased lymphocyte proliferation in response to mitogen,HP:0009098 Chronic oral candidiasis,HP:0004429 Recurrent viral infections,HP:0040219 Absent natural killer cells,HP:0001433 Hepatosplenomegaly,HP:0006532 Recurrent pneumonia,HP:0000988 Skin rash,HP:0002850 Decreased circulating total IgM,HP:0001888 Lymphopenia,HP:0002205 Recurrent respiratory infections,HP:0000371 Acute otitis media",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "59.0",
            "diseaseModelAvgRaw": "1.31",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "68.04",
            "markerNumModels": "9",
            "diseaseTerm": "T-B+ Severe Combined Immunodeficiency Due To Jak3 Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:3409",
            "phenodigmScore": 47.625,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003212 Increased circulating IgE level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "15.63",
            "diseaseModelAvgRaw": "0.34",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "79.62",
            "markerNumModels": "9",
            "diseaseTerm": "Urban-Rogers-Meyer Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:233690",
            "phenodigmScore": 53.974999999999994,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002740 Recurrent E. coli infections,HP:0000976 Eczematoid dermatitis,HP:0002240 Hepatomegaly,HP:0002840 Lymphadenitis,HP:0002716 Lymphadenopathy,HP:0007417 Discoid lupus rash,HP:0002754 Osteomyelitis,HP:0001744 Splenomegaly,HP:0002955 Granulomatosis,HP:0003203 Impaired oxidative burst,HP:0002724 Recurrent Aspergillus infections,HP:0006532 Recurrent pneumonia,HP:0005406 Recurrent bacterial skin infections,HP:0002842 Recurrent Burkholderia cepacia infections,HP:0005224 Rectal abscess,HP:0002741 Recurrent Serratia marcescens infections,HP:0002726 Recurrent Staphylococcus aureus infections,HP:0002742 Recurrent Klebsiella infections,HP:0100523 Liver abscess",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "43.82",
            "diseaseModelAvgRaw": "1.01",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "64.13",
            "markerNumModels": "9",
            "diseaseTerm": "Granulomatous Disease, Chronic, Autosomal Recessive, 4",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:307200",
            "phenodigmScore": 69.965,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0001412 Enteroviral hepatitis,HP:0002718 Recurrent bacterial infections,HP:0002383 Infectious encephalitis,HP:0000999 Pyoderma,HP:0003729 Enteroviral dermatomyositis syndrome,HP:0002090 Pneumonia,HP:0000024 Prostatitis,HP:0030252 Absent circulating B cells,HP:0000031 Epididymitis,HP:0000403 Recurrent otitis media,HP:0003095 Septic arthritis,HP:0000010 Recurrent urinary tract infections,HP:0001287 Meningitis,HP:0003139 Panhypogammaglobulinemia,HP:0002743 Recurrent enteroviral infections,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "52.67",
            "diseaseModelAvgRaw": "1.18",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "87.26",
            "markerNumModels": "9",
            "diseaseTerm": "Isolated Growth Hormone Deficiency, Type Iii, With Agammaglobulinemia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:612852",
            "phenodigmScore": 47.254999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0200039 Pustule,HP:0010280 Stomatitis,HP:0025615 Abscess,HP:0002754 Osteomyelitis,HP:0001744 Splenomegaly,HP:0011897 Neutrophilia,HP:0000988 Skin rash,HP:0011227 Elevated circulating C-reactive protein concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "24.88",
            "diseaseModelAvgRaw": "0.58",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "69.63",
            "markerNumModels": "9",
            "diseaseTerm": "Osteomyelitis, Sterile Multifocal, With Periostitis And Pustulosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:95512",
            "phenodigmScore": 42.08,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0007041 Chronic lymphocytic meningitis,HP:0001895 Normochromic anemia,HP:0002902 Hyponatremia,HP:0000872 Hashimoto thyroiditis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "13.7",
            "diseaseModelAvgRaw": "0.33",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.18",
            "diseaseModelMaxNorm": "70.46",
            "markerNumModels": "9",
            "diseaseTerm": "Adenohypophysitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:1116",
            "phenodigmScore": 56.855000000000004,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia,HP:0004313 Decreased circulating antibody level,HP:0001888 Lymphopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "44.45",
            "diseaseModelAvgRaw": "0.88",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.07",
            "diseaseModelMaxNorm": "69.26",
            "markerNumModels": "9",
            "diseaseTerm": "Aplasia Cutis Congenita-Intestinal Lymphangiectasia Syndrome",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:397",
            "phenodigmScore": 41.73,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001701 Pericarditis,HP:0100721 Mediastinal lymphadenopathy,HP:0001369 Arthritis,HP:0001287 Meningitis,HP:0100776 Recurrent pharyngitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "9.05",
            "diseaseModelAvgRaw": "0.19",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "74.41",
            "markerNumModels": "9",
            "diseaseTerm": "Giant Cell Arteritis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:158061",
            "phenodigmScore": 57.225,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0012156 Hemophagocytosis,HP:0030783 Increased circulating interleukin 6,HP:0001875 Neutropenia,HP:0002716 Lymphadenopathy,HP:0012115 Hepatitis,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0012649 Increased inflammatory response,HP:0003281 Increased circulating ferritin concentration,HP:0005681 Juvenile rheumatoid arthritis,HP:0002155 Hypertriglyceridemia,HP:0030782 Abnormal serum interleukin level,HP:0003073 Hypoalbuminemia,HP:0001873 Thrombocytopenia,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0030356 Increased serum interferon-gamma level,HP:0040089 Abnormal natural killer cell count,HP:0011118 Abnormality of tumor necrosis factor secretion",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "42.41",
            "diseaseModelAvgRaw": "0.95",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "72.04",
            "markerNumModels": "9",
            "diseaseTerm": "Macrophage Activation Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:3203",
            "phenodigmScore": 43.005,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004446 Stomatocytosis,HP:0025065 Abnormal mean corpuscular volume,HP:0001744 Splenomegaly,HP:0011273 Anisocytosis,HP:0001923 Reticulocytosis,HP:0001878 Hemolytic anemia,HP:0001046 Intermittent jaundice,HP:0025547 Decreased mean corpuscular hemoglobin concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.86",
            "diseaseModelAvgRaw": "0.47",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "67.15",
            "markerNumModels": "9",
            "diseaseTerm": "Overhydrated Hereditary Stomatocytosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618847",
            "phenodigmScore": 58.53999999999999,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0030253 Defective T cell proliferation,HP:0200039 Pustule,HP:0001287 Meningitis,HP:0001581 Recurrent skin infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "35.87",
            "diseaseModelAvgRaw": "0.79",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "81.21",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 66",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:292",
            "phenodigmScore": 64.235,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0100806 Sepsis,HP:0001791 Fetal ascites,HP:0001974 Leukocytosis,HP:0002383 Infectious encephalitis,HP:0001875 Neutropenia,HP:0001882 Leukopenia,HP:0012115 Hepatitis,HP:0001903 Anemia,HP:0001987 Hyperammonemia,HP:0004311 Abnormal macrophage morphology,HP:0001287 Meningitis,HP:0000988 Skin rash,HP:0001396 Cholestasis,HP:0003073 Hypoalbuminemia,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "32.62",
            "diseaseModelAvgRaw": "0.77",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "95.85",
            "markerNumModels": "9",
            "diseaseTerm": "Congenital Enterovirus Infection",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:604173",
            "phenodigmScore": 54.34,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001875 Neutropenia,HP:0003236 Elevated circulating creatine kinase concentration,HP:0000403 Recurrent otitis media,HP:0001744 Splenomegaly,HP:0006532 Recurrent pneumonia,HP:0000498 Blepharitis,HP:0011108 Recurrent sinusitis,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "35.62",
            "diseaseModelAvgRaw": "0.77",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "73.06",
            "markerNumModels": "9",
            "diseaseTerm": "Poikiloderma With Neutropenia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:616452",
            "phenodigmScore": 69.3,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0005404 Increased B cell count,HP:0410299 Decreased specific antibody response to polysaccharide vaccine,HP:0002720 Decreased circulating IgA level,HP:0002719 Recurrent infections,HP:0001744 Splenomegaly,HP:0002850 Decreased circulating total IgM",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "55.27",
            "diseaseModelAvgRaw": "1.34",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "83.33",
            "markerNumModels": "9",
            "diseaseTerm": "B-Cell Expansion With Nfkb And T-Cell Anergy",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:171",
            "phenodigmScore": 53.93,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100575 Neoplasm of the gallbladder,HP:0030153 Cholangiocarcinoma,HP:0012115 Hepatitis,HP:0001744 Splenomegaly,HP:0001433 Hepatosplenomegaly,HP:0000554 Uveitis,HP:0001409 Portal hypertension,HP:0000952 Jaundice,HP:0001395 Hepatic fibrosis,HP:0012440 Abnormal biliary tract morphology,HP:0001394 Cirrhosis,HP:0001396 Cholestasis,HP:0003073 Hypoalbuminemia,HP:0100279 Ulcerative colitis,HP:0002240 Hepatomegaly,HP:0001402 Hepatocellular carcinoma,HP:0001541 Ascites,HP:0001733 Pancreatitis,HP:0001081 Cholelithiasis,HP:0100646 Thyroiditis,HP:0003459 Polyclonal elevation of IgM",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "26.14",
            "diseaseModelAvgRaw": "0.64",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.64",
            "diseaseModelMaxNorm": "81.72",
            "markerNumModels": "9",
            "diseaseTerm": "Primary Sclerosing Cholangitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:99824",
            "phenodigmScore": 56.83,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000952 Jaundice,HP:0100806 Sepsis,HP:0003496 Increased circulating IgM level,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "26.03",
            "diseaseModelAvgRaw": "0.53",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "87.63",
            "markerNumModels": "9",
            "diseaseTerm": "Lassa Fever",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:166705",
            "phenodigmScore": 64.925,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010739 Osteopoikilosis",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "53.26",
            "diseaseModelAvgRaw": "1.33",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.93",
            "diseaseModelMaxNorm": "76.59",
            "markerNumModels": "9",
            "diseaseTerm": "Osteopoikilosis And Dacryocystitis",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "OMIM:618495",
            "phenodigmScore": 72.05,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002716 Lymphadenopathy,HP:0000403 Recurrent otitis media,HP:0001744 Splenomegaly,HP:0000010 Recurrent urinary tract infections,HP:0010702 Increased circulating antibody level,HP:0002205 Recurrent respiratory infections,HP:0001890 Autoimmune hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "52.15",
            "diseaseModelAvgRaw": "1.05",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "91.95",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 63 With Lymphoproliferation And Autoimmunity",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618944",
            "phenodigmScore": 73.67999999999999,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001047 Atopic dermatitis,HP:0030783 Increased circulating interleukin 6,HP:0030388 Decreased proportion of class-switched memory B cells,HP:0004315 Decreased circulating IgG level,HP:0000403 Recurrent otitis media,HP:0032437 Reduced C-reactive protein level,HP:0003212 Increased circulating IgE level,HP:0002788 Recurrent upper respiratory tract infections,HP:0001581 Recurrent skin infections,HP:0002850 Decreased circulating total IgM,HP:0031292 Cutaneous abscess",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "63.48",
            "diseaseModelAvgRaw": "1.3",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "83.88",
            "markerNumModels": "9",
            "diseaseTerm": "Hyper-Ige Recurrent Infection Syndrome 5, Autosomal Recessive",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:612526",
            "phenodigmScore": 49.089999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001744 Splenomegaly,HP:0003124 Hypercholesterolemia,HP:0001397 Hepatic steatosis,HP:0001433 Hepatosplenomegaly,HP:0002155 Hypertriglyceridemia,HP:0002901 Hypocalcemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.33",
            "diseaseModelAvgRaw": "0.46",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "77.85",
            "markerNumModels": "9",
            "diseaseTerm": "Lipodystrophy, Congenital Generalized, Type 3",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:1951",
            "phenodigmScore": 55.5,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002720 Decreased circulating IgA level,HP:0004313 Decreased circulating antibody level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "41.55",
            "diseaseModelAvgRaw": "0.88",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "69.45",
            "markerNumModels": "9",
            "diseaseTerm": "Epilepsy-Telangiectasia Syndrome",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:260920",
            "phenodigmScore": 56.48,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0003261 Increased circulating IgA level,HP:0002840 Lymphadenitis,HP:0009098 Chronic oral candidiasis,HP:0002716 Lymphadenopathy,HP:0002719 Recurrent infections,HP:0001369 Arthritis,HP:0001744 Splenomegaly,HP:0011897 Neutrophilia,HP:0045073 Serositis,HP:0001433 Hepatosplenomegaly,HP:0000988 Skin rash,HP:0032163 Molluscum contagiosum,HP:0410246 Increased circulating IgD level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "44.61",
            "diseaseModelAvgRaw": "0.97",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "68.35",
            "markerNumModels": "9",
            "diseaseTerm": "Hyper-Igd Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615593",
            "phenodigmScore": 48.540000000000006,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004844 Coombs-positive hemolytic anemia,HP:0001876 Pancytopenia,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "17.29",
            "diseaseModelAvgRaw": "0.39",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "79.79",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 16",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:3162",
            "phenodigmScore": 54.24,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001019 Erythroderma,HP:0002716 Lymphadenopathy,HP:0010701 Abnormal immunoglobulin level,HP:0004332 Abnormal lymphocyte morphology,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "35.56",
            "diseaseModelAvgRaw": "0.75",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "72.92",
            "markerNumModels": "9",
            "diseaseTerm": "Sézary Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:3452",
            "phenodigmScore": 58.849999999999994,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0002902 Hyponatremia,HP:0002240 Hepatomegaly,HP:0002383 Infectious encephalitis,HP:0001701 Pericarditis,HP:0100721 Mediastinal lymphadenopathy,HP:0100614 Myositis,HP:0001903 Anemia,HP:0001369 Arthritis,HP:0001744 Splenomegaly,HP:0000554 Uveitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.85",
            "diseaseModelAvgRaw": "0.48",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "95.85",
            "markerNumModels": "9",
            "diseaseTerm": "Whipple Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:251880",
            "phenodigmScore": 48.120000000000005,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001404 Hepatocellular necrosis,HP:0001541 Ascites,HP:0006581 Depletion of mitochondrial DNA in liver,HP:0001413 Micronodular cirrhosis,HP:0002904 Hyperbilirubinemia,HP:0001744 Splenomegaly,HP:0001397 Hepatic steatosis,HP:0003073 Hypoalbuminemia,HP:0001873 Thrombocytopenia,HP:0001409 Portal hypertension,HP:0002059 Cerebral atrophy,HP:0001405 Periportal fibrosis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "22.23",
            "diseaseModelAvgRaw": "0.5",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "74.01",
            "markerNumModels": "9",
            "diseaseTerm": "Mitochondrial Dna Depletion Syndrome 3 (Hepatocerebral Type)",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:601675",
            "phenodigmScore": 47.405,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001097 Keratoconjunctivitis sicca,HP:0004315 Decreased circulating IgG level,HP:0002719 Recurrent infections,HP:0001019 Erythroderma",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.37",
            "diseaseModelAvgRaw": "0.41",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "76.44",
            "markerNumModels": "9",
            "diseaseTerm": "Trichothiodystrophy 1, Photosensitive",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:105200",
            "phenodigmScore": 47.839999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001396 Cholestasis,HP:0000988 Skin rash,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "16.38",
            "diseaseModelAvgRaw": "0.38",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "79.3",
            "markerNumModels": "9",
            "diseaseTerm": "Amyloidosis, Familial Visceral",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:2314",
            "phenodigmScore": 51.974999999999994,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000964 Eczema,HP:0001880 Eosinophilia,HP:0000389 Chronic otitis media,HP:0002719 Recurrent infections,HP:0002754 Osteomyelitis,HP:0003212 Increased circulating IgE level,HP:0000988 Skin rash,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "29.65",
            "diseaseModelAvgRaw": "0.64",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "74.3",
            "markerNumModels": "9",
            "diseaseTerm": "Autosomal Dominant Hyper-Ige Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:329918",
            "phenodigmScore": 54.42,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0045042 Decreased serum complement C4,HP:0003259 Elevated circulating creatinine concentration,HP:0002719 Recurrent infections,HP:0031047 Paraproteinemia,HP:0005421 Decreased serum complement C3,HP:0000793 Membranoproliferative glomerulonephritis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "28.87",
            "diseaseModelAvgRaw": "0.62",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "79.97",
            "markerNumModels": "9",
            "diseaseTerm": "C3 Glomerulopathy",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:75563",
            "phenodigmScore": 48.7,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0011031 Abnormality of iron homeostasis,HP:0001903 Anemia,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.43",
            "diseaseModelAvgRaw": "0.41",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "78.97",
            "markerNumModels": "9",
            "diseaseTerm": "X-Linked Sideroblastic Anemia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:301068",
            "phenodigmScore": 40.95,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0030151 Cholangitis,HP:0002240 Hepatomegaly,HP:0001395 Hepatic fibrosis,HP:0005209 Intrahepatic bile duct cysts,HP:0001408 Bile duct proliferation,HP:0012330 Pyelonephritis,HP:0002904 Hyperbilirubinemia,HP:0001744 Splenomegaly,HP:0000010 Recurrent urinary tract infections,HP:0001394 Cirrhosis,HP:0001433 Hepatosplenomegaly,HP:0001971 Hypersplenism,HP:0033149 Intrahepatic bile duct dilatation,HP:0001396 Cholestasis,HP:0006579 Prolonged neonatal jaundice,HP:0001873 Thrombocytopenia,HP:0001409 Portal hypertension,HP:0033196 Portal inflammation,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "16.95",
            "diseaseModelAvgRaw": "0.4",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "64.95",
            "markerNumModels": "9",
            "diseaseTerm": "Hardikar Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:200900",
            "phenodigmScore": 66.1,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000778 Hypoplasia of the thymus,HP:0004432 Agammaglobulinemia,HP:0001888 Lymphopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "55.49",
            "diseaseModelAvgRaw": "1.12",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.03",
            "diseaseModelMaxNorm": "76.71",
            "markerNumModels": "9",
            "diseaseTerm": "Short-Limb Skeletal Dysplasia With Severe Combined Immunodeficiency",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:77261",
            "phenodigmScore": 48.559999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0010702 Increased circulating antibody level,HP:0001876 Pancytopenia,HP:0001873 Thrombocytopenia,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "28.02",
            "diseaseModelAvgRaw": "0.63",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "69.1",
            "markerNumModels": "9",
            "diseaseTerm": "Gaucher Disease Type 3",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:185000",
            "phenodigmScore": 45.78,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0004446 Stomatocytosis,HP:0002904 Hyperbilirubinemia,HP:0001744 Splenomegaly,HP:0001923 Reticulocytosis,HP:0001878 Hemolytic anemia,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "24.41",
            "diseaseModelAvgRaw": "0.63",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "67.15",
            "markerNumModels": "9",
            "diseaseTerm": "Overhydrated Hereditary Stomatocytosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:194380",
            "phenodigmScore": 47.69499999999999,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0008269 Increased red cell hemolysis by shear stress,HP:0012115 Hepatitis,HP:0001081 Cholelithiasis,HP:0001744 Splenomegaly,HP:0003281 Increased circulating ferritin concentration,HP:0005535 Exercise-induced hemolysis,HP:0025548 Increased mean corpuscular hemoglobin concentration,HP:0001923 Reticulocytosis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "28.79",
            "diseaseModelAvgRaw": "0.71",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "66.6",
            "markerNumModels": "9",
            "diseaseTerm": "Dehydrated Hereditary Stomatocytosis 1 With Or Without Pseudohyperkalemia And/Or Perinatal Edema",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:137817",
            "phenodigmScore": 41.56,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001287 Meningitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "9.79",
            "diseaseModelAvgRaw": "0.21",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "73.33",
            "markerNumModels": "9",
            "diseaseTerm": "Arachnoiditis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:131",
            "phenodigmScore": 42.93000000000001,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001541 Ascites,HP:0002586 Peritonitis,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0001082 Cholecystitis,HP:0001409 Portal hypertension,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "16.57",
            "diseaseModelAvgRaw": "0.4",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "69.29",
            "markerNumModels": "9",
            "diseaseTerm": "Budd-Chiari Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:601495",
            "phenodigmScore": 61.790000000000006,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0000246 Sinusitis,HP:0010976 B lymphocytopenia,HP:0004432 Agammaglobulinemia,HP:0001875 Neutropenia,HP:0002090 Pneumonia,HP:0002110 Bronchiectasis,HP:0004313 Decreased circulating antibody level,HP:0000403 Recurrent otitis media,HP:0100280 Crohn's disease,HP:0002743 Recurrent enteroviral infections,HP:0006532 Recurrent pneumonia,HP:0002205 Recurrent respiratory infections,HP:0011108 Recurrent sinusitis,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "50.79",
            "diseaseModelAvgRaw": "1.18",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.01",
            "diseaseModelMaxNorm": "72.79",
            "markerNumModels": "9",
            "diseaseTerm": "Agammaglobulinemia 1, Autosomal Recessive",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613501",
            "phenodigmScore": 66.41,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0004432 Agammaglobulinemia,HP:0001875 Neutropenia,HP:0002837 Recurrent bronchitis,HP:0000403 Recurrent otitis media,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "54.91",
            "diseaseModelAvgRaw": "1.13",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "1.98",
            "diseaseModelMaxNorm": "77.91",
            "markerNumModels": "9",
            "diseaseTerm": "Agammaglobulinemia 3, Autosomal Recessive",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:79477",
            "phenodigmScore": 48.54,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001875 Neutropenia,HP:0003077 Hyperlipidemia,HP:0002716 Lymphadenopathy,HP:0001744 Splenomegaly,HP:0001876 Pancytopenia,HP:0012156 Hemophagocytosis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.45",
            "diseaseModelAvgRaw": "0.54",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "73.63",
            "markerNumModels": "9",
            "diseaseTerm": "Griscelli Syndrome Type 2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615631",
            "phenodigmScore": 47.585,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0012132 Erythroid hyperplasia,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0000952 Jaundice,HP:0011273 Anisocytosis,HP:0004447 Poikilocytosis,HP:0001923 Reticulocytosis,HP:0010972 Anemia of inadequate production",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.39",
            "diseaseModelAvgRaw": "0.44",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "75.78",
            "markerNumModels": "9",
            "diseaseTerm": "Anemia, Congenital Dyserythropoietic, Type Ib",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:608809",
            "phenodigmScore": 58.25,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000964 Eczema,HP:0002037 Inflammation of the large intestine,HP:0001875 Neutropenia,HP:0004315 Decreased circulating IgG level,HP:0002719 Recurrent infections,HP:0001369 Arthritis,HP:0005231 Chronic gastritis,HP:0007371 Corpus callosum atrophy,HP:0002583 Colitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "38.3",
            "diseaseModelAvgRaw": "0.85",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "78.2",
            "markerNumModels": "9",
            "diseaseTerm": "Leukoencephalopathy, Arthritis, Colitis, And Hypogammaglobulinema",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:544482",
            "phenodigmScore": 48.964999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0030049 Brain abscess,HP:0002902 Hyponatremia,HP:0030783 Increased circulating interleukin 6,HP:0002153 Hyperkalemia,HP:0001974 Leukocytosis,HP:0002090 Pneumonia,HP:0100282 Acute colitis,HP:0001733 Pancreatitis,HP:0003095 Septic arthritis,HP:0011115 Abnormality of chemokine secretion,HP:0001287 Meningitis,HP:0031691 Severe viral infection,HP:0002901 Hypocalcemia,HP:0001873 Thrombocytopenia,HP:0032169 Severe infection,HP:0001878 Hemolytic anemia,HP:0011116 Abnormality of interferon secretion",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "27.88",
            "diseaseModelAvgRaw": "0.65",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "70.05",
            "markerNumModels": "9",
            "diseaseTerm": "Infection-Related Hemolytic Uremic Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:600802",
            "phenodigmScore": 62.8,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003347 Impaired lymphocyte transformation with phytohemagglutinin,HP:0002090 Pneumonia,HP:0002965 Cutaneous anergy,HP:0000403 Recurrent otitis media,HP:0031382 Decreased lymphocyte proliferation in response to anti-CD3,HP:0002783 Recurrent lower respiratory tract infections,HP:0040219 Absent natural killer cells,HP:0001287 Meningitis,HP:0002788 Recurrent upper respiratory tract infections,HP:0003139 Panhypogammaglobulinemia,HP:0001888 Lymphopenia,HP:0005372 Abnormality of B cell physiology,HP:0033581 Absent peripheral lymph nodes in presence of infection,HP:0005403 T lymphocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "59.44",
            "diseaseModelAvgRaw": "1.31",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "66.16",
            "markerNumModels": "9",
            "diseaseTerm": "Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Positive, Nk Cell-Negative",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:304790",
            "phenodigmScore": 55.895,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000964 Eczema,HP:0001880 Eosinophilia,HP:0001019 Erythroderma,HP:0001875 Neutropenia,HP:0000099 Glomerulonephritis,HP:0002716 Lymphadenopathy,HP:0004844 Coombs-positive hemolytic anemia,HP:0012115 Hepatitis,HP:0001903 Anemia,HP:0001369 Arthritis,HP:0003212 Increased circulating IgE level,HP:0001973 Autoimmune thrombocytopenia,HP:0001873 Thrombocytopenia,HP:0032169 Severe infection",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "38.11",
            "diseaseModelAvgRaw": "0.91",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "73.68",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodysregulation, Polyendocrinopathy, And Enteropathy, X-Linked",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:614700",
            "phenodigmScore": 61.0,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0002037 Inflammation of the large intestine,HP:0002716 Lymphadenopathy,HP:0002719 Recurrent infections,HP:0001744 Splenomegaly,HP:0000554 Uveitis,HP:0002850 Decreased circulating total IgM,HP:0001876 Pancytopenia,HP:0002205 Recurrent respiratory infections,HP:0000509 Conjunctivitis,HP:0001890 Autoimmune hemolytic anemia,HP:0010976 B lymphocytopenia,HP:0030388 Decreased proportion of class-switched memory B cells,HP:0001973 Autoimmune thrombocytopenia,HP:0006532 Recurrent pneumonia,HP:0012219 Erythema nodosum,HP:0410252 Chronic neutropenia,HP:0002090 Pneumonia,HP:0002720 Decreased circulating IgA level,HP:0001369 Arthritis,HP:0008940 Generalized lymphadenopathy,HP:0032140 Decreased specific antibody response to vaccination,HP:0002110 Bronchiectasis,HP:0004315 Decreased circulating IgG level,HP:0000403 Recurrent otitis media,HP:0100646 Thyroiditis,HP:0001873 Thrombocytopenia,HP:0002583 Colitis,HP:0011108 Recurrent sinusitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "45.2",
            "diseaseModelAvgRaw": "1.05",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "76.8",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency, Common Variable, 8, With Autoimmunity",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:847",
            "phenodigmScore": 53.205,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002383 Infectious encephalitis,HP:0011902 Abnormal hemoglobin,HP:0001903 Anemia,HP:0000010 Recurrent urinary tract infections,HP:0002120 Cerebral cortical atrophy",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "13.27",
            "diseaseModelAvgRaw": "0.28",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "93.14",
            "markerNumModels": "9",
            "diseaseTerm": "Alpha-Thalassemia-X-Linked Intellectual Disability Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615206",
            "phenodigmScore": 69.76,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004313 Decreased circulating antibody level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "51.29",
            "diseaseModelAvgRaw": "1.07",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.07",
            "diseaseModelMaxNorm": "88.23",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 11",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:549",
            "phenodigmScore": 64.03,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0100806 Sepsis,HP:0002902 Hyponatremia,HP:0002383 Infectious encephalitis,HP:0001701 Pericarditis,HP:0100584 Endocarditis,HP:0002716 Lymphadenopathy,HP:0012115 Hepatitis,HP:0005528 Bone marrow hypocellularity,HP:0001733 Pancreatitis,HP:0001744 Splenomegaly,HP:0001888 Lymphopenia,HP:0100776 Recurrent pharyngitis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "32.21",
            "diseaseModelAvgRaw": "0.71",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "95.85",
            "markerNumModels": "9",
            "diseaseTerm": "Legionnaires Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:601847",
            "phenodigmScore": 45.169999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001402 Hepatocellular carcinoma,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0002908 Conjugated hyperbilirubinemia,HP:0001406 Intrahepatic cholestasis,HP:0001046 Intermittent jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.88",
            "diseaseModelAvgRaw": "0.45",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "70.46",
            "markerNumModels": "9",
            "diseaseTerm": "Cholestasis, Progressive Familial Intrahepatic, 2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:158048",
            "phenodigmScore": 57.575,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012647 Abnormal inflammatory response,HP:0001875 Neutropenia,HP:0001744 Splenomegaly,HP:0003281 Increased circulating ferritin concentration,HP:0001876 Pancytopenia,HP:0002152 Hyperproteinemia,HP:0031700 Invasive parasitic infection,HP:0002155 Hypertriglyceridemia,HP:0020101 Invasive fungal infection,HP:0025540 Abnormal T cell subset distribution,HP:0002240 Hepatomegaly,HP:0031406 Abnormal cytokine signaling,HP:0031692 Severe cytomegalovirus infection,HP:0032260 Opportunistic bacterial infection,HP:0032169 Severe infection,HP:0012156 Hemophagocytosis,HP:0032204 Chronic active Epstein-Barr virus infection,HP:0001903 Anemia,HP:0032256 Histoplasmosis,HP:0031691 Severe viral infection,HP:0001873 Thrombocytopenia,HP:0040089 Abnormal natural killer cell count",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "50.17",
            "diseaseModelAvgRaw": "1.02",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "64.98",
            "markerNumModels": "9",
            "diseaseTerm": "Hemophagocytic Syndrome Associated With An Infection",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613385",
            "phenodigmScore": 49.385000000000005,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002720 Decreased circulating IgA level,HP:0012115 Hepatitis,HP:0001744 Splenomegaly,HP:0001971 Hypersplenism,HP:0001876 Pancytopenia,HP:0000872 Hashimoto thyroiditis,HP:0002205 Recurrent respiratory infections,HP:0001409 Portal hypertension",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "24.76",
            "diseaseModelAvgRaw": "0.51",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "74.01",
            "markerNumModels": "9",
            "diseaseTerm": "Autoimmune Disease, Multisystem, With Facial Dysmorphism",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615214",
            "phenodigmScore": 66.695,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004432 Agammaglobulinemia,HP:0001875 Neutropenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "53.22",
            "diseaseModelAvgRaw": "1.16",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.03",
            "diseaseModelMaxNorm": "80.17",
            "markerNumModels": "9",
            "diseaseTerm": "Agammaglobulinemia 7, Autosomal Recessive",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:619418",
            "phenodigmScore": 42.83,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0001414 Microvesicular hepatic steatosis,HP:0002240 Hepatomegaly,HP:0006577 Macronodular cirrhosis,HP:0002716 Lymphadenopathy,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0001747 Accessory spleen,HP:0001397 Hepatic steatosis,HP:0002611 Cholestatic liver disease,HP:0002155 Hypertriglyceridemia,HP:0006579 Prolonged neonatal jaundice,HP:0001738 Exocrine pancreatic insufficiency,HP:0001748 Polysplenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.03",
            "diseaseModelAvgRaw": "0.39",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "67.63",
            "markerNumModels": "9",
            "diseaseTerm": "Neurologic, Endocrine, And Pancreatic Disease, Multisystem, Infantile-Onset 2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:53035",
            "phenodigmScore": 45.635,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0030151 Cholangitis,HP:0001974 Leukocytosis,HP:0002240 Hepatomegaly,HP:0030153 Cholangiocarcinoma,HP:0001395 Hepatic fibrosis,HP:0001541 Ascites,HP:0001081 Cholelithiasis,HP:0001744 Splenomegaly,HP:0100523 Liver abscess,HP:0001394 Cirrhosis,HP:0002908 Conjugated hyperbilirubinemia,HP:0001396 Cholestasis,HP:0001406 Intrahepatic cholestasis,HP:0002613 Biliary cirrhosis,HP:0001409 Portal hypertension,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "22.74",
            "diseaseModelAvgRaw": "0.55",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "68.53",
            "markerNumModels": "9",
            "diseaseTerm": "Caroli Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:607765",
            "phenodigmScore": 45.894999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0200084 Giant cell hepatitis,HP:0011985 Acholic stools,HP:0003146 Hypocholesterolemia,HP:0002904 Hyperbilirubinemia,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0001406 Intrahepatic cholestasis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.33",
            "diseaseModelAvgRaw": "0.52",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "70.46",
            "markerNumModels": "9",
            "diseaseTerm": "Bile Acid Synthesis Defect, Congenital, 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:246550",
            "phenodigmScore": 53.724999999999994,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002720 Decreased circulating IgA level,HP:0001875 Neutropenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "26.4",
            "diseaseModelAvgRaw": "0.54",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "81.05",
            "markerNumModels": "9",
            "diseaseTerm": "Lichtenstein Syndrome",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615285",
            "phenodigmScore": 69.86,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001875 Neutropenia,HP:0001882 Leukopenia,HP:0002719 Recurrent infections,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0010702 Increased circulating antibody level,HP:0001978 Extramedullary hematopoiesis,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "57.35",
            "diseaseModelAvgRaw": "1.27",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "82.37",
            "markerNumModels": "9",
            "diseaseTerm": "Neutropenia, Severe Congenital, 5, Autosomal Recessive",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:355",
            "phenodigmScore": 45.004999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0012115 Hepatitis,HP:0001903 Anemia,HP:0002754 Osteomyelitis,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0010702 Increased circulating antibody level,HP:0001876 Pancytopenia,HP:0001873 Thrombocytopenia,HP:0002758 Osteoarthritis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.91",
            "diseaseModelAvgRaw": "0.44",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "69.1",
            "markerNumModels": "9",
            "diseaseTerm": "Gaucher Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:235700",
            "phenodigmScore": 48.215,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001897 Normocytic anemia,HP:0001895 Normochromic anemia,HP:0001081 Cholelithiasis,HP:0002904 Hyperbilirubinemia,HP:0001744 Splenomegaly,HP:0001930 Nonspherocytic hemolytic anemia,HP:0001082 Cholecystitis,HP:0001923 Reticulocytosis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "27.14",
            "diseaseModelAvgRaw": "0.71",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "69.29",
            "markerNumModels": "9",
            "diseaseTerm": "Hemolytic Anemia, Nonspherocytic, Due To Hexokinase Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:169154",
            "phenodigmScore": 74.9,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001875 Neutropenia,HP:0002716 Lymphadenopathy,HP:0002719 Recurrent infections,HP:0045080 Decreased proportion of CD3-positive T cells,HP:0001433 Hepatosplenomegaly,HP:0100827 Lymphocytosis,HP:0005401 Recurrent candida infections,HP:0040187 Neonatal sepsis,HP:0001880 Eosinophilia,HP:0001019 Erythroderma,HP:0002783 Recurrent lower respiratory tract infections,HP:0001973 Autoimmune thrombocytopenia,HP:0001888 Lymphopenia,HP:0005415 Decreased proportion of CD8-positive T cells,HP:0005403 T lymphocytopenia,HP:0031381 Decreased lymphocyte proliferation in response to mitogen,HP:0003261 Increased circulating IgA level,HP:0004429 Recurrent viral infections,HP:0003237 Increased circulating IgG level,HP:0003212 Increased circulating IgE level,HP:0010702 Increased circulating antibody level,HP:0002788 Recurrent upper respiratory tract infections,HP:0005407 Decreased proportion of CD4-positive helper T cells",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "60.63",
            "diseaseModelAvgRaw": "1.39",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.65",
            "diseaseModelMaxNorm": "89.17",
            "markerNumModels": "9",
            "diseaseTerm": "T-B+ Severe Combined Immunodeficiency Due To Il-7Ralpha Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:2688",
            "phenodigmScore": 71.2,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0001875 Neutropenia,HP:0005202 Helicobacter pylori infection,HP:0012311 Monocytosis,HP:0002841 Recurrent fungal infections,HP:0002719 Recurrent infections,HP:0003496 Increased circulating IgM level,HP:0001888 Lymphopenia,HP:0012312 Monocytopenia,HP:0011107 Recurrent aphthous stomatitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "51.95",
            "diseaseModelAvgRaw": "1.2",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "90.45",
            "markerNumModels": "9",
            "diseaseTerm": "Adult Idiopathic Neutropenia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:48377",
            "phenodigmScore": 51.199999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010702 Increased circulating antibody level,HP:0001370 Rheumatoid arthritis,HP:0200039 Pustule",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "28.83",
            "diseaseModelAvgRaw": "0.68",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "73.57",
            "markerNumModels": "9",
            "diseaseTerm": "Subcorneal Pustular Dermatosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:454836",
            "phenodigmScore": 61.78,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0003073 Hypoalbuminemia,HP:0002383 Infectious encephalitis,HP:0002090 Pneumonia,HP:0001882 Leukopenia,HP:0003236 Elevated circulating creatine kinase concentration,HP:0012115 Hepatitis,HP:0001287 Meningitis,HP:0001888 Lymphopenia,HP:0012486 Myelitis,HP:0001873 Thrombocytopenia,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "28.71",
            "diseaseModelAvgRaw": "0.65",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "94.85",
            "markerNumModels": "9",
            "diseaseTerm": "Avian Influenza",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:167635",
            "phenodigmScore": 45.655,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003236 Elevated circulating creatine kinase concentration,HP:0031047 Paraproteinemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "17.65",
            "diseaseModelAvgRaw": "0.34",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "73.66",
            "markerNumModels": "9",
            "diseaseTerm": "Scleromyxedema",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613789",
            "phenodigmScore": 64.185,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001287 Meningitis,HP:0004434 Decreased serum complement C8,HP:0005430 Recurrent Neisserial infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "29.53",
            "diseaseModelAvgRaw": "0.55",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0002494 increased IgM level,MP:0002493 increased IgG level,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "98.84",
            "markerNumModels": "9",
            "diseaseTerm": "Complement Component 8 Deficiency, Type Ii",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:607685",
            "phenodigmScore": 48.625,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001880 Eosinophilia,HP:0005547 Myeloproliferative disorder,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.01",
            "diseaseModelAvgRaw": "0.38",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "79.24",
            "markerNumModels": "9",
            "diseaseTerm": "Hypereosinophilic Syndrome, Idiopathic",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:235555",
            "phenodigmScore": 44.339999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002904 Hyperbilirubinemia,HP:0001744 Splenomegaly,HP:0001406 Intrahepatic cholestasis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.22",
            "diseaseModelAvgRaw": "0.43",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "70.46",
            "markerNumModels": "9",
            "diseaseTerm": "Bile Acid Synthesis Defect, Congenital, 2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:616740",
            "phenodigmScore": 65.595,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0001875 Neutropenia,HP:0005425 Recurrent sinopulmonary infections,HP:0009098 Chronic oral candidiasis,HP:0004313 Decreased circulating antibody level,HP:0001903 Anemia,HP:0004854 Intermittent thrombocytopenia,HP:0001287 Meningitis,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "51.54",
            "diseaseModelAvgRaw": "1.16",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "79.65",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 46",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:306400",
            "phenodigmScore": 53.974999999999994,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002740 Recurrent E. coli infections,HP:0000976 Eczematoid dermatitis,HP:0002240 Hepatomegaly,HP:0002840 Lymphadenitis,HP:0002716 Lymphadenopathy,HP:0007417 Discoid lupus rash,HP:0002754 Osteomyelitis,HP:0001744 Splenomegaly,HP:0002955 Granulomatosis,HP:0003203 Impaired oxidative burst,HP:0002724 Recurrent Aspergillus infections,HP:0006532 Recurrent pneumonia,HP:0005406 Recurrent bacterial skin infections,HP:0002842 Recurrent Burkholderia cepacia infections,HP:0005224 Rectal abscess,HP:0002741 Recurrent Serratia marcescens infections,HP:0002726 Recurrent Staphylococcus aureus infections,HP:0002742 Recurrent Klebsiella infections,HP:0100523 Liver abscess",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "43.82",
            "diseaseModelAvgRaw": "1.01",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "64.13",
            "markerNumModels": "9",
            "diseaseTerm": "Granulomatous Disease, Chronic, X-Linked",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:235200",
            "phenodigmScore": 46.41,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003452 Increased serum iron,HP:0002240 Hepatomegaly,HP:0001402 Hepatocellular carcinoma,HP:0001541 Ascites,HP:0001640 Cardiomegaly,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0003281 Increased circulating ferritin concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "17.57",
            "diseaseModelAvgRaw": "0.41",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "75.25",
            "markerNumModels": "9",
            "diseaseTerm": "Hemochromatosis, Type 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:144200",
            "phenodigmScore": 55.63,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003212 Increased circulating IgE level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "29.98",
            "diseaseModelAvgRaw": "0.64",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "81.28",
            "markerNumModels": "9",
            "diseaseTerm": "Palmoplantar Keratoderma, Epidermolytic",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:99829",
            "phenodigmScore": 53.845,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0030783 Increased circulating interleukin 6,HP:0003236 Elevated circulating creatine kinase concentration,HP:0003259 Elevated circulating creatinine concentration,HP:0031690 Opportunistic infection,HP:0002904 Hyperbilirubinemia,HP:0011897 Neutrophilia,HP:0003496 Increased circulating IgM level,HP:0001735 Acute pancreatitis,HP:0000988 Skin rash,HP:0006277 Pancreatic hyperplasia,HP:0001873 Thrombocytopenia,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "31.2",
            "diseaseModelAvgRaw": "0.67",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "76.49",
            "markerNumModels": "9",
            "diseaseTerm": "Yellow Fever",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:600145",
            "phenodigmScore": 39.49,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001287 Meningitis,HP:0005224 Rectal abscess",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "12.8",
            "diseaseModelAvgRaw": "0.3",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "66.18",
            "markerNumModels": "9",
            "diseaseTerm": "Sacral Defect With Anterior Meningocele",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:619549",
            "phenodigmScore": 77.185,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004315 Decreased circulating IgG level,HP:0003203 Impaired oxidative burst,HP:0003496 Increased circulating IgM level,HP:0020086 BCGitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "54.37",
            "diseaseModelAvgRaw": "1.23",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 86",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:612132",
            "phenodigmScore": 51.305,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004798 Recurrent infection of the gastrointestinal tract,HP:0011114 Defective production of NFKB1-dependent cytokines,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "40.13",
            "diseaseModelAvgRaw": "0.85",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008565 decreased interferon-beta secretion,MP:0005025 abnormal response to infection,MP:0020937 increased susceptibility to Picornaviridae infection,MP:0008706 decreased interleukin-6 secretion,MP:0008563 decreased interferon-alpha secretion,MP:0003009 abnormal cytokine secretion",
            "modelId": "MGI:3773164",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "62.48",
            "markerNumModels": "9",
            "diseaseTerm": "Ectodermal Dysplasia And Immunodeficiency 2",
            "modelGeneticBackground": "Not Specified"
        },
        {
            "diseaseId": "OMIM:269840",
            "phenodigmScore": 71.255,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000976 Eczematoid dermatitis,HP:0002240 Hepatomegaly,HP:0002090 Pneumonia,HP:0001744 Splenomegaly,HP:0003139 Panhypogammaglobulinemia,HP:0005401 Recurrent candida infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "52.76",
            "diseaseModelAvgRaw": "1.13",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "89.75",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 48",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615897",
            "phenodigmScore": 83.55,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012476 Decreased specific pneumococcal antibody level,HP:0030253 Defective T cell proliferation,HP:0032170 Severe varicella zoster infection,HP:0004315 Decreased circulating IgG level,HP:0004429 Recurrent viral infections,HP:0032248 Persistent viremia,HP:0031402 Reduced antigen-specific T cell proliferation,HP:0031691 Severe viral infection,HP:0001888 Lymphopenia,HP:4000039 Reduced proportion of mucosal-associated invariant T cells,HP:0030374 Decreased proportion of memory B cells,HP:0033222 Decreased CD4:CD8 ratio,HP:0410297 Partial absence of specific antibody response to tetanus vaccine,HP:0008348 Decreased circulating IgG2 level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "67.1",
            "diseaseModelAvgRaw": "1.33",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 24",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:611762",
            "phenodigmScore": 54.93000000000001,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0002716 Lymphadenopathy,HP:0001369 Arthritis,HP:0001744 Splenomegaly,HP:0000988 Skin rash,HP:0011107 Recurrent aphthous stomatitis,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0012219 Erythema nodosum",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "35.96",
            "diseaseModelAvgRaw": "0.7",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "73.9",
            "markerNumModels": "9",
            "diseaseTerm": "Familial Cold Autoinflammatory Syndrome 2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:617099",
            "phenodigmScore": 64.64,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0032219 Increased proportion of CD4-positive T cells,HP:0003261 Increased circulating IgA level,HP:0002716 Lymphadenopathy,HP:0012490 Panniculitis,HP:0011897 Neutrophilia,HP:0003496 Increased circulating IgM level,HP:0000988 Skin rash,HP:0011227 Elevated circulating C-reactive protein concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "45.39",
            "diseaseModelAvgRaw": "1.03",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "83.89",
            "markerNumModels": "9",
            "diseaseTerm": "Autoinflammation, Panniculitis, And Dermatosis Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:73263",
            "phenodigmScore": 54.21,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0030049 Brain abscess,HP:0012819 Myocarditis,HP:0001875 Neutropenia,HP:0100537 Fasciitis,HP:0012115 Hepatitis,HP:0005263 Gastritis,HP:0001701 Pericarditis,HP:0002383 Infectious encephalitis,HP:0020101 Invasive fungal infection,HP:0200039 Pustule,HP:0100721 Mediastinal lymphadenopathy,HP:0100584 Endocarditis,HP:0000123 Nephritis,HP:0032162 Unusual skin infection,HP:0025059 Splenic abscess,HP:0002586 Peritonitis,HP:0001733 Pancreatitis,HP:0011949 Acute infectious pneumonia,HP:0004387 Enterocolitis,HP:0002583 Colitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.44",
            "diseaseModelAvgRaw": "0.46",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "87.98",
            "markerNumModels": "9",
            "diseaseTerm": "Zygomycosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:610910",
            "phenodigmScore": 46.3,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0030049 Brain abscess,HP:0025044 Lung abscess,HP:0002090 Pneumonia,HP:0002205 Recurrent respiratory infections,HP:0006517 Intraalveolar phospholipid accumulation",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "26.8",
            "diseaseModelAvgRaw": "0.56",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.13",
            "diseaseModelMaxNorm": "65.8",
            "markerNumModels": "9",
            "diseaseTerm": "Pulmonary Alveolar Proteinosis, Acquired",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613496",
            "phenodigmScore": 62.275000000000006,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0002240 Hepatomegaly,HP:0012476 Decreased specific pneumococcal antibody level,HP:0000099 Glomerulonephritis,HP:0410295 Complete or near-complete absence of specific antibody response to tetanus vaccine,HP:0001973 Autoimmune thrombocytopenia,HP:0032134 Chronic decreased circulating total IgG,HP:0002205 Recurrent respiratory infections,HP:0000105 Enlarged kidney",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "43.6",
            "diseaseModelAvgRaw": "0.98",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "80.95",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency, Common Variable, 6",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:2298",
            "phenodigmScore": 54.675,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002090 Pneumonia,HP:0001882 Leukopenia,HP:0003261 Increased circulating IgA level,HP:0003119 Abnormal circulating lipid concentration,HP:0004359 Abnormal circulating fatty-acid concentration,HP:0000123 Nephritis,HP:0100879 Enlarged ovaries,HP:0005416 Decreased serum complement factor B,HP:0003237 Increased circulating IgG level,HP:0012153 Hypotriglyceridemia,HP:0000988 Skin rash,HP:0003073 Hypoalbuminemia,HP:0001873 Thrombocytopenia,HP:0002613 Biliary cirrhosis,HP:0002758 Osteoarthritis,HP:0008675 Enlarged polycystic ovaries",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "27.27",
            "diseaseModelAvgRaw": "0.63",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.6",
            "diseaseModelMaxNorm": "82.08",
            "markerNumModels": "9",
            "diseaseTerm": "Insulin-Resistance Syndrome Type B",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:829",
            "phenodigmScore": 57.635,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0001974 Leukocytosis,HP:0002240 Hepatomegaly,HP:0001701 Pericarditis,HP:0003119 Abnormal circulating lipid concentration,HP:0012115 Hepatitis,HP:0005528 Bone marrow hypocellularity,HP:0001369 Arthritis,HP:0001744 Splenomegaly,HP:0001287 Meningitis,HP:0011897 Neutrophilia,HP:0008940 Generalized lymphadenopathy,HP:0000988 Skin rash,HP:0100776 Recurrent pharyngitis,HP:0011227 Elevated circulating C-reactive protein concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "39.8",
            "diseaseModelAvgRaw": "0.88",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "75.47",
            "markerNumModels": "9",
            "diseaseTerm": "Adult-Onset Still Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:617441",
            "phenodigmScore": 41.94499999999999,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001873 Thrombocytopenia,HP:0004823 Anisopoikilocytosis,HP:0001903 Anemia,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "15.57",
            "diseaseModelAvgRaw": "0.4",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "68.32",
            "markerNumModels": "9",
            "diseaseTerm": "Thrombocytopenia, Anemia, And Myelofibrosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:50918",
            "phenodigmScore": 46.725,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0002240 Hepatomegaly,HP:0200039 Pustule,HP:0001875 Neutropenia,HP:0001882 Leukopenia,HP:0002716 Lymphadenopathy,HP:0001903 Anemia,HP:0002733 Abnormality of the lymph nodes,HP:0001744 Splenomegaly,HP:0001287 Meningitis,HP:0025300 Malar rash,HP:0100827 Lymphocytosis,HP:0008940 Generalized lymphadenopathy,HP:0000988 Skin rash,HP:0025289 Cervical lymphadenopathy,HP:0001873 Thrombocytopenia,HP:0011227 Elevated circulating C-reactive protein concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "28.31",
            "diseaseModelAvgRaw": "0.6",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "65.14",
            "markerNumModels": "9",
            "diseaseTerm": "Kikuchi-Fujimoto Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:166450",
            "phenodigmScore": 65.935,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0011001 Increased bone mineral density",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "54.17",
            "diseaseModelAvgRaw": "1.1",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.99",
            "diseaseModelMaxNorm": "77.7",
            "markerNumModels": "9",
            "diseaseTerm": "Osteomesopyknosis",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "OMIM:613011",
            "phenodigmScore": 64.94,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001882 Leukopenia,HP:0010280 Stomatitis,HP:0002716 Lymphadenopathy,HP:0004315 Decreased circulating IgG level,HP:0004313 Decreased circulating antibody level,HP:0002719 Recurrent infections,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0003281 Increased circulating ferritin concentration,HP:0001973 Autoimmune thrombocytopenia,HP:0005407 Decreased proportion of CD4-positive helper T cells,HP:0001876 Pancytopenia,HP:0001873 Thrombocytopenia,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0020072 Persistent EBV viremia,HP:0001890 Autoimmune hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "55.09",
            "diseaseModelAvgRaw": "1.19",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "74.79",
            "markerNumModels": "9",
            "diseaseTerm": "Lymphoproliferative Syndrome 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:543",
            "phenodigmScore": 49.870000000000005,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001743 Abnormality of the spleen,HP:0002733 Abnormality of the lymph nodes,HP:0001732 Abnormality of the pancreas,HP:0001392 Abnormality of the liver,HP:0002149 Hyperuricemia,HP:0005407 Decreased proportion of CD4-positive helper T cells",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "25.87",
            "diseaseModelAvgRaw": "0.55",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.15",
            "diseaseModelMaxNorm": "73.87",
            "markerNumModels": "9",
            "diseaseTerm": "Burkitt Lymphoma",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:101096",
            "phenodigmScore": 52.60000000000001,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001875 Neutropenia,HP:0031393 Abnormal proportion of CD8-positive T cells,HP:0011117 Abnormality of interleukin secretion,HP:0005528 Bone marrow hypocellularity,HP:0012133 Erythroid hypoplasia,HP:0005407 Decreased proportion of CD4-positive helper T cells,HP:0001896 Reticulocytopenia,HP:0001876 Pancytopenia,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "36.02",
            "diseaseModelAvgRaw": "0.81",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.19",
            "diseaseModelMaxNorm": "69.18",
            "markerNumModels": "9",
            "diseaseTerm": "Aregenerative Anemia",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:300636",
            "phenodigmScore": 61.215,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003261 Increased circulating IgA level,HP:0032283 Disseminated nontuberculous mycobacterial infection,HP:0002718 Recurrent bacterial infections,HP:0002850 Decreased circulating total IgM",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "41.14",
            "diseaseModelAvgRaw": "0.93",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "81.29",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 33",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:2552",
            "phenodigmScore": 57.14,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0030049 Brain abscess,HP:0030151 Cholangitis,HP:0012819 Myocarditis,HP:0100806 Sepsis,HP:0012115 Hepatitis,HP:0002383 Infectious encephalitis,HP:0002840 Lymphadenitis,HP:0002754 Osteomyelitis,HP:0001743 Abnormality of the spleen,HP:0002090 Pneumonia,HP:0100584 Endocarditis,HP:0012384 Rhinitis,HP:0000123 Nephritis,HP:0001080 Biliary tract abnormality,HP:0000024 Prostatitis,HP:0002586 Peritonitis,HP:0100614 Myositis,HP:0001733 Pancreatitis,HP:0000491 Keratitis,HP:0011950 Bronchiolitis,HP:0100646 Thyroiditis,HP:0005407 Decreased proportion of CD4-positive helper T cells,HP:0001096 Keratoconjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "27.02",
            "diseaseModelAvgRaw": "0.65",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "87.26",
            "markerNumModels": "9",
            "diseaseTerm": "Microsporidiosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:257220",
            "phenodigmScore": 43.315,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001791 Fetal ascites,HP:0002240 Hepatomegaly,HP:0002529 Neuronal loss in central nervous system,HP:0004333 Bone-marrow foam cells,HP:0001744 Splenomegaly,HP:0006579 Prolonged neonatal jaundice,HP:0001982 Sea-blue histiocytosis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.53",
            "diseaseModelAvgRaw": "0.4",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000691 enlarged spleen,MP:0003224 neuron degeneration,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "68.1",
            "markerNumModels": "9",
            "diseaseTerm": "Niemann-Pick Disease, Type C1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:611521",
            "phenodigmScore": 64.5,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002841 Recurrent fungal infections,HP:0004429 Recurrent viral infections,HP:0003212 Increased circulating IgE level,HP:0011274 Recurrent mycobacterial infections,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "47.72",
            "diseaseModelAvgRaw": "1.04",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "81.28",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 35",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:212050",
            "phenodigmScore": 70.235,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002716 Lymphadenopathy,HP:0009098 Chronic oral candidiasis,HP:0040303 Decreased serum iron,HP:0032259 Chronic tinea infection,HP:0012203 Onychomycosis,HP:0003212 Increased circulating IgE level,HP:0001287 Meningitis,HP:0032061 Hypereosinophilia,HP:0032515 Deep dermatophytosis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "58.92",
            "diseaseModelAvgRaw": "1.29",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "81.55",
            "markerNumModels": "9",
            "diseaseTerm": "Candidiasis, Familial, 2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:217260",
            "phenodigmScore": 53.99,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001287 Meningitis,HP:0005415 Decreased proportion of CD8-positive T cells,HP:0031392 Abnormal proportion of CD4-positive T cells",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.48",
            "diseaseModelAvgRaw": "0.4",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.65",
            "diseaseModelMaxNorm": "88.5",
            "markerNumModels": "9",
            "diseaseTerm": "Progressive Multifocal Leukoencephalopathy",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615947",
            "phenodigmScore": 54.75,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002583 Colitis,HP:0010980 Hyperlipoproteinemia,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "26.46",
            "diseaseModelAvgRaw": "0.57",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "83.04",
            "markerNumModels": "9",
            "diseaseTerm": "Hyperlipoproteinemia, Type Id",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613812",
            "phenodigmScore": 43.434999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0011985 Acholic stools,HP:0012115 Hepatitis,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0001406 Intrahepatic cholestasis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "16.41",
            "diseaseModelAvgRaw": "0.39",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "70.46",
            "markerNumModels": "9",
            "diseaseTerm": "Bile Acid Synthesis Defect, Congenital, 3",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:289390",
            "phenodigmScore": 50.525,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001970 Tubulointerstitial nephritis,HP:0002716 Lymphadenopathy,HP:0001895 Normochromic anemia,HP:0004313 Decreased circulating antibody level,HP:0011850 Parotitis,HP:0100653 Optic neuritis,HP:0100778 Cryoglobulinemia,HP:0012089 Arteritis,HP:0001888 Lymphopenia,HP:0012219 Erythema nodosum,HP:0002613 Biliary cirrhosis,HP:0001897 Normocytic anemia,HP:0001369 Arthritis,HP:0200123 Chronic hepatitis,HP:0001097 Keratoconjunctivitis sicca,HP:0200120 Chronic active hepatitis,HP:0006527 Lymphocytic interstitial pneumonia,HP:0001882 Leukopenia,HP:0100614 Myositis,HP:0045042 Decreased serum complement C4,HP:0004431 Complement deficiency,HP:0001287 Meningitis,HP:0010702 Increased circulating antibody level,HP:0100646 Thyroiditis,HP:0005407 Decreased proportion of CD4-positive helper T cells,HP:0005421 Decreased serum complement C3,HP:0001873 Thrombocytopenia,HP:0000099 Glomerulonephritis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "32.31",
            "diseaseModelAvgRaw": "0.72",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "68.74",
            "markerNumModels": "9",
            "diseaseTerm": "Primary Sjögren Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:610551",
            "phenodigmScore": 61.965,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012302 Herpes simplex encephalitis,HP:0005353 Recurrent herpes",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.93",
            "diseaseModelAvgRaw": "0.54",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0006082 CNS inflammation",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.7",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Encephalopathy, Acute, Infection-Induced (Herpes-Specific), Susceptibility To, 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:300291",
            "phenodigmScore": 63.06,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0003261 Increased circulating IgA level,HP:0012178 Reduced natural killer cell activity,HP:0031692 Severe cytomegalovirus infection,HP:0002961 Dysgammaglobulinemia,HP:0003496 Increased circulating IgM level,HP:0032163 Molluscum contagiosum,HP:0410242 Abnormal circulating IgG level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "43.46",
            "diseaseModelAvgRaw": "1.02",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "82.66",
            "markerNumModels": "9",
            "diseaseTerm": "Ectodermal Dysplasia And Immunodeficiency 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:619281",
            "phenodigmScore": 67.28,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0001974 Leukocytosis,HP:0002037 Inflammation of the large intestine,HP:0010976 B lymphocytopenia,HP:0012311 Monocytosis,HP:0002720 Decreased circulating IgA level,HP:0012178 Reduced natural killer cell activity,HP:0004315 Decreased circulating IgG level,HP:0011897 Neutrophilia,HP:0006532 Recurrent pneumonia,HP:0011108 Recurrent sinusitis,HP:0002850 Decreased circulating total IgM,HP:0002583 Colitis,HP:0033351 Candida esophagitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "52.75",
            "diseaseModelAvgRaw": "1.26",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "81.81",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 14B, Autosomal Recessive",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:86843",
            "phenodigmScore": 45.94,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004820 Acute myelomonocytic leukemia,HP:0005528 Bone marrow hypocellularity,HP:0001744 Splenomegaly,HP:0004808 Acute myeloid leukemia,HP:0100827 Lymphocytosis,HP:0001876 Pancytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.56",
            "diseaseModelAvgRaw": "0.53",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "68.32",
            "markerNumModels": "9",
            "diseaseTerm": "Acute Panmyelosis With Myelofibrosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:313900",
            "phenodigmScore": 50.02,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000964 Eczema,HP:0003261 Increased circulating IgA level,HP:0005537 Decreased mean platelet volume,HP:0004854 Intermittent thrombocytopenia,HP:0003212 Increased circulating IgE level,HP:0001905 Congenital thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "34.06",
            "diseaseModelAvgRaw": "0.94",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "65.98",
            "markerNumModels": "9",
            "diseaseTerm": "Thrombocytopenia 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:616576",
            "phenodigmScore": 60.005,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002110 Bronchiectasis,HP:0005425 Recurrent sinopulmonary infections,HP:0004313 Decreased circulating antibody level,HP:0002719 Recurrent infections,HP:0001581 Recurrent skin infections,HP:0006532 Recurrent pneumonia,HP:0001873 Thrombocytopenia,HP:0011108 Recurrent sinusitis,HP:0001890 Autoimmune hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "47.22",
            "diseaseModelAvgRaw": "1.06",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.01",
            "diseaseModelMaxNorm": "72.79",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency, Common Variable, 12, With Autoimmunity",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:464",
            "phenodigmScore": 51.735,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002383 Infectious encephalitis,HP:0000491 Keratitis,HP:0000554 Uveitis,HP:0000988 Skin rash,HP:0001880 Eosinophilia,HP:0002120 Cerebral cortical atrophy",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "11.56",
            "diseaseModelAvgRaw": "0.25",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "91.91",
            "markerNumModels": "9",
            "diseaseTerm": "Incontinentia Pigmenti",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:900",
            "phenodigmScore": 44.3,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0001701 Pericarditis,HP:0000024 Prostatitis,HP:0000389 Chronic otitis media,HP:0001733 Pancreatitis,HP:0002955 Granulomatosis,HP:0012649 Increased inflammatory response,HP:0001287 Meningitis,HP:0000388 Otitis media,HP:0100533 Inflammatory abnormality of the eye,HP:0000988 Skin rash,HP:0002205 Recurrent respiratory infections,HP:0011227 Elevated circulating C-reactive protein concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.9",
            "diseaseModelAvgRaw": "0.43",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "68.7",
            "markerNumModels": "9",
            "diseaseTerm": "Granulomatosis With Polyangiitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:83317",
            "phenodigmScore": 60.305,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0002383 Infectious encephalitis,HP:0002716 Lymphadenopathy,HP:0012122 Anterior uveitis,HP:0001744 Splenomegaly,HP:0001287 Meningitis,HP:0000988 Skin rash",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "24.76",
            "diseaseModelAvgRaw": "0.52",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "95.85",
            "markerNumModels": "9",
            "diseaseTerm": "Scrub Typhus",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:619652",
            "phenodigmScore": 63.84,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0030151 Cholangitis,HP:0001974 Leukocytosis,HP:0010976 B lymphocytopenia,HP:0030388 Decreased proportion of class-switched memory B cells,HP:0002240 Hepatomegaly,HP:0002090 Pneumonia,HP:0020087 BCGosis,HP:0002720 Decreased circulating IgA level,HP:0410028 Recurrent oral herpes,HP:0004315 Decreased circulating IgG level,HP:0100633 Esophagitis,HP:0031380 Abnormal B cell proliferation,HP:0002754 Osteomyelitis,HP:0001894 Thrombocytosis,HP:0100827 Lymphocytosis,HP:0032247 Persistent CMV viremia,HP:0410297 Partial absence of specific antibody response to tetanus vaccine,HP:0030991 Sclerosing cholangitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "52.88",
            "diseaseModelAvgRaw": "1.26",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "74.8",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 92",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613327",
            "phenodigmScore": 48.36,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002720 Decreased circulating IgA level,HP:0003236 Elevated circulating creatine kinase concentration,HP:0002719 Recurrent infections,HP:0001744 Splenomegaly,HP:0001397 Hepatic steatosis,HP:0002155 Hypertriglyceridemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "25.08",
            "diseaseModelAvgRaw": "0.57",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "71.64",
            "markerNumModels": "9",
            "diseaseTerm": "Lipodystrophy, Congenital Generalized, Type 4",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:51636",
            "phenodigmScore": 54.35,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0002718 Recurrent bacterial infections,HP:0100806 Sepsis,HP:0001875 Neutropenia,HP:0002090 Pneumonia,HP:0002110 Bronchiectasis,HP:0002840 Lymphadenitis,HP:0004313 Decreased circulating antibody level,HP:0011850 Parotitis,HP:0001287 Meningitis,HP:0000166 Severe periodontitis,HP:0000388 Otitis media,HP:0006532 Recurrent pneumonia,HP:0002788 Recurrent upper respiratory tract infections,HP:0001888 Lymphopenia,HP:0011992 Abnormality of neutrophil morphology",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "40.64",
            "diseaseModelAvgRaw": "0.91",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "68.06",
            "markerNumModels": "9",
            "diseaseTerm": "Whim Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:172",
            "phenodigmScore": 49.335,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001744 Splenomegaly,HP:0001396 Cholestasis,HP:0002901 Hypocalcemia,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.97",
            "diseaseModelAvgRaw": "0.39",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "78.7",
            "markerNumModels": "9",
            "diseaseTerm": "Progressive Familial Intrahepatic Cholestasis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:533",
            "phenodigmScore": 57.945,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0030049 Brain abscess,HP:0100806 Sepsis,HP:0003095 Septic arthritis,HP:0011450 Unusual CNS infection,HP:0002955 Granulomatosis,HP:0000952 Jaundice,HP:0100523 Liver abscess,HP:0000509 Conjunctivitis,HP:0001701 Pericarditis,HP:0002383 Infectious encephalitis,HP:0002754 Osteomyelitis,HP:0012089 Arteritis,HP:0010987 Abnormal cellular immune system morphology,HP:0001082 Cholecystitis,HP:0200039 Pustule,HP:0002090 Pneumonia,HP:0100584 Endocarditis,HP:0025615 Abscess,HP:0012330 Pyelonephritis,HP:0011955 Hepatic granulomatosis,HP:0032162 Unusual skin infection,HP:0025059 Splenic abscess,HP:0002586 Peritonitis,HP:0001287 Meningitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "27.25",
            "diseaseModelAvgRaw": "0.59",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "88.64",
            "markerNumModels": "9",
            "diseaseTerm": "Listeriosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615846",
            "phenodigmScore": 61.235,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001047 Atopic dermatitis,HP:0002240 Hepatomegaly,HP:0001744 Splenomegaly,HP:0010702 Increased circulating antibody level,HP:0002059 Cerebral atrophy,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "40.96",
            "diseaseModelAvgRaw": "0.82",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "81.51",
            "markerNumModels": "9",
            "diseaseTerm": "Aicardi-Goutieres Syndrome 7",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613502",
            "phenodigmScore": 63.14,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0004432 Agammaglobulinemia,HP:0001875 Neutropenia,HP:0011109 Chronic sinusitis,HP:0000403 Recurrent otitis media,HP:0006532 Recurrent pneumonia,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "52.2",
            "diseaseModelAvgRaw": "1.16",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "1.98",
            "diseaseModelMaxNorm": "74.08",
            "markerNumModels": "9",
            "diseaseTerm": "Agammaglobulinemia 4, Autosomal Recessive",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:179494",
            "phenodigmScore": 49.56,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002788 Recurrent upper respiratory tract infections,HP:0005419 Decreased T cell activation,HP:0002155 Hypertriglyceridemia,HP:0005407 Decreased proportion of CD4-positive helper T cells",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "28.87",
            "diseaseModelAvgRaw": "0.64",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.15",
            "diseaseModelMaxNorm": "70.25",
            "markerNumModels": "9",
            "diseaseTerm": "Obesity Due To Leptin Receptor Gene Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:608971",
            "phenodigmScore": 63.42,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0000964 Eczema,HP:0005390 Recurrent opportunistic infections,HP:0002090 Pneumonia,HP:0008866 Failure to thrive secondary to recurrent infections,HP:0002716 Lymphadenopathy,HP:0001744 Splenomegaly,HP:0000388 Otitis media,HP:0005403 T lymphocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "39.62",
            "diseaseModelAvgRaw": "0.84",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "87.22",
            "markerNumModels": "9",
            "diseaseTerm": "Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Positive, Nk Cell-Positive",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:29073",
            "phenodigmScore": 55.614999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002152 Hyperproteinemia,HP:0003072 Hypercalcemia,HP:0003261 Increased circulating IgA level,HP:0002716 Lymphadenopathy,HP:0003259 Elevated circulating creatinine concentration,HP:0004313 Decreased circulating antibody level,HP:0001903 Anemia,HP:0003237 Increased circulating IgG level,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "33.4",
            "diseaseModelAvgRaw": "0.77",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.6",
            "diseaseModelMaxNorm": "77.83",
            "markerNumModels": "9",
            "diseaseTerm": "Multiple Myeloma",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:236000",
            "phenodigmScore": 74.89,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003347 Impaired lymphocyte transformation with phytohemagglutinin,HP:0003459 Polyclonal elevation of IgM",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "49.78",
            "diseaseModelAvgRaw": "1.0",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.64",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Lymphoma, Hodgkin, Classic",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615518",
            "phenodigmScore": 55.485,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010976 B lymphocytopenia,HP:0002110 Bronchiectasis,HP:0000403 Recurrent otitis media,HP:0002788 Recurrent upper respiratory tract infections,HP:0032275 Recurrent shingles,HP:0006532 Recurrent pneumonia,HP:0005407 Decreased proportion of CD4-positive helper T cells,HP:0001888 Lymphopenia,HP:0033222 Decreased CD4:CD8 ratio,HP:0005403 T lymphocytopenia,HP:0011108 Recurrent sinusitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "38.57",
            "diseaseModelAvgRaw": "0.86",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.15",
            "diseaseModelMaxNorm": "72.4",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 13",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:664",
            "phenodigmScore": 46.12,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001744 Splenomegaly,HP:0001987 Hyperammonemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "16.78",
            "diseaseModelAvgRaw": "0.44",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "75.46",
            "markerNumModels": "9",
            "diseaseTerm": "Ornithine Transcarbamylase Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:99811",
            "phenodigmScore": 54.07,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004313 Decreased circulating antibody level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "36.0",
            "diseaseModelAvgRaw": "0.82",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.07",
            "diseaseModelMaxNorm": "72.14",
            "markerNumModels": "9",
            "diseaseTerm": "Neuronal Intestinal Pseudoobstruction",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:98292",
            "phenodigmScore": 45.475,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003072 Hypercalcemia,HP:0002240 Hepatomegaly,HP:0002488 Acute leukemia,HP:0005558 Chronic leukemia,HP:0001744 Splenomegaly,HP:0100495 Mastocytosis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.59",
            "diseaseModelAvgRaw": "0.49",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "69.36",
            "markerNumModels": "9",
            "diseaseTerm": "Mastocytosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:36412",
            "phenodigmScore": 50.545,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0002240 Hepatomegaly,HP:0100534 Episcleritis,HP:0001541 Ascites,HP:0002716 Lymphadenopathy,HP:0001369 Arthritis,HP:0001744 Splenomegaly,HP:0004431 Complement deficiency,HP:0001287 Meningitis,HP:0000554 Uveitis,HP:0100533 Inflammatory abnormality of the eye,HP:0000988 Skin rash,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.75",
            "diseaseModelAvgRaw": "0.5",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "77.34",
            "markerNumModels": "9",
            "diseaseTerm": "Hypocomplementemic Urticarial Vasculitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:619632",
            "phenodigmScore": 66.175,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004840 Hypochromic microcytic anemia,HP:0002110 Bronchiectasis,HP:0003261 Increased circulating IgA level,HP:0003237 Increased circulating IgG level,HP:0002783 Recurrent lower respiratory tract infections,HP:0003212 Increased circulating IgE level,HP:0100280 Crohn's disease,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0031891 Decreased eosinophil count",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "46.6",
            "diseaseModelAvgRaw": "1.1",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.6",
            "diseaseModelMaxNorm": "85.75",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 89 And Autoimmunity",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:183675",
            "phenodigmScore": 59.724999999999994,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0030151 Cholangitis,HP:0100806 Sepsis,HP:0012476 Decreased specific pneumococcal antibody level,HP:0005353 Recurrent herpes,HP:0002719 Recurrent infections,HP:0002850 Decreased circulating total IgM,HP:0002205 Recurrent respiratory infections,HP:0100523 Liver abscess,HP:0003193 Allergic rhinitis,HP:0032262 Pulmonary tuberculosis,HP:0000031 Epididymitis,HP:0011109 Chronic sinusitis,HP:0002783 Recurrent lower respiratory tract infections,HP:0000010 Recurrent urinary tract infections,HP:0006532 Recurrent pneumonia,HP:0000988 Skin rash,HP:0020096 Recurrent streptococcal infections,HP:0001082 Cholecystitis,HP:0011110 Recurrent tonsillitis,HP:0001047 Atopic dermatitis,HP:0002090 Pneumonia,HP:0002720 Decreased circulating IgA level,HP:0001369 Arthritis,HP:0032275 Recurrent shingles,HP:0006562 Viral hepatitis,HP:0032169 Severe infection,HP:0002718 Recurrent bacterial infections,HP:0003765 Psoriasiform dermatitis,HP:0002110 Bronchiectasis,HP:0004315 Decreased circulating IgG level,HP:0000403 Recurrent otitis media,HP:0005231 Chronic gastritis,HP:0002788 Recurrent upper respiratory tract infections,HP:0001370 Rheumatoid arthritis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "46.29",
            "diseaseModelAvgRaw": "1.04",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "73.16",
            "markerNumModels": "9",
            "diseaseTerm": "Recurrent Infections Associated With Rare Immunoglobulin Isotypes Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:606002",
            "phenodigmScore": 46.515,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0006879 Pontocerebellar atrophy,HP:0001272 Cerebellar atrophy,HP:0003236 Elevated circulating creatine kinase concentration,HP:0010702 Increased circulating antibody level,HP:0006254 Elevated alpha-fetoprotein",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "22.9",
            "diseaseModelAvgRaw": "0.49",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "70.13",
            "markerNumModels": "9",
            "diseaseTerm": "Spinocerebellar Ataxia, Autosomal Recessive, With Axonal Neuropathy 2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:259660",
            "phenodigmScore": 62.86,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0005789 Generalized osteosclerosis,HP:0002749 Osteomalacia,HP:0011001 Increased bone mineral density",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "60.05",
            "diseaseModelAvgRaw": "1.33",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.99",
            "diseaseModelMaxNorm": "65.67",
            "markerNumModels": "9",
            "diseaseTerm": "Osteomalacia, Sclerosing, With Cerebral Calcification",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "ORPHA:457485",
            "phenodigmScore": 46.065,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002720 Decreased circulating IgA level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "14.94",
            "diseaseModelAvgRaw": "0.3",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "77.19",
            "markerNumModels": "9",
            "diseaseTerm": "Macrocephaly-Intellectual Disability-Neurodevelopmental Disorder-Small Thorax Syndrome",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:605309",
            "phenodigmScore": 60.67,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0004313 Decreased circulating antibody level,HP:0002719 Recurrent infections,HP:0001744 Splenomegaly,HP:0001888 Lymphopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "48.79",
            "diseaseModelAvgRaw": "1.05",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "72.55",
            "markerNumModels": "9",
            "diseaseTerm": "Macrocephaly/Autism Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:379",
            "phenodigmScore": 50.684999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0100806 Sepsis,HP:0000964 Eczema,HP:0002240 Hepatomegaly,HP:0100721 Mediastinal lymphadenopathy,HP:0001744 Splenomegaly,HP:0001287 Meningitis,HP:0000388 Otitis media,HP:0100533 Inflammatory abnormality of the eye,HP:0002205 Recurrent respiratory infections,HP:0001874 Abnormality of neutrophils,HP:0100523 Liver abscess",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "30.24",
            "diseaseModelAvgRaw": "0.67",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "71.13",
            "markerNumModels": "9",
            "diseaseTerm": "Chronic Granulomatous Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:616100",
            "phenodigmScore": 66.48,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003765 Psoriasiform dermatitis,HP:0000964 Eczema,HP:0100806 Sepsis,HP:0002240 Hepatomegaly,HP:0002110 Bronchiectasis,HP:0002720 Decreased circulating IgA level,HP:0002716 Lymphadenopathy,HP:0004315 Decreased circulating IgG level,HP:0004313 Decreased circulating antibody level,HP:0001369 Arthritis,HP:0002783 Recurrent lower respiratory tract infections,HP:0001744 Splenomegaly,HP:0100280 Crohn's disease,HP:0002788 Recurrent upper respiratory tract infections,HP:0001973 Autoimmune thrombocytopenia,HP:0001888 Lymphopenia,HP:0002850 Decreased circulating total IgM,HP:0001890 Autoimmune hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "56.43",
            "diseaseModelAvgRaw": "1.32",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "76.53",
            "markerNumModels": "9",
            "diseaseTerm": "Immune Dysregulation With Autoimmunity, Immunodeficiency, And Lymphoproliferation",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:906",
            "phenodigmScore": 47.065,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0100806 Sepsis,HP:0000964 Eczema,HP:0002037 Inflammation of the large intestine,HP:0001875 Neutropenia,HP:0011869 Abnormal platelet function,HP:0000389 Chronic otitis media,HP:0000778 Hypoplasia of the thymus,HP:0005558 Chronic leukemia,HP:0002205 Recurrent respiratory infections,HP:0001878 Hemolytic anemia,HP:0000509 Conjunctivitis,HP:0002488 Acute leukemia,HP:0011875 Abnormal platelet morphology,HP:0001888 Lymphopenia,HP:0000498 Blepharitis,HP:0001369 Arthritis,HP:0000388 Otitis media,HP:0001935 Microcytic anemia,HP:0001903 Anemia,HP:0000491 Keratitis,HP:0001287 Meningitis,HP:0001879 Abnormal eosinophil morphology,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "24.86",
            "diseaseModelAvgRaw": "0.6",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "69.27",
            "markerNumModels": "9",
            "diseaseTerm": "Wiskott-Aldrich Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:2137",
            "phenodigmScore": 60.405,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002037 Inflammation of the large intestine,HP:0001402 Hepatocellular carcinoma,HP:0001541 Ascites,HP:0030991 Sclerosing cholangitis,HP:0004787 Fulminant hepatitis,HP:0003237 Increased circulating IgG level,HP:0001369 Arthritis,HP:0200119 Acute hepatitis,HP:0003573 Increased total bilirubin,HP:0001744 Splenomegaly,HP:0010702 Increased circulating antibody level,HP:0100646 Thyroiditis,HP:0006555 Diffuse hepatic steatosis,HP:0001394 Cirrhosis,HP:0006562 Viral hepatitis,HP:0000099 Glomerulonephritis,HP:0100279 Ulcerative colitis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "34.14",
            "diseaseModelAvgRaw": "0.81",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.6",
            "diseaseModelMaxNorm": "86.67",
            "markerNumModels": "9",
            "diseaseTerm": "Autoimmune Hepatitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:181000",
            "phenodigmScore": 46.83,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002037 Inflammation of the large intestine,HP:0100721 Mediastinal lymphadenopathy,HP:0002110 Bronchiectasis,HP:0001369 Arthritis,HP:0001744 Splenomegaly,HP:0010702 Increased circulating antibody level,HP:0000554 Uveitis,HP:0001094 Iridocyclitis,HP:0008940 Generalized lymphadenopathy,HP:0011840 Abnormality of T cell physiology,HP:0001876 Pancytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "27.35",
            "diseaseModelAvgRaw": "0.64",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "66.31",
            "markerNumModels": "9",
            "diseaseTerm": "Sarcoidosis, Susceptibility To, 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:90000",
            "phenodigmScore": 55.614999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010702 Increased circulating antibody level,HP:0000988 Skin rash",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "35.93",
            "diseaseModelAvgRaw": "0.74",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "75.3",
            "markerNumModels": "9",
            "diseaseTerm": "Erythema Elevatum Diutinum",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:449400",
            "phenodigmScore": 60.135000000000005,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0032300 Increased circulating IgG4 level,HP:0004431 Complement deficiency,HP:0003212 Increased circulating IgE level,HP:0010702 Increased circulating antibody level,HP:0012649 Increased inflammatory response,HP:0032061 Hypereosinophilia,HP:0011227 Elevated circulating C-reactive protein concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "36.34",
            "diseaseModelAvgRaw": "0.8",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.52",
            "diseaseModelMaxNorm": "83.93",
            "markerNumModels": "9",
            "diseaseTerm": "Igg4-Related Aortitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:74",
            "phenodigmScore": 61.05499999999999,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003261 Increased circulating IgA level,HP:0003237 Increased circulating IgG level,HP:0032336 Increased circulating specific IgE antibody,HP:0001287 Meningitis,HP:0032061 Hypereosinophilia,HP:0003496 Increased circulating IgM level,HP:0011450 Unusual CNS infection",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "33.79",
            "diseaseModelAvgRaw": "0.69",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "88.32",
            "markerNumModels": "9",
            "diseaseTerm": "Angiostrongyliasis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:217390",
            "phenodigmScore": 65.4,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001047 Atopic dermatitis,HP:0010976 B lymphocytopenia,HP:0002090 Pneumonia,HP:0000389 Chronic otitis media,HP:0004429 Recurrent viral infections,HP:0012203 Onychomycosis,HP:0003212 Increased circulating IgE level,HP:0005406 Recurrent bacterial skin infections,HP:0005401 Recurrent candida infections,HP:0002205 Recurrent respiratory infections,HP:0005403 T lymphocytopenia,HP:0011108 Recurrent sinusitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "51.89",
            "diseaseModelAvgRaw": "1.13",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "78.91",
            "markerNumModels": "9",
            "diseaseTerm": "Combined Immunodeficiency Due To Dock8 Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:70593",
            "phenodigmScore": 67.86500000000001,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0001047 Atopic dermatitis,HP:0010976 B lymphocytopenia,HP:0410299 Decreased specific antibody response to polysaccharide vaccine,HP:0012384 Rhinitis,HP:0200117 Recurrent upper and lower respiratory tract infections,HP:0002848 Decreased specific anti-polysaccharide antibody level,HP:0410303 Complete or near-complete absence of specific antibody response to Haemophilus influenzae type b (Hib) vaccine,HP:0410302 Decreased specific antibody response to protein-conjugated polysaccharide vaccine,HP:0007274 Recurrent bacterial meningitis,HP:0000388 Otitis media,HP:0031949 Recurrent bacterial upper respiratory tract infections,HP:0030374 Decreased proportion of memory B cells,HP:0410300 Complete or near-complete absence of specific antibody response to unconjugated pneumococcus vaccine",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "59.75",
            "diseaseModelAvgRaw": "1.28",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.18",
            "diseaseModelMaxNorm": "75.98",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency Due To Selective Anti-Polysaccharide Antibody Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:3202",
            "phenodigmScore": 47.815000000000005,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004804 Congenital hemolytic anemia,HP:0001972 Macrocytic anemia,HP:0001981 Schistocytosis,HP:0005518 Increased mean corpuscular volume,HP:0003265 Neonatal hyperbilirubinemia,HP:0001901 Polycythemia,HP:0020063 Increased hemoglobin concentration,HP:0003573 Increased total bilirubin,HP:0001081 Cholelithiasis,HP:0001744 Splenomegaly,HP:0003281 Increased circulating ferritin concentration,HP:0011042 Abnormal blood potassium concentration,HP:0001930 Nonspherocytic hemolytic anemia,HP:0025548 Increased mean corpuscular hemoglobin concentration,HP:0001923 Reticulocytosis,HP:0001878 Hemolytic anemia,HP:0001046 Intermittent jaundice,HP:0010972 Anemia of inadequate production",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "27.98",
            "diseaseModelAvgRaw": "0.67",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "67.65",
            "markerNumModels": "9",
            "diseaseTerm": "Dehydrated Hereditary Stomatocytosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:48104",
            "phenodigmScore": 55.03999999999999,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002037 Inflammation of the large intestine,HP:0200039 Pustule,HP:0100614 Myositis,HP:0010702 Increased circulating antibody level,HP:0001370 Rheumatoid arthritis,HP:0012324 Myeloid leukemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "36.51",
            "diseaseModelAvgRaw": "0.83",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "73.57",
            "markerNumModels": "9",
            "diseaseTerm": "Pyoderma Gangrenosum",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:1414",
            "phenodigmScore": 47.335,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0011985 Acholic stools,HP:0003077 Hyperlipidemia,HP:0001080 Biliary tract abnormality,HP:0100763 Abnormality of the lymphatic system,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0006566 Neonatal cholestatic liver disease,HP:0001409 Portal hypertension,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.66",
            "diseaseModelAvgRaw": "0.46",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "74.01",
            "markerNumModels": "9",
            "diseaseTerm": "Cholestasis-Lymphedema Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:95513",
            "phenodigmScore": 41.629999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0007041 Chronic lymphocytic meningitis,HP:0001895 Normochromic anemia,HP:0002902 Hyponatremia,HP:0000872 Hashimoto thyroiditis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "12.8",
            "diseaseModelAvgRaw": "0.31",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.18",
            "diseaseModelMaxNorm": "70.46",
            "markerNumModels": "9",
            "diseaseTerm": "Panhypophysitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:90280",
            "phenodigmScore": 59.47,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0011123 Inflammatory abnormality of the skin,HP:0007417 Discoid lupus rash,HP:0012325 Chronic myelomonocytic leukemia,HP:0025300 Malar rash,HP:0010702 Increased circulating antibody level,HP:0000988 Skin rash",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "35.4",
            "diseaseModelAvgRaw": "0.75",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "83.54",
            "markerNumModels": "9",
            "diseaseTerm": "Chilblain Lupus",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:202700",
            "phenodigmScore": 64.3,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0001894 Thrombocytosis,HP:0001875 Neutropenia,HP:0012311 Monocytosis,HP:0005541 Congenital agranulocytosis,HP:0001903 Anemia,HP:0010702 Increased circulating antibody level,HP:0004845 Acute monocytic leukemia,HP:0001880 Eosinophilia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "48.27",
            "diseaseModelAvgRaw": "1.21",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "80.33",
            "markerNumModels": "9",
            "diseaseTerm": "Neutropenia, Severe Congenital, 1, Autosomal Dominant",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:231393",
            "phenodigmScore": 53.084999999999994,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0011869 Abnormal platelet function,HP:0001903 Anemia,HP:0011902 Abnormal hemoglobin,HP:0001744 Splenomegaly,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "25.93",
            "diseaseModelAvgRaw": "0.57",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "80.24",
            "markerNumModels": "9",
            "diseaseTerm": "Beta-Thalassemia-X-Linked Thrombocytopenia Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:90003",
            "phenodigmScore": 53.175,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0031140 Abnormal liver sonography,HP:0002896 Neoplasm of the liver,HP:0001394 Cirrhosis,HP:0410369 Increased hepatitis B virus antibody level,HP:0001080 Biliary tract abnormality",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "25.64",
            "diseaseModelAvgRaw": "0.56",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "80.71",
            "markerNumModels": "9",
            "diseaseTerm": "Inflammatory Pseudotumor Of The Liver",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:206594",
            "phenodigmScore": 61.43,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0032169 Severe infection,HP:0003237 Increased circulating IgG level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "27.67",
            "diseaseModelAvgRaw": "0.53",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.6",
            "diseaseModelMaxNorm": "95.19",
            "markerNumModels": "9",
            "diseaseTerm": "Subacute Inflammatory Demyelinating Polyneuropathy",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:269920",
            "phenodigmScore": 50.635,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001541 Ascites,HP:0001922 Vacuolated lymphocytes,HP:0001640 Cardiomegaly,HP:0001744 Splenomegaly,HP:0002908 Conjugated hyperbilirubinemia,HP:0002059 Cerebral atrophy",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.42",
            "diseaseModelAvgRaw": "0.41",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "80.85",
            "markerNumModels": "9",
            "diseaseTerm": "Infantile Sialic Acid Storage Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:90368",
            "phenodigmScore": 51.44,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001047 Atopic dermatitis,HP:0003212 Increased circulating IgE level,HP:0003193 Allergic rhinitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "27.02",
            "diseaseModelAvgRaw": "0.64",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "75.86",
            "markerNumModels": "9",
            "diseaseTerm": "Hypotrichosis Simplex Of The Scalp",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:3226",
            "phenodigmScore": 52.065,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0002240 Hepatomegaly,HP:0001873 Thrombocytopenia,HP:0002488 Acute leukemia,HP:0000389 Chronic otitis media,HP:0002716 Lymphadenopathy,HP:0005528 Bone marrow hypocellularity,HP:0001744 Splenomegaly,HP:0005547 Myeloproliferative disorder,HP:0011991 Abnormal neutrophil count,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "29.18",
            "diseaseModelAvgRaw": "0.65",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "74.95",
            "markerNumModels": "9",
            "diseaseTerm": "Deafness-Lymphedema-Leukemia Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:614493",
            "phenodigmScore": 72.61500000000001,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000964 Eczema,HP:0030253 Defective T cell proliferation,HP:0012178 Reduced natural killer cell activity,HP:0002719 Recurrent infections,HP:0005415 Decreased proportion of CD8-positive T cells,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "47.47",
            "diseaseModelAvgRaw": "1.13",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.65",
            "diseaseModelMaxNorm": "97.76",
            "markerNumModels": "9",
            "diseaseTerm": "Wiskott-Aldrich Syndrome 2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:616828",
            "phenodigmScore": 52.06999999999999,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0003141 Increased LDL cholesterol concentration,HP:0003236 Elevated circulating creatine kinase concentration,HP:0010837 Decreased circulating ceruloplasmin concentration,HP:0001744 Splenomegaly,HP:0003124 Hypercholesterolemia,HP:0001394 Cirrhosis,HP:0001433 Hepatosplenomegaly,HP:0002611 Cholestatic liver disease,HP:0006579 Prolonged neonatal jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "24.15",
            "diseaseModelAvgRaw": "0.51",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "79.99",
            "markerNumModels": "9",
            "diseaseTerm": "Congenital Disorder Of Glycosylation, Type Iio",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:1562",
            "phenodigmScore": 58.99,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010739 Osteopoikilosis,HP:0011001 Increased bone mineral density",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "47.36",
            "diseaseModelAvgRaw": "1.23",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.99",
            "diseaseModelMaxNorm": "70.62",
            "markerNumModels": "9",
            "diseaseTerm": "Dacryocystitis-Osteopoikilosis Syndrome",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "ORPHA:83471",
            "phenodigmScore": 61.35,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0100806 Sepsis,HP:0000389 Chronic otitis media,HP:0002716 Lymphadenopathy,HP:0002719 Recurrent infections,HP:0005401 Recurrent candida infections,HP:0031430 Oligoclonal T cell expansion,HP:0003472 Hypocalcemic tetany,HP:0031690 Opportunistic infection,HP:0000010 Recurrent urinary tract infections,HP:0020101 Invasive fungal infection,HP:0005366 Recurrent streptococcus pneumoniae infections,HP:0005403 T lymphocytopenia,HP:0031397 Decreased proportion of naive T cells,HP:0002090 Pneumonia,HP:0004844 Coombs-positive hemolytic anemia,HP:0009098 Chronic oral candidiasis,HP:0031381 Decreased lymphocyte proliferation in response to mitogen,HP:0032169 Severe infection,HP:0002726 Recurrent Staphylococcus aureus infections,HP:0200122 Atypical or prolonged hepatitis,HP:0002718 Recurrent bacterial infections,HP:0000976 Eczematoid dermatitis,HP:0004798 Recurrent infection of the gastrointestinal tract,HP:0005359 Aplasia of the thymus,HP:0001287 Meningitis,HP:0031691 Severe viral infection,HP:0100646 Thyroiditis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "52.92",
            "diseaseModelAvgRaw": "1.18",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "69.78",
            "markerNumModels": "9",
            "diseaseTerm": "Thymic Aplasia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:233600",
            "phenodigmScore": 64.505,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012302 Herpes simplex encephalitis,HP:0100806 Sepsis,HP:0002240 Hepatomegaly,HP:0030388 Decreased proportion of class-switched memory B cells,HP:0004313 Decreased circulating antibody level,HP:0040154 Acne inversa,HP:0002783 Recurrent lower respiratory tract infections,HP:0002788 Recurrent upper respiratory tract infections,HP:0001581 Recurrent skin infections,HP:0012089 Arteritis,HP:0006579 Prolonged neonatal jaundice,HP:0011107 Recurrent aphthous stomatitis,HP:0410300 Complete or near-complete absence of specific antibody response to unconjugated pneumococcus vaccine",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "43.6",
            "diseaseModelAvgRaw": "0.95",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.7",
            "diseaseModelMaxNorm": "85.41",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 59 And Hypoglycemia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:612260",
            "phenodigmScore": 53.769999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0010976 B lymphocytopenia,HP:0002840 Lymphadenitis,HP:0025615 Abscess,HP:0003095 Septic arthritis,HP:0001581 Recurrent skin infections,HP:0005403 T lymphocytopenia,HP:0040089 Abnormal natural killer cell count,HP:0006946 Recurrent meningitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "35.15",
            "diseaseModelAvgRaw": "0.86",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "72.39",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 68",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615688",
            "phenodigmScore": 52.760000000000005,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000964 Eczema,HP:0002716 Lymphadenopathy,HP:0004313 Decreased circulating antibody level,HP:0002719 Recurrent infections,HP:0001744 Splenomegaly,HP:0001433 Hepatosplenomegaly,HP:0001876 Pancytopenia,HP:0001409 Portal hypertension,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0001974 Leukocytosis,HP:0005528 Bone marrow hypocellularity,HP:0000988 Skin rash,HP:0001888 Lymphopenia,HP:0012219 Erythema nodosum,HP:0002240 Hepatomegaly,HP:0012490 Panniculitis,HP:0001369 Arthritis,HP:0001894 Thrombocytosis,HP:0001882 Leukopenia,HP:0000403 Recurrent otitis media,HP:0001903 Anemia,HP:0000872 Hashimoto thyroiditis,HP:0011108 Recurrent sinusitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "37.65",
            "diseaseModelAvgRaw": "0.83",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "67.87",
            "markerNumModels": "9",
            "diseaseTerm": "Vasculitis, Autoinflammation, Immunodeficiency, And Hematologic Defects Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:90362",
            "phenodigmScore": 59.96,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia,HP:0001541 Ascites,HP:0100766 Abnormal lymphatic vessel morphology,HP:0002720 Decreased circulating IgA level,HP:0004315 Decreased circulating IgG level,HP:0004313 Decreased circulating antibody level,HP:0031690 Opportunistic infection,HP:0001903 Anemia,HP:0002901 Hypocalcemia,HP:0002917 Hypomagnesemia,HP:0025624 Reduced proportion of CD4+ effector memory T cells,HP:0045080 Decreased proportion of CD3-positive T cells,HP:0002593 Intestinal lymphangiectasia,HP:0001888 Lymphopenia,HP:0002850 Decreased circulating total IgM,HP:0003073 Hypoalbuminemia,HP:0032160 Cryptococcal meningitis,HP:0030995 Peritoneal effusion",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "44.78",
            "diseaseModelAvgRaw": "1.04",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "75.14",
            "markerNumModels": "9",
            "diseaseTerm": "Primary Intestinal Lymphangiectasia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:610333",
            "phenodigmScore": 49.68000000000001,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001272 Cerebellar atrophy,HP:0001744 Splenomegaly,HP:0001433 Hepatosplenomegaly,HP:0002059 Cerebral atrophy,HP:0001876 Pancytopenia,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.57",
            "diseaseModelAvgRaw": "0.39",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000691 enlarged spleen,MP:0003224 neuron degeneration,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "79.79",
            "markerNumModels": "9",
            "diseaseTerm": "Aicardi-Goutieres Syndrome 4",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:77293",
            "phenodigmScore": 39.775,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0003233 Decreased HDL cholesterol concentration,HP:0003077 Hyperlipidemia,HP:0003141 Increased LDL cholesterol concentration,HP:0003119 Abnormal circulating lipid concentration,HP:0001081 Cholelithiasis,HP:0002896 Neoplasm of the liver,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0004836 Acute promyelocytic leukemia,HP:0001971 Hypersplenism,HP:0001973 Autoimmune thrombocytopenia,HP:0002155 Hypertriglyceridemia,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.49",
            "diseaseModelAvgRaw": "0.4",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "61.06",
            "markerNumModels": "9",
            "diseaseTerm": "Chronic Visceral Acid Sphingomyelinase Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618394",
            "phenodigmScore": 63.875,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002110 Bronchiectasis,HP:0002720 Decreased circulating IgA level,HP:0005425 Recurrent sinopulmonary infections,HP:0004315 Decreased circulating IgG level,HP:0001744 Splenomegaly,HP:0100280 Crohn's disease,HP:0031808 Decreased basophil count,HP:0002850 Decreased circulating total IgM,HP:0030374 Decreased proportion of memory B cells,HP:0001876 Pancytopenia,HP:0002583 Colitis,HP:0005479 Decreased circulating IgE,HP:0100279 Ulcerative colitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "48.28",
            "diseaseModelAvgRaw": "1.18",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "79.47",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 60 And Autoimmunity",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:162700",
            "phenodigmScore": 68.265,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000704 Periodontitis,HP:0010702 Increased circulating antibody level,HP:0001875 Neutropenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "47.49",
            "diseaseModelAvgRaw": "0.93",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "89.04",
            "markerNumModels": "9",
            "diseaseTerm": "Neutropenia, Chronic Familial",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:98849",
            "phenodigmScore": 46.73,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0002240 Hepatomegaly,HP:0005550 Chronic lymphatic leukemia,HP:0001897 Normocytic anemia,HP:0002716 Lymphadenopathy,HP:0001895 Normochromic anemia,HP:0012325 Chronic myelomonocytic leukemia,HP:0001744 Splenomegaly,HP:0100494 Abnormal mast cell morphology,HP:0004808 Acute myeloid leukemia,HP:0005547 Myeloproliferative disorder,HP:0011897 Neutrophilia,HP:0031807 Increased basophil count,HP:0012324 Myeloid leukemia,HP:0001873 Thrombocytopenia,HP:0001880 Eosinophilia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "22.83",
            "diseaseModelAvgRaw": "0.51",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "70.63",
            "markerNumModels": "9",
            "diseaseTerm": "Systemic Mastocytosis With Associated Hematologic Neoplasm",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:228119",
            "phenodigmScore": 51.375,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0030049 Brain abscess,HP:0001875 Neutropenia,HP:0100537 Fasciitis,HP:0040186 Maculopapular exanthema,HP:0011450 Unusual CNS infection,HP:0025044 Lung abscess,HP:0012203 Onychomycosis,HP:0002754 Osteomyelitis,HP:0001888 Lymphopenia,HP:0020101 Invasive fungal infection,HP:0001743 Abnormality of the spleen,HP:0002090 Pneumonia,HP:0012490 Panniculitis,HP:0001369 Arthritis,HP:0001392 Abnormality of the liver,HP:0002110 Bronchiectasis,HP:0002586 Peritonitis,HP:0100614 Myositis,HP:0000491 Keratitis,HP:0032252 Granuloma",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "30.89",
            "diseaseModelAvgRaw": "0.64",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "71.86",
            "markerNumModels": "9",
            "diseaseTerm": "Fusariosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:237800",
            "phenodigmScore": 52.805,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0012132 Erythroid hyperplasia,HP:0002904 Hyperbilirubinemia,HP:0001744 Splenomegaly,HP:0000952 Jaundice,HP:0001923 Reticulocytosis,HP:0010972 Anemia of inadequate production",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "26.62",
            "diseaseModelAvgRaw": "0.63",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "78.99",
            "markerNumModels": "9",
            "diseaseTerm": "Hyperbilirubinemia, Shunt, Primary",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:75564",
            "phenodigmScore": 54.165000000000006,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0031035 Chronic infection,HP:0002240 Hepatomegaly,HP:0001875 Neutropenia,HP:0001897 Normocytic anemia,HP:0001894 Thrombocytosis,HP:0200143 Megaloblastic erythroid hyperplasia,HP:0012132 Erythroid hyperplasia,HP:0001895 Normochromic anemia,HP:0005528 Bone marrow hypocellularity,HP:0011447 Hyposegmentation of neutrophil nuclei,HP:0001931 Hypochromic anemia,HP:0001744 Splenomegaly,HP:0004808 Acute myeloid leukemia,HP:0001876 Pancytopenia,HP:0001873 Thrombocytopenia,HP:0001913 Granulocytopenia,HP:0010972 Anemia of inadequate production",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "33.38",
            "diseaseModelAvgRaw": "0.73",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "74.95",
            "markerNumModels": "9",
            "diseaseTerm": "Acquired Idiopathic Sideroblastic Anemia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618165",
            "phenodigmScore": 56.955,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004313 Decreased circulating antibody level,HP:0001903 Anemia,HP:0012410 Pure red cell aplasia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "42.24",
            "diseaseModelAvgRaw": "0.85",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.07",
            "diseaseModelMaxNorm": "71.67",
            "markerNumModels": "9",
            "diseaseTerm": "Bone Marrow Failure Syndrome 5",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:210250",
            "phenodigmScore": 50.06,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004446 Stomatocytosis,HP:0004802 Episodic hemolytic anemia,HP:0033341 Elevated circulating sitosterol concentration,HP:0001369 Arthritis,HP:0001744 Splenomegaly,HP:0003124 Hypercholesterolemia,HP:0001392 Abnormality of the liver,HP:0001902 Giant platelets,HP:0004870 Chronic hemolytic anemia,HP:0001923 Reticulocytosis,HP:0003540 Impaired platelet aggregation,HP:0008158 Hyperapobetalipoproteinemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "32.97",
            "diseaseModelAvgRaw": "0.73",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "67.15",
            "markerNumModels": "9",
            "diseaseTerm": "Sitosterolemia 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:612714",
            "phenodigmScore": 45.645,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0003193 Allergic rhinitis,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0000952 Jaundice,HP:0000988 Skin rash,HP:0001738 Exocrine pancreatic insufficiency,HP:0010972 Anemia of inadequate production",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.09",
            "diseaseModelAvgRaw": "0.43",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "71.2",
            "markerNumModels": "9",
            "diseaseTerm": "Exocrine Pancreatic Insufficiency, Dyserythropoietic Anemia, And Calvarial Hyperostosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:449427",
            "phenodigmScore": 54.17,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0002840 Lymphadenitis,HP:0000123 Nephritis,HP:0032300 Increased circulating IgG4 level,HP:0001733 Pancreatitis,HP:0011850 Parotitis,HP:0004431 Complement deficiency,HP:0001880 Eosinophilia,HP:0011227 Elevated circulating C-reactive protein concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "31.57",
            "diseaseModelAvgRaw": "0.65",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.52",
            "diseaseModelMaxNorm": "76.77",
            "markerNumModels": "9",
            "diseaseTerm": "Igg4-Related Pachymeningitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:90051",
            "phenodigmScore": 50.69,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0002240 Hepatomegaly,HP:0030783 Increased circulating interleukin 6,HP:0001875 Neutropenia,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0031696 Disseminated viral infection,HP:0001287 Meningitis,HP:0040187 Neonatal sepsis,HP:0004387 Enterocolitis,HP:0001873 Thrombocytopenia,HP:0032169 Severe infection,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "28.21",
            "diseaseModelAvgRaw": "0.61",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "73.17",
            "markerNumModels": "9",
            "diseaseTerm": "Sepsis In Premature Infants",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:267900",
            "phenodigmScore": 71.09,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002972 Reduced delayed hypersensitivity,HP:0004315 Decreased circulating IgG level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Camb>/Mavs<tm1Camb>",
            "diseaseModelAvgNorm": "58.99",
            "diseaseModelAvgRaw": "1.34",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008664 decreased interleukin-12 secretion,MP:0002459 abnormal B cell physiology,MP:0005093 decreased B cell proliferation,MP:0008561 decreased tumor necrosis factor secretion",
            "modelId": "MGI:5308089",
            "diseaseModelMaxRaw": "1.91",
            "diseaseModelMaxNorm": "83.19",
            "markerNumModels": "9",
            "diseaseTerm": "Retinal Telangiectasia And Hypogammaglobulinemia",
            "modelGeneticBackground": "involves: 129S6/SvEvTac * C57BL/6"
        },
        {
            "diseaseId": "OMIM:251190",
            "phenodigmScore": 60.085,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004315 Decreased circulating IgG level,HP:0002205 Recurrent respiratory infections,HP:0001875 Neutropenia,HP:0002850 Decreased circulating total IgM",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "35.72",
            "diseaseModelAvgRaw": "0.74",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "84.45",
            "markerNumModels": "9",
            "diseaseTerm": "Microcephalic Primordial Dwarfism, Toriello Type",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:39041",
            "phenodigmScore": 49.0,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0001974 Leukocytosis,HP:0002240 Hepatomegaly,HP:0001019 Erythroderma,HP:0002090 Pneumonia,HP:0002716 Lymphadenopathy,HP:0004332 Abnormal lymphocyte morphology,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0100646 Thyroiditis,HP:0001880 Eosinophilia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "25.08",
            "diseaseModelAvgRaw": "0.56",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "72.92",
            "markerNumModels": "9",
            "diseaseTerm": "Omenn Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615234",
            "phenodigmScore": 52.93,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0032231 Hypochromia,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0003281 Increased circulating ferritin concentration,HP:0004447 Poikilocytosis,HP:0025066 Decreased mean corpuscular volume",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "26.78",
            "diseaseModelAvgRaw": "0.58",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "79.08",
            "markerNumModels": "9",
            "diseaseTerm": "Anemia, Hypochromic Microcytic, With Iron Overload 2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:212750",
            "phenodigmScore": 44.395,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0001972 Macrocytic anemia,HP:0002720 Decreased circulating IgA level,HP:0001891 Iron deficiency anemia,HP:0002901 Hypocalcemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "15.62",
            "diseaseModelAvgRaw": "0.35",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "73.17",
            "markerNumModels": "9",
            "diseaseTerm": "Celiac Disease, Susceptibility To, 1",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:542323",
            "phenodigmScore": 47.73,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0011112 Abnormality of serum cytokine level,HP:0030783 Increased circulating interleukin 6,HP:0003259 Elevated circulating creatinine concentration,HP:0011117 Abnormality of interleukin secretion,HP:0002904 Hyperbilirubinemia,HP:0030356 Increased serum interferon-gamma level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.99",
            "diseaseModelAvgRaw": "0.51",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.18",
            "diseaseModelMaxNorm": "73.47",
            "markerNumModels": "9",
            "diseaseTerm": "Car T Cell Therapy-Associated Cytokine Release Syndrome",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:144120",
            "phenodigmScore": 63.455,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003261 Increased circulating IgA level,HP:0003237 Increased circulating IgG level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "48.47",
            "diseaseModelAvgRaw": "1.25",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.22",
            "diseaseModelMaxNorm": "78.44",
            "markerNumModels": "9",
            "diseaseTerm": "Hyperimmunoglobulin G1(A1) Syndrome",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:79329",
            "phenodigmScore": 49.155,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003347 Impaired lymphocyte transformation with phytohemagglutinin,HP:0004315 Decreased circulating IgG level,HP:0004313 Decreased circulating antibody level,HP:0200117 Recurrent upper and lower respiratory tract infections,HP:0031381 Decreased lymphocyte proliferation in response to mitogen,HP:0012444 Brain atrophy,HP:0003540 Impaired platelet aggregation",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.79",
            "diseaseModelAvgRaw": "0.47",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "74.52",
            "markerNumModels": "9",
            "diseaseTerm": "Mgat2-Cdg",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:555905",
            "phenodigmScore": 52.515,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0200039 Pustule,HP:0003261 Increased circulating IgA level,HP:0031234 Neutrophilic infiltration of the skin,HP:0032335 Monoclonal elevation of circulating IgA,HP:0001880 Eosinophilia,HP:0100279 Ulcerative colitis,HP:0031292 Cutaneous abscess",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "35.7",
            "diseaseModelAvgRaw": "0.81",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "69.33",
            "markerNumModels": "9",
            "diseaseTerm": "Iga Pemphigus",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:169160",
            "phenodigmScore": 68.98,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003460 Decreased circulating total IgA,HP:0001019 Erythroderma,HP:0005353 Recurrent herpes,HP:0002090 Pneumonia,HP:0008866 Failure to thrive secondary to recurrent infections,HP:0004315 Decreased circulating IgG level,HP:0031381 Decreased lymphocyte proliferation in response to mitogen,HP:0012115 Hepatitis,HP:0002719 Recurrent infections,HP:0009098 Chronic oral candidiasis,HP:0045080 Decreased proportion of CD3-positive T cells,HP:0010702 Increased circulating antibody level,HP:0002722 Recurrent abscess formation,HP:0006532 Recurrent pneumonia,HP:0005401 Recurrent candida infections,HP:0000388 Otitis media,HP:0001433 Hepatosplenomegaly,HP:0001888 Lymphopenia,HP:0001880 Eosinophilia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "61.02",
            "diseaseModelAvgRaw": "1.31",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "76.94",
            "markerNumModels": "9",
            "diseaseTerm": "T-B+ Severe Combined Immunodeficiency Due To Cd3Delta/Cd3Epsilon/Cd3Zeta",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:608805",
            "phenodigmScore": 68.17,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0040160 Generalized osteoporosis",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "61.66",
            "diseaseModelAvgRaw": "1.25",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.82",
            "diseaseModelMaxNorm": "74.68",
            "markerNumModels": "9",
            "diseaseTerm": "Avascular Necrosis Of Femoral Head, Primary, 1",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "OMIM:247800",
            "phenodigmScore": 67.09,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002090 Pneumonia,HP:0010702 Increased circulating antibody level,HP:0001888 Lymphopenia,HP:0030150 Plasmacytosis,HP:0000099 Glomerulonephritis,HP:0001890 Autoimmune hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "50.49",
            "diseaseModelAvgRaw": "1.17",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "83.69",
            "markerNumModels": "9",
            "diseaseTerm": "Lymphopenic Hypergammaglobulinemia, Antibody Deficiency, Autoimmune Hemolytic Anemia, And Glomerulonephritis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618987",
            "phenodigmScore": 70.755,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010976 B lymphocytopenia,HP:0004315 Decreased circulating IgG level,HP:0031545 Abnormally low T cell receptor excision circle level,HP:0002850 Decreased circulating total IgM,HP:0025289 Cervical lymphadenopathy,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "57.0",
            "diseaseModelAvgRaw": "1.24",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "84.51",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 73C With Defective Neutrophil Chemotaxis And Hypogammaglobulinemia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:761",
            "phenodigmScore": 49.825,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002383 Infectious encephalitis,HP:0100534 Episcleritis,HP:0200039 Pustule,HP:0001369 Arthritis,HP:0000988 Skin rash,HP:0100796 Orchitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "13.61",
            "diseaseModelAvgRaw": "0.29",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0006082 CNS inflammation",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "86.04",
            "markerNumModels": "9",
            "diseaseTerm": "Immunoglobulin A Vasculitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:169090",
            "phenodigmScore": 52.265,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0100806 Sepsis,HP:0002240 Hepatomegaly,HP:0002090 Pneumonia,HP:0000389 Chronic otitis media,HP:0002841 Recurrent fungal infections,HP:0004429 Recurrent viral infections,HP:0002716 Lymphadenopathy,HP:0001744 Splenomegaly,HP:0001287 Meningitis,HP:0011274 Recurrent mycobacterial infections,HP:0001873 Thrombocytopenia,HP:0001878 Hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "31.2",
            "diseaseModelAvgRaw": "0.72",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "73.33",
            "markerNumModels": "9",
            "diseaseTerm": "Combined Immunodeficiency Due To Crac Channel Dysfunction",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:611490",
            "phenodigmScore": 45.27,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0001433 Hepatosplenomegaly,HP:0001923 Reticulocytosis,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "17.62",
            "diseaseModelAvgRaw": "0.39",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "72.92",
            "markerNumModels": "9",
            "diseaseTerm": "Osteopetrosis,  Autosomal Recessive 4",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:607271",
            "phenodigmScore": 71.78999999999999,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000964 Eczema,HP:0002090 Pneumonia,HP:0005353 Recurrent herpes,HP:0002720 Decreased circulating IgA level,HP:0005425 Recurrent sinopulmonary infections,HP:0004315 Decreased circulating IgG level,HP:0002716 Lymphadenopathy,HP:0033278 Reduced CD95-induced lymphocyte apoptosis,HP:0001744 Splenomegaly,HP:0005384 Defective B cell activation,HP:0005419 Decreased T cell activation,HP:0002850 Decreased circulating total IgM,HP:0033222 Decreased CD4:CD8 ratio,HP:0410300 Complete or near-complete absence of specific antibody response to unconjugated pneumococcus vaccine",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "61.66",
            "diseaseModelAvgRaw": "1.34",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "81.92",
            "markerNumModels": "9",
            "diseaseTerm": "Caspase 8 Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:699",
            "phenodigmScore": 43.144999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001875 Neutropenia,HP:0001873 Thrombocytopenia,HP:0002900 Hypokalemia,HP:0006577 Macronodular cirrhosis,HP:0005528 Bone marrow hypocellularity,HP:0002148 Hypophosphatemia,HP:0001903 Anemia,HP:0003348 Hyperalaninemia,HP:0002917 Hypomagnesemia,HP:0001744 Splenomegaly,HP:0001397 Hepatic steatosis,HP:0001392 Abnormality of the liver,HP:0001923 Reticulocytosis,HP:0002901 Hypocalcemia,HP:0001876 Pancytopenia,HP:0001738 Exocrine pancreatic insufficiency,HP:0032169 Severe infection,HP:0100732 Pancreatic fibrosis,HP:0006270 Hypoplastic spleen",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.13",
            "diseaseModelAvgRaw": "0.44",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "67.16",
            "markerNumModels": "9",
            "diseaseTerm": "Pearson Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:36234",
            "phenodigmScore": 62.97,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0012819 Myocarditis,HP:0100806 Sepsis,HP:0032170 Severe varicella zoster infection,HP:0100537 Fasciitis,HP:0012115 Hepatitis,HP:0003095 Septic arthritis,HP:0032237 Increased circulating myelocyte count,HP:0002383 Infectious encephalitis,HP:0002754 Osteomyelitis,HP:0000010 Recurrent urinary tract infections,HP:0032238 Increased circulating metamyelocyte count,HP:0000988 Skin rash,HP:0003073 Hypoalbuminemia,HP:0002090 Pneumonia,HP:0003236 Elevated circulating creatine kinase concentration,HP:0025615 Abscess,HP:0001369 Arthritis,HP:0002901 Hypocalcemia,HP:0032169 Severe infection,HP:0002586 Peritonitis,HP:0100614 Myositis,HP:0003259 Elevated circulating creatinine concentration,HP:0001287 Meningitis,HP:0001581 Recurrent skin infections,HP:0031691 Severe viral infection,HP:0001873 Thrombocytopenia,HP:0000099 Glomerulonephritis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "31.92",
            "diseaseModelAvgRaw": "0.7",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "94.02",
            "markerNumModels": "9",
            "diseaseTerm": "Bacterial Toxic-Shock Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:1493",
            "phenodigmScore": 53.71,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004315 Decreased circulating IgG level,HP:0002719 Recurrent infections,HP:0002282 Gray matter heterotopia,HP:0002205 Recurrent respiratory infections,HP:0008348 Decreased circulating IgG2 level,HP:0002120 Cerebral cortical atrophy",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "29.22",
            "diseaseModelAvgRaw": "0.59",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0004811 abnormal neuron physiology,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "78.2",
            "markerNumModels": "9",
            "diseaseTerm": "Vici Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:2331",
            "phenodigmScore": 42.980000000000004,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0001974 Leukocytosis,HP:0001701 Pericarditis,HP:0025289 Cervical lymphadenopathy,HP:0100825 Cheilitis,HP:0012115 Hepatitis,HP:0001369 Arthritis,HP:0000952 Jaundice,HP:0001287 Meningitis,HP:0000988 Skin rash,HP:0001082 Cholecystitis,HP:0100776 Recurrent pharyngitis,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.85",
            "diseaseModelAvgRaw": "0.5",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "65.11",
            "markerNumModels": "9",
            "diseaseTerm": "Kawasaki Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:2481",
            "phenodigmScore": 54.43,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0002383 Infectious encephalitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "14.33",
            "diseaseModelAvgRaw": "0.3",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0004811 abnormal neuron physiology,MP:0006082 CNS inflammation,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "94.53",
            "markerNumModels": "9",
            "diseaseTerm": "Neurocutaneous Melanocytosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613673",
            "phenodigmScore": 52.08,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0012132 Erythroid hyperplasia,HP:0001903 Anemia,HP:0002904 Hyperbilirubinemia,HP:0001744 Splenomegaly,HP:0001923 Reticulocytosis,HP:0010972 Anemia of inadequate production",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "25.17",
            "diseaseModelAvgRaw": "0.58",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "78.99",
            "markerNumModels": "9",
            "diseaseTerm": "Anemia, Congenital Dyserythropoietic, Type Iv",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:182900",
            "phenodigmScore": 45.82,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001878 Hemolytic anemia,HP:0001081 Cholelithiasis,HP:0002904 Hyperbilirubinemia,HP:0001744 Splenomegaly,HP:0001923 Reticulocytosis,HP:0004444 Spherocytosis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "22.91",
            "diseaseModelAvgRaw": "0.61",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "68.73",
            "markerNumModels": "9",
            "diseaseTerm": "Spherocytosis, Type 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:300755",
            "phenodigmScore": 68.22,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0001412 Enteroviral hepatitis,HP:0004432 Agammaglobulinemia,HP:0002383 Infectious encephalitis,HP:0000999 Pyoderma,HP:0003729 Enteroviral dermatomyositis syndrome,HP:0002090 Pneumonia,HP:0000024 Prostatitis,HP:0002732 Lymph node hypoplasia,HP:0000031 Epididymitis,HP:0002719 Recurrent infections,HP:0003095 Septic arthritis,HP:0000010 Recurrent urinary tract infections,HP:0001287 Meningitis,HP:0000388 Otitis media,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "49.18",
            "diseaseModelAvgRaw": "1.13",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "87.26",
            "markerNumModels": "9",
            "diseaseTerm": "Agammaglobulinemia, X-Linked",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:602079",
            "phenodigmScore": 54.56,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001903 Anemia,HP:0006532 Recurrent pneumonia,HP:0001875 Neutropenia,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "25.62",
            "diseaseModelAvgRaw": "0.57",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "83.5",
            "markerNumModels": "9",
            "diseaseTerm": "Trimethylaminuria",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:612541",
            "phenodigmScore": 47.629999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0100806 Sepsis,HP:0002240 Hepatomegaly,HP:0001875 Neutropenia,HP:0001882 Leukopenia,HP:0012311 Monocytosis,HP:0000778 Hypoplasia of the thymus,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0012133 Erythroid hypoplasia,HP:0001888 Lymphopenia,HP:0001873 Thrombocytopenia,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "24.63",
            "diseaseModelAvgRaw": "0.54",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "70.63",
            "markerNumModels": "9",
            "diseaseTerm": "Neutropenia, Severe Congenital, 4, Autosomal Recessive",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613470",
            "phenodigmScore": 48.84,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0011981 Pigment gallstones,HP:0001081 Cholelithiasis,HP:0001744 Splenomegaly,HP:0011993 Impaired neutrophil bactericidal activity,HP:0001930 Nonspherocytic hemolytic anemia,HP:0001082 Cholecystitis,HP:0005525 Spontaneous hemolytic crises,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "28.39",
            "diseaseModelAvgRaw": "0.68",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "69.29",
            "markerNumModels": "9",
            "diseaseTerm": "Hemolytic Anemia, Nonspherocytic, Due To Glucose Phosphate Isomerase Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615577",
            "phenodigmScore": 58.995000000000005,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003765 Psoriasiform dermatitis,HP:0002720 Decreased circulating IgA level,HP:0033166 Recurrent viral upper respiratory tract infections,HP:0004315 Decreased circulating IgG level,HP:0410028 Recurrent oral herpes,HP:0000403 Recurrent otitis media,HP:0012203 Onychomycosis,HP:0006532 Recurrent pneumonia,HP:0002850 Decreased circulating total IgM,HP:0005215 Frequent Giardia lamblia infestation,HP:0011108 Recurrent sinusitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "41.46",
            "diseaseModelAvgRaw": "0.88",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "76.53",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency, Common Variable, 10",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:619396",
            "phenodigmScore": 58.35,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012302 Herpes simplex encephalitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "16.7",
            "diseaseModelAvgRaw": "0.45",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0006082 CNS inflammation",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.7",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Encephalopathy, Acute, Infection-Induced (Herpes-Specific), Susceptibility To, 10",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:260100",
            "phenodigmScore": 81.375,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010701 Abnormal immunoglobulin level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Camb>/Mavs<tm1Camb>",
            "diseaseModelAvgNorm": "71.46",
            "diseaseModelAvgRaw": "1.57",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008664 decreased interleukin-12 secretion,MP:0002459 abnormal B cell physiology,MP:0005093 decreased B cell proliferation,MP:0008561 decreased tumor necrosis factor secretion",
            "modelId": "MGI:5308089",
            "diseaseModelMaxRaw": "2.01",
            "diseaseModelMaxNorm": "91.29",
            "markerNumModels": "9",
            "diseaseTerm": "Pa Polymorphism Of Alpha-2-Globulin",
            "modelGeneticBackground": "involves: 129S6/SvEvTac * C57BL/6"
        },
        {
            "diseaseId": "OMIM:616084",
            "phenodigmScore": 49.585,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010976 B lymphocytopenia,HP:0004840 Hypochromic microcytic anemia,HP:0001981 Schistocytosis,HP:0004313 Decreased circulating antibody level,HP:0001924 Sideroblastic anemia,HP:0001744 Splenomegaly,HP:0002059 Cerebral atrophy",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "31.52",
            "diseaseModelAvgRaw": "0.72",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "67.65",
            "markerNumModels": "9",
            "diseaseTerm": "Sideroblastic Anemia With B-Cell Immunodeficiency, Periodic Fevers, And Developmental Delay",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:443811",
            "phenodigmScore": 65.175,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0000964 Eczema,HP:0001875 Neutropenia,HP:0001904 Neutropenia in presence of anti-neutropil antibodies,HP:0000389 Chronic otitis media,HP:0002719 Recurrent infections,HP:0031402 Reduced antigen-specific T cell proliferation,HP:0045080 Decreased proportion of CD3-positive T cells,HP:0002205 Recurrent respiratory infections,HP:0001880 Eosinophilia,HP:0001878 Hemolytic anemia,HP:0031394 Abnormal CD4:CD8 ratio,HP:0003193 Allergic rhinitis,HP:0002841 Recurrent fungal infections,HP:0011109 Chronic sinusitis,HP:0005528 Bone marrow hypocellularity,HP:0002754 Osteomyelitis,HP:0040218 Reduced natural killer cell count,HP:0006532 Recurrent pneumonia,HP:0001888 Lymphopenia,HP:0005403 T lymphocytopenia,HP:0001047 Atopic dermatitis,HP:0031393 Abnormal proportion of CD8-positive T cells,HP:0100633 Esophagitis,HP:0000793 Membranoproliferative glomerulonephritis,HP:0002718 Recurrent bacterial infections,HP:0001882 Leukopenia,HP:0002110 Bronchiectasis,HP:0003261 Increased circulating IgA level,HP:0004429 Recurrent viral infections,HP:0003237 Increased circulating IgG level,HP:0003212 Increased circulating IgE level,HP:0001581 Recurrent skin infections,HP:0005407 Decreased proportion of CD4-positive helper T cells,HP:0031292 Cutaneous abscess",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "45.44",
            "diseaseModelAvgRaw": "1.02",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.6",
            "diseaseModelMaxNorm": "84.91",
            "markerNumModels": "9",
            "diseaseTerm": "Pgm3-Cdg",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:381",
            "phenodigmScore": 54.125,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001541 Ascites,HP:0001882 Leukopenia,HP:0003119 Abnormal circulating lipid concentration,HP:0002716 Lymphadenopathy,HP:0012115 Hepatitis,HP:0004313 Decreased circulating antibody level,HP:0005528 Bone marrow hypocellularity,HP:0001744 Splenomegaly,HP:0001873 Thrombocytopenia,HP:0001874 Abnormality of neutrophils,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "33.3",
            "diseaseModelAvgRaw": "0.75",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "74.95",
            "markerNumModels": "9",
            "diseaseTerm": "Griscelli Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:1451",
            "phenodigmScore": 53.425000000000004,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0002240 Hepatomegaly,HP:0100654 Retrobulbar optic neuritis,HP:0002716 Lymphadenopathy,HP:0001903 Anemia,HP:0001911 Abnormal granulocyte morphology,HP:0001744 Splenomegaly,HP:0001287 Meningitis,HP:0000554 Uveitis,HP:0100533 Inflammatory abnormality of the eye,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0001874 Abnormality of neutrophils",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "29.51",
            "diseaseModelAvgRaw": "0.6",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "77.34",
            "markerNumModels": "9",
            "diseaseTerm": "Cinca Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:158057",
            "phenodigmScore": 56.17,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0006721 Acute lymphoblastic leukemia,HP:0001875 Neutropenia,HP:0001402 Hepatocellular carcinoma,HP:0001903 Anemia,HP:0002904 Hyperbilirubinemia,HP:0001744 Splenomegaly,HP:0003281 Increased circulating ferritin concentration,HP:0001433 Hepatosplenomegaly,HP:0004808 Acute myeloid leukemia,HP:0040218 Reduced natural killer cell count,HP:0002155 Hypertriglyceridemia,HP:0030782 Abnormal serum interleukin level,HP:0001876 Pancytopenia,HP:0001873 Thrombocytopenia,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0012156 Hemophagocytosis,HP:0020072 Persistent EBV viremia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "35.61",
            "diseaseModelAvgRaw": "0.74",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "76.73",
            "markerNumModels": "9",
            "diseaseTerm": "Acquired Hemophagocytic Lymphohistiocytosis Associated With Malignant Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613978",
            "phenodigmScore": 50.53,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0011907 Reduced alpha/beta synthesis ratio,HP:0011903 HbH hemoglobin,HP:0001744 Splenomegaly,HP:0001878 Hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.09",
            "diseaseModelAvgRaw": "0.42",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "82.97",
            "markerNumModels": "9",
            "diseaseTerm": "Hemoglobin H Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:233700",
            "phenodigmScore": 54.415,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002740 Recurrent E. coli infections,HP:0000976 Eczematoid dermatitis,HP:0002240 Hepatomegaly,HP:0002840 Lymphadenitis,HP:0002716 Lymphadenopathy,HP:0007417 Discoid lupus rash,HP:0002754 Osteomyelitis,HP:0001744 Splenomegaly,HP:0002955 Granulomatosis,HP:0003203 Impaired oxidative burst,HP:0002724 Recurrent Aspergillus infections,HP:0006532 Recurrent pneumonia,HP:0005406 Recurrent bacterial skin infections,HP:0002842 Recurrent Burkholderia cepacia infections,HP:0005224 Rectal abscess,HP:0002741 Recurrent Serratia marcescens infections,HP:0002726 Recurrent Staphylococcus aureus infections,HP:0002742 Recurrent Klebsiella infections,HP:0100523 Liver abscess",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "44.7",
            "diseaseModelAvgRaw": "1.04",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "64.13",
            "markerNumModels": "9",
            "diseaseTerm": "Granulomatous Disease, Chronic, Autosomal Recessive, 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:3132",
            "phenodigmScore": 47.43,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002843 Abnormal T cell morphology,HP:0000964 Eczema,HP:0005432 Transient hypogammaglobulinemia of infancy,HP:0004315 Decreased circulating IgG level,HP:0004313 Decreased circulating antibody level,HP:0012490 Panniculitis,HP:0040238 Impaired neutrophil chemotaxis,HP:0012219 Erythema nodosum",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.24",
            "diseaseModelAvgRaw": "0.48",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "71.62",
            "markerNumModels": "9",
            "diseaseTerm": "Say-Barber-Miller Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:507",
            "phenodigmScore": 60.275,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001882 Leukopenia,HP:0012384 Rhinitis,HP:0002716 Lymphadenopathy,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0004311 Abnormal macrophage morphology,HP:0010702 Increased circulating antibody level,HP:0003073 Hypoalbuminemia,HP:0001876 Pancytopenia,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "41.92",
            "diseaseModelAvgRaw": "0.89",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "78.63",
            "markerNumModels": "9",
            "diseaseTerm": "Leishmaniasis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613500",
            "phenodigmScore": 72.41,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0004432 Agammaglobulinemia,HP:0001287 Meningitis,HP:0006532 Recurrent pneumonia,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "52.37",
            "diseaseModelAvgRaw": "1.11",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "92.45",
            "markerNumModels": "9",
            "diseaseTerm": "Agammaglobulinemia 2, Autosomal Recessive",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:444463",
            "phenodigmScore": 57.47,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002716 Lymphadenopathy,HP:0012115 Hepatitis,HP:0000403 Recurrent otitis media,HP:0001744 Splenomegaly,HP:0001973 Autoimmune thrombocytopenia,HP:0001888 Lymphopenia,HP:0001878 Hemolytic anemia,HP:0001890 Autoimmune hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "31.97",
            "diseaseModelAvgRaw": "0.68",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "82.97",
            "markerNumModels": "9",
            "diseaseTerm": "Autoimmune Hemolytic Anemia-Autoimmune Thrombocytopenia-Primary Immunodeficiency Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:231226",
            "phenodigmScore": 46.02,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0031035 Chronic infection,HP:0011031 Abnormality of iron homeostasis,HP:0001395 Hepatic fibrosis,HP:0004840 Hypochromic microcytic anemia,HP:0001402 Hepatocellular carcinoma,HP:0001744 Splenomegaly,HP:0011904 Persistence of hemoglobin F,HP:0001394 Cirrhosis,HP:0001433 Hepatosplenomegaly,HP:0001971 Hypersplenism,HP:0011273 Anisocytosis,HP:0001978 Extramedullary hematopoiesis,HP:0011905 Reduced hemoglobin A,HP:0200123 Chronic hepatitis,HP:0025066 Decreased mean corpuscular volume,HP:0025547 Decreased mean corpuscular hemoglobin concentration,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.11",
            "diseaseModelAvgRaw": "0.47",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "70.93",
            "markerNumModels": "9",
            "diseaseTerm": "Dominant Beta-Thalassemia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:242840",
            "phenodigmScore": 55.36,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0002841 Recurrent fungal infections,HP:0002965 Cutaneous anergy,HP:0004315 Decreased circulating IgG level,HP:0004429 Recurrent viral infections,HP:0002728 Chronic mucocutaneous candidiasis,HP:0001712 Left ventricular hypertrophy,HP:0000777 Abnormality of the thymus,HP:0005419 Decreased T cell activation,HP:0005407 Decreased proportion of CD4-positive helper T cells,HP:0002282 Gray matter heterotopia,HP:0002205 Recurrent respiratory infections,HP:0008348 Decreased circulating IgG2 level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "36.56",
            "diseaseModelAvgRaw": "0.77",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0004811 abnormal neuron physiology,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "74.16",
            "markerNumModels": "9",
            "diseaseTerm": "Vici Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:275",
            "phenodigmScore": 65.14500000000001,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0005390 Recurrent opportunistic infections,HP:0002720 Decreased circulating IgA level,HP:0004315 Decreased circulating IgG level,HP:0004429 Recurrent viral infections,HP:0009098 Chronic oral candidiasis,HP:0200117 Recurrent upper and lower respiratory tract infections,HP:0045080 Decreased proportion of CD3-positive T cells,HP:0000388 Otitis media,HP:0005681 Juvenile rheumatoid arthritis,HP:0000988 Skin rash,HP:0011274 Recurrent mycobacterial infections,HP:0000872 Hashimoto thyroiditis,HP:0011107 Recurrent aphthous stomatitis,HP:0031123 Recurrent gastroenteritis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "54.28",
            "diseaseModelAvgRaw": "1.2",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "76.01",
            "markerNumModels": "9",
            "diseaseTerm": "Severe Combined Immunodeficiency Due To Dclre1C Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:465508",
            "phenodigmScore": 45.375,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0011031 Abnormality of iron homeostasis,HP:0030153 Cholangiocarcinoma,HP:0001402 Hepatocellular carcinoma,HP:0001640 Cardiomegaly,HP:0012463 Elevated transferrin saturation,HP:0001369 Arthritis,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0003281 Increased circulating ferritin concentration,HP:0001409 Portal hypertension",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "17.0",
            "diseaseModelAvgRaw": "0.38",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "73.75",
            "markerNumModels": "9",
            "diseaseTerm": "Symptomatic Form Of Hemochromatosis Type 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:1194",
            "phenodigmScore": 59.845,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002383 Infectious encephalitis,HP:0002120 Cerebral cortical atrophy,HP:0001987 Hyperammonemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.69",
            "diseaseModelAvgRaw": "0.41",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0003224 neuron degeneration,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Tmem70-Related Mitochondrial Encephalo-Cardio-Myopathy",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:600351",
            "phenodigmScore": 57.209999999999994,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia,HP:0004315 Decreased circulating IgG level,HP:0001875 Neutropenia,HP:0003073 Hypoalbuminemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "37.71",
            "diseaseModelAvgRaw": "0.85",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "76.71",
            "markerNumModels": "9",
            "diseaseTerm": "Enteropathy, Familial, With Villous Edema And Immunoglobulin G2 Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613493",
            "phenodigmScore": 69.92,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0030388 Decreased proportion of class-switched memory B cells,HP:0032139 Reduced isohemagglutinin level,HP:0002720 Decreased circulating IgA level,HP:0000403 Recurrent otitis media,HP:0002205 Recurrent respiratory infections,HP:0002850 Decreased circulating total IgM,HP:0032134 Chronic decreased circulating total IgG,HP:0011108 Recurrent sinusitis,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "56.51",
            "diseaseModelAvgRaw": "1.3",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "83.33",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency, Common Variable, 3",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:3243",
            "phenodigmScore": 45.49,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0030783 Increased circulating interleukin 6,HP:0002719 Recurrent infections,HP:0030782 Abnormal serum interleukin level,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0011118 Abnormality of tumor necrosis factor secretion",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.2",
            "diseaseModelAvgRaw": "0.5",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008565 decreased interferon-beta secretion,MP:0005025 abnormal response to infection,MP:0020937 increased susceptibility to Picornaviridae infection,MP:0008706 decreased interleukin-6 secretion,MP:0008563 decreased interferon-alpha secretion,MP:0003009 abnormal cytokine secretion",
            "modelId": "MGI:3773164",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "67.78",
            "markerNumModels": "9",
            "diseaseTerm": "Sweet Syndrome",
            "modelGeneticBackground": "Not Specified"
        },
        {
            "diseaseId": "ORPHA:231242",
            "phenodigmScore": 46.49,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001935 Microcytic anemia,HP:0001903 Anemia,HP:0011902 Abnormal hemoglobin,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "16.45",
            "diseaseModelAvgRaw": "0.4",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "76.53",
            "markerNumModels": "9",
            "diseaseTerm": "Hemoglobin C-Beta-Thalassemia Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:639",
            "phenodigmScore": 65.215,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0005508 Monoclonal immunoglobulin M proteinemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "30.43",
            "diseaseModelAvgRaw": "0.6",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.47",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Polyneuropathy Associated With Igm Monoclonal Gammapathy With Anti-Mag",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615270",
            "phenodigmScore": 67.03,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000939 Osteoporosis,HP:0000938 Osteopenia",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "57.22",
            "diseaseModelAvgRaw": "1.2",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.93",
            "diseaseModelMaxNorm": "76.84",
            "markerNumModels": "9",
            "diseaseTerm": "Hypogonadotropic Hypogonadism 20 With Or Without Anosmia",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "ORPHA:822",
            "phenodigmScore": 46.805,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001997 Gout,HP:0002904 Hyperbilirubinemia,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0001081 Cholelithiasis,HP:0040186 Maculopapular exanthema,HP:0001978 Extramedullary hematopoiesis,HP:0025548 Increased mean corpuscular hemoglobin concentration,HP:0001923 Reticulocytosis,HP:0004444 Spherocytosis,HP:0005525 Spontaneous hemolytic crises,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "24.88",
            "diseaseModelAvgRaw": "0.54",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "68.73",
            "markerNumModels": "9",
            "diseaseTerm": "Hereditary Spherocytosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:208600",
            "phenodigmScore": 59.11,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003261 Increased circulating IgA level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "49.32",
            "diseaseModelAvgRaw": "1.02",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "1.95",
            "diseaseModelMaxNorm": "68.9",
            "markerNumModels": "9",
            "diseaseTerm": "Asthma, Short Stature, And Elevated Iga",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:33475",
            "phenodigmScore": 57.730000000000004,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0002383 Infectious encephalitis,HP:0000988 Skin rash",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.95",
            "diseaseModelAvgRaw": "0.4",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "96.51",
            "markerNumModels": "9",
            "diseaseTerm": "Meningococcal Meningitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:449280",
            "phenodigmScore": 50.84,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0005059 Arthralgia/arthritis,HP:0100806 Sepsis,HP:0032262 Pulmonary tuberculosis,HP:0001701 Pericarditis,HP:0032255 Opportunistic fungal infection,HP:0002090 Pneumonia,HP:0100584 Endocarditis,HP:0032162 Unusual skin infection,HP:0032159 Fungal meningitis,HP:0003095 Septic arthritis,HP:0002754 Osteomyelitis,HP:0011450 Unusual CNS infection,HP:0020101 Invasive fungal infection,HP:0032169 Severe infection",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.92",
            "diseaseModelAvgRaw": "0.52",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0006082 CNS inflammation",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "77.76",
            "markerNumModels": "9",
            "diseaseTerm": "Scedosporiosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:235550",
            "phenodigmScore": 69.7,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001392 Abnormality of the liver,HP:0004315 Decreased circulating IgG level,HP:0002849 Absence of lymph node germinal center",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "39.4",
            "diseaseModelAvgRaw": "0.78",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Hepatic Venoocclusive Disease With Immunodeficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:1546",
            "phenodigmScore": 43.89,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0100721 Mediastinal lymphadenopathy,HP:0002090 Pneumonia,HP:0000024 Prostatitis,HP:0002586 Peritonitis,HP:0005526 Lymphoid leukemia,HP:0002754 Osteomyelitis,HP:0001394 Cirrhosis,HP:0001287 Meningitis,HP:0002120 Cerebral cortical atrophy",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.08",
            "diseaseModelAvgRaw": "0.42",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "68.7",
            "markerNumModels": "9",
            "diseaseTerm": "Cryptococcosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:616941",
            "phenodigmScore": 64.38499999999999,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010976 B lymphocytopenia,HP:0004432 Agammaglobulinemia,HP:0002719 Recurrent infections,HP:0000403 Recurrent otitis media",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "56.16",
            "diseaseModelAvgRaw": "1.25",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "1.98",
            "diseaseModelMaxNorm": "72.61",
            "markerNumModels": "9",
            "diseaseTerm": "Agammaglobulinemia 8, Autosomal Dominant",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:68",
            "phenodigmScore": 51.14,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0032162 Unusual skin infection,HP:0002383 Infectious encephalitis,HP:0002090 Pneumonia,HP:0200039 Pustule,HP:0020059 Increased red blood cell count,HP:0032252 Granuloma",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "12.5",
            "diseaseModelAvgRaw": "0.26",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "89.78",
            "markerNumModels": "9",
            "diseaseTerm": "Amoebiasis Due To Free-Living Amoebae",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:231154",
            "phenodigmScore": 50.895,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0010976 B lymphocytopenia,HP:0006515 Interstitial pneumonitis,HP:0001904 Neutropenia in presence of anti-neutropil antibodies,HP:0001744 Splenomegaly,HP:0005403 T lymphocytopenia,HP:0001890 Autoimmune hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "31.81",
            "diseaseModelAvgRaw": "0.8",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "69.98",
            "markerNumModels": "9",
            "diseaseTerm": "Combined Immunodeficiency Due To Partial Rag1 Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:47",
            "phenodigmScore": 58.365,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0100806 Sepsis,HP:0004432 Agammaglobulinemia,HP:0001875 Neutropenia,HP:0100838 Recurrent cutaneous abscess formation,HP:0000389 Chronic otitis media,HP:0100763 Abnormality of the lymphatic system,HP:0012115 Hepatitis,HP:0001903 Anemia,HP:0001369 Arthritis,HP:0100765 Abnormality of the tonsils,HP:0002754 Osteomyelitis,HP:0001287 Meningitis,HP:0006532 Recurrent pneumonia,HP:0000988 Skin rash,HP:0002901 Hypocalcemia,HP:0001873 Thrombocytopenia,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "38.45",
            "diseaseModelAvgRaw": "0.86",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "78.28",
            "markerNumModels": "9",
            "diseaseTerm": "X-Linked Agammaglobulinemia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:619374",
            "phenodigmScore": 56.795,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0030388 Decreased proportion of class-switched memory B cells,HP:0100838 Recurrent cutaneous abscess formation,HP:0012178 Reduced natural killer cell activity,HP:0025615 Abscess,HP:0002719 Recurrent infections,HP:0008320 Impaired collagen-induced platelet aggregation,HP:0031402 Reduced antigen-specific T cell proliferation,HP:0031545 Abnormally low T cell receptor excision circle level,HP:0000988 Skin rash,HP:0032218 Decreased proportion of CD4-positive T cells,HP:0040238 Impaired neutrophil chemotaxis,HP:0001890 Autoimmune hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "45.83",
            "diseaseModelAvgRaw": "1.08",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.04",
            "diseaseModelMaxNorm": "67.76",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 81",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:610984",
            "phenodigmScore": 52.33,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0000099 Glomerulonephritis,HP:0005369 Decreased serum complement factor H,HP:0000403 Recurrent otitis media,HP:0012330 Pyelonephritis,HP:0005416 Decreased serum complement factor B,HP:0005356 Decreased serum complement factor I,HP:0001369 Arthritis,HP:0000010 Recurrent urinary tract infections,HP:0005376 Recurrent Haemophilus influenzae infections,HP:0001581 Recurrent skin infections,HP:0005421 Decreased serum complement C3,HP:0005366 Recurrent streptococcus pneumoniae infections,HP:0005381 Recurrent meningococcal disease,HP:0011108 Recurrent sinusitis,HP:0006946 Recurrent meningitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "34.87",
            "diseaseModelAvgRaw": "0.76",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0002493 increased IgG level,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "69.79",
            "markerNumModels": "9",
            "diseaseTerm": "Complement Factor I Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:91500",
            "phenodigmScore": 49.1,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0031851 Reduced hematocrit,HP:0001970 Tubulointerstitial nephritis,HP:0012123 Posterior uveitis,HP:0001897 Normocytic anemia,HP:0003259 Elevated circulating creatinine concentration,HP:0001895 Normochromic anemia,HP:0003237 Increased circulating IgG level,HP:0012122 Anterior uveitis,HP:0012121 Panuveitis,HP:0010702 Increased circulating antibody level,HP:0100532 Scleritis,HP:0000988 Skin rash,HP:0012124 Intermediate uveitis,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0007813 Nongranulomatous uveitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "24.08",
            "diseaseModelAvgRaw": "0.56",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.6",
            "diseaseModelMaxNorm": "74.12",
            "markerNumModels": "9",
            "diseaseTerm": "Tubulointerstitial Nephritis And Uveitis Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:607676",
            "phenodigmScore": 57.83,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003212 Increased circulating IgE level,HP:0410255 Transient neutropenia,HP:0007499 Recurrent staphylococcal infections,HP:0020096 Recurrent streptococcal infections,HP:0100523 Liver abscess",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "44.77",
            "diseaseModelAvgRaw": "1.18",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "70.89",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 67",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:30391",
            "phenodigmScore": 41.335,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0011985 Acholic stools,HP:0011984 Atretic gallbladder,HP:0001408 Bile duct proliferation,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0002908 Conjugated hyperbilirubinemia,HP:0001396 Cholestasis,HP:0006579 Prolonged neonatal jaundice,HP:0001405 Periportal fibrosis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "15.59",
            "diseaseModelAvgRaw": "0.38",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "67.08",
            "markerNumModels": "9",
            "diseaseTerm": "Isolated Biliary Atresia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:614878",
            "phenodigmScore": 57.025000000000006,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0006515 Interstitial pneumonitis,HP:0002720 Decreased circulating IgA level,HP:0002719 Recurrent infections,HP:0011950 Bronchiolitis,HP:0002850 Decreased circulating total IgM,HP:0100279 Ulcerative colitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "39.77",
            "diseaseModelAvgRaw": "0.89",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "74.28",
            "markerNumModels": "9",
            "diseaseTerm": "Autoinflammation, Antibody Deficiency, And Immune Dysregulation",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:146830",
            "phenodigmScore": 67.555,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002720 Decreased circulating IgA level,HP:0004315 Decreased circulating IgG level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "54.06",
            "diseaseModelAvgRaw": "1.27",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "81.05",
            "markerNumModels": "9",
            "diseaseTerm": "Immune Deficiency, Familial Variable",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:449432",
            "phenodigmScore": 54.565,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0030151 Cholangitis,HP:0000024 Prostatitis,HP:0002716 Lymphadenopathy,HP:0005200 Retroperitoneal fibrosis,HP:0032300 Increased circulating IgG4 level,HP:0003237 Increased circulating IgG level,HP:0004431 Complement deficiency,HP:0003212 Increased circulating IgE level,HP:0010702 Increased circulating antibody level,HP:0012090 Abnormal pancreas morphology,HP:0001880 Eosinophilia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "33.52",
            "diseaseModelAvgRaw": "0.84",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.6",
            "diseaseModelMaxNorm": "75.61",
            "markerNumModels": "9",
            "diseaseTerm": "Igg4-Related Submandibular Gland Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:312863",
            "phenodigmScore": 79.3,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0002090 Pneumonia,HP:0002837 Recurrent bronchitis,HP:0004315 Decreased circulating IgG level,HP:0000388 Otitis media,HP:0005407 Decreased proportion of CD4-positive helper T cells,HP:0005415 Decreased proportion of CD8-positive T cells",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "60.99",
            "diseaseModelAvgRaw": "1.36",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.65",
            "diseaseModelMaxNorm": "97.61",
            "markerNumModels": "9",
            "diseaseTerm": "Combined Immunodeficiency, X-Linked",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:301000",
            "phenodigmScore": 62.345,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0000964 Eczema,HP:0002037 Inflammation of the large intestine,HP:0003347 Impaired lymphocyte transformation with phytohemagglutinin,HP:0005353 Recurrent herpes,HP:0002850 Decreased circulating total IgM,HP:0001880 Eosinophilia,HP:0001890 Autoimmune hemolytic anemia,HP:0002971 Absent microvilli on the surface of peripheral blood lymphocytes,HP:0002848 Decreased specific anti-polysaccharide antibody level,HP:0002783 Recurrent lower respiratory tract infections,HP:0006532 Recurrent pneumonia,HP:0001888 Lymphopenia,HP:0005415 Decreased proportion of CD8-positive T cells,HP:0006946 Recurrent meningitis,HP:0001891 Iron deficiency anemia,HP:0002963 Abnormal delayed hypersensitivity skin test,HP:0003261 Increased circulating IgA level,HP:0005537 Decreased mean platelet volume,HP:0000403 Recurrent otitis media,HP:0003212 Increased circulating IgE level,HP:0002788 Recurrent upper respiratory tract infections,HP:0005407 Decreased proportion of CD4-positive helper T cells,HP:0001873 Thrombocytopenia,HP:0011108 Recurrent sinusitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "46.24",
            "diseaseModelAvgRaw": "1.13",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.65",
            "diseaseModelMaxNorm": "78.45",
            "markerNumModels": "9",
            "diseaseTerm": "Wiskott-Aldrich Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:259750",
            "phenodigmScore": 62.89,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000939 Osteoporosis",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "51.39",
            "diseaseModelAvgRaw": "1.29",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.87",
            "diseaseModelMaxNorm": "74.39",
            "markerNumModels": "9",
            "diseaseTerm": "Osteoporosis, Juvenile",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "OMIM:618523",
            "phenodigmScore": 59.44,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000964 Eczema,HP:0001880 Eosinophilia,HP:0002110 Bronchiectasis,HP:0000403 Recurrent otitis media,HP:0000491 Keratitis,HP:0003212 Increased circulating IgE level,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "39.5",
            "diseaseModelAvgRaw": "0.84",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "79.38",
            "markerNumModels": "9",
            "diseaseTerm": "Hyper-Ige Recurrent Infection Syndrome 4B, Autosomal Recessive",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:400",
            "phenodigmScore": 53.695,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0030423 Splenic cyst,HP:0100592 Peritoneal abscess,HP:0012578 Membranous nephropathy,HP:0032101 Unusual infection,HP:0005230 Biliary tract obstruction,HP:0001407 Hepatic cysts,HP:0002904 Hyperbilirubinemia,HP:0002585 Abnormality of the peritoneum,HP:0001732 Abnormality of the pancreas,HP:0002611 Cholestatic liver disease,HP:0025615 Abscess,HP:0010702 Increased circulating antibody level,HP:0031700 Invasive parasitic infection,HP:0001880 Eosinophilia,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "33.78",
            "diseaseModelAvgRaw": "0.71",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "73.61",
            "markerNumModels": "9",
            "diseaseTerm": "Cystic Echinococcosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:242880",
            "phenodigmScore": 70.58,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004315 Decreased circulating IgG level,HP:0012133 Erythroid hypoplasia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "42.35",
            "diseaseModelAvgRaw": "0.84",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "98.81",
            "markerNumModels": "9",
            "diseaseTerm": "Immunoerythromyeloid Hypoplasia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:33226",
            "phenodigmScore": 53.52,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001897 Normocytic anemia,HP:0100778 Cryoglobulinemia,HP:0001909 Leukemia,HP:0005508 Monoclonal immunoglobulin M proteinemia,HP:0002716 Lymphadenopathy,HP:0002719 Recurrent infections,HP:0001744 Splenomegaly,HP:0001874 Abnormality of neutrophils",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "27.14",
            "diseaseModelAvgRaw": "0.59",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.47",
            "diseaseModelMaxNorm": "79.9",
            "markerNumModels": "9",
            "diseaseTerm": "Waldenström Macroglobulinemia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615190",
            "phenodigmScore": 51.395,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004313 Decreased circulating antibody level,HP:0005528 Bone marrow hypocellularity,HP:0001882 Leukopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "37.7",
            "diseaseModelAvgRaw": "0.89",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.07",
            "diseaseModelMaxNorm": "65.09",
            "markerNumModels": "9",
            "diseaseTerm": "Dyskeratosis Congenita, Autosomal Recessive 5",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:2585",
            "phenodigmScore": 63.625,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001908 Hypoplastic anemia,HP:0001272 Cerebellar atrophy,HP:0011869 Abnormal platelet function,HP:0004313 Decreased circulating antibody level,HP:0004820 Acute myelomonocytic leukemia,HP:0001744 Splenomegaly,HP:0004311 Abnormal macrophage morphology,HP:0001876 Pancytopenia,HP:0002205 Recurrent respiratory infections,HP:0001874 Abnormality of neutrophils",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "48.6",
            "diseaseModelAvgRaw": "1.07",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "78.65",
            "markerNumModels": "9",
            "diseaseTerm": "Ataxia-Pancytopenia Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:1572",
            "phenodigmScore": 54.434999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002090 Pneumonia,HP:0002110 Bronchiectasis,HP:0000389 Chronic otitis media,HP:0002837 Recurrent bronchitis,HP:0002716 Lymphadenopathy,HP:0004313 Decreased circulating antibody level,HP:0001744 Splenomegaly,HP:0001392 Abnormality of the liver,HP:0001973 Autoimmune thrombocytopenia,HP:0000388 Otitis media,HP:0001888 Lymphopenia,HP:0002205 Recurrent respiratory infections,HP:0001878 Hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "43.91",
            "diseaseModelAvgRaw": "0.95",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "64.96",
            "markerNumModels": "9",
            "diseaseTerm": "Common Variable Immunodeficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:859",
            "phenodigmScore": 66.24,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001875 Neutropenia,HP:0002720 Decreased circulating IgA level,HP:0004315 Decreased circulating IgG level,HP:0004313 Decreased circulating antibody level,HP:0001888 Lymphopenia,HP:0002850 Decreased circulating total IgM,HP:0001876 Pancytopenia,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "51.43",
            "diseaseModelAvgRaw": "1.25",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "81.05",
            "markerNumModels": "9",
            "diseaseTerm": "Transcobalamin Deficiency",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:572",
            "phenodigmScore": 64.655,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0001875 Neutropenia,HP:0005354 Lack of T cell function,HP:0005353 Recurrent herpes,HP:0005386 Recurrent protozoan infections,HP:0001904 Neutropenia in presence of anti-neutropil antibodies,HP:0004313 Decreased circulating antibody level,HP:0005401 Recurrent candida infections,HP:0001876 Pancytopenia,HP:0002205 Recurrent respiratory infections,HP:0000371 Acute otitis media,HP:0001890 Autoimmune hemolytic anemia,HP:0031394 Abnormal CD4:CD8 ratio,HP:0002841 Recurrent fungal infections,HP:0001973 Autoimmune thrombocytopenia,HP:0000988 Skin rash,HP:0005403 T lymphocytopenia,HP:0012384 Rhinitis,HP:0031381 Decreased lymphocyte proliferation in response to mitogen,HP:0002728 Chronic mucocutaneous candidiasis,HP:0003139 Panhypogammaglobulinemia,HP:0002726 Recurrent Staphylococcus aureus infections,HP:0030991 Sclerosing cholangitis,HP:0005368 Abnormality of humoral immunity,HP:0002718 Recurrent bacterial infections,HP:0004798 Recurrent infection of the gastrointestinal tract,HP:0004429 Recurrent viral infections,HP:0005407 Decreased proportion of CD4-positive helper T cells,HP:0025347 Decreased circulating beta-2-microglobulin level,HP:0200124 Chronic hepatitis due to cryptosporidium infection",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "57.29",
            "diseaseModelAvgRaw": "1.23",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.15",
            "diseaseModelMaxNorm": "72.02",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency By Defective Expression Of Mhc Class Ii",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:239100",
            "phenodigmScore": 57.864999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004437 Cranial hyperostosis,HP:0000935 Thickened cortex of long bones,HP:0011001 Increased bone mineral density",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "43.77",
            "diseaseModelAvgRaw": "1.04",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.99",
            "diseaseModelMaxNorm": "71.96",
            "markerNumModels": "9",
            "diseaseTerm": "Van Buchem Disease",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "ORPHA:297",
            "phenodigmScore": 57.614999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0011112 Abnormality of serum cytokine level,HP:0001882 Leukopenia,HP:0003237 Increased circulating IgG level,HP:0001287 Meningitis,HP:0003496 Increased circulating IgM level,HP:0011450 Unusual CNS infection,HP:0012486 Myelitis,HP:0001873 Thrombocytopenia,HP:0011227 Elevated circulating C-reactive protein concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "30.04",
            "diseaseModelAvgRaw": "0.62",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "85.19",
            "markerNumModels": "9",
            "diseaseTerm": "Tick-Borne Encephalitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:208900",
            "phenodigmScore": 56.165,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0002110 Bronchiectasis,HP:0002720 Decreased circulating IgA level,HP:0002837 Recurrent bronchitis,HP:0005357 Defective B cell differentiation,HP:0004315 Decreased circulating IgG level,HP:0001909 Leukemia,HP:0000778 Hypoplasia of the thymus,HP:0006254 Elevated alpha-fetoprotein,HP:0005407 Decreased proportion of CD4-positive helper T cells,HP:0001888 Lymphopenia,HP:0005403 T lymphocytopenia,HP:0008348 Decreased circulating IgG2 level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "41.34",
            "diseaseModelAvgRaw": "0.91",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "70.99",
            "markerNumModels": "9",
            "diseaseTerm": "Ataxia-Telangiectasia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:509",
            "phenodigmScore": 42.55,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002152 Hyperproteinemia,HP:0002240 Hepatomegaly,HP:0001701 Pericarditis,HP:0002716 Lymphadenopathy,HP:0012115 Hepatitis,HP:0100653 Optic neuritis,HP:0001287 Meningitis,HP:0000554 Uveitis,HP:0000988 Skin rash,HP:0001873 Thrombocytopenia,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "22.43",
            "diseaseModelAvgRaw": "0.5",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "62.67",
            "markerNumModels": "9",
            "diseaseTerm": "Leptospirosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:209950",
            "phenodigmScore": 73.235,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0025043 Enlarged mesenteric lymph node,HP:0001894 Thrombocytosis,HP:0002090 Pneumonia,HP:0002716 Lymphadenopathy,HP:0005661 Salmonella osteomyelitis,HP:0001903 Anemia,HP:0003237 Increased circulating IgG level,HP:0001744 Splenomegaly,HP:0012649 Increased inflammatory response,HP:0001433 Hepatosplenomegaly,HP:0003496 Increased circulating IgM level,HP:0003073 Hypoalbuminemia,HP:0100727 Histiocytosis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "51.21",
            "diseaseModelAvgRaw": "1.13",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "95.26",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 27A",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:271500",
            "phenodigmScore": 49.349999999999994,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0005201 Anomalous splenoportal venous system,HP:0001395 Hepatic fibrosis,HP:0001541 Ascites,HP:0001744 Splenomegaly,HP:0001987 Hyperammonemia,HP:0001394 Cirrhosis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.4",
            "diseaseModelAvgRaw": "0.53",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "77.3",
            "markerNumModels": "9",
            "diseaseTerm": "Splenoportal Vascular Anomalies",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:603554",
            "phenodigmScore": 56.765,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0003075 Hypoproteinemia,HP:0002240 Hepatomegaly,HP:0010976 B lymphocytopenia,HP:0001019 Erythroderma,HP:0002090 Pneumonia,HP:0002716 Lymphadenopathy,HP:0002841 Recurrent fungal infections,HP:0004429 Recurrent viral infections,HP:0000778 Hypoplasia of the thymus,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0005365 Severe B lymphocytopenia,HP:0001873 Thrombocytopenia,HP:0001880 Eosinophilia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "40.82",
            "diseaseModelAvgRaw": "0.97",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "72.71",
            "markerNumModels": "9",
            "diseaseTerm": "Omenn Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:3261",
            "phenodigmScore": 61.3,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002851 Elevated proportion of CD4-negative\\, CD8-negative\\, alpha-beta regulatory T cells,HP:0011107 Recurrent aphthous stomatitis,HP:0001904 Neutropenia in presence of anti-neutropil antibodies,HP:0002716 Lymphadenopathy,HP:0012115 Hepatitis,HP:0001744 Splenomegaly,HP:0005263 Gastritis,HP:0001971 Hypersplenism,HP:0000554 Uveitis,HP:0100827 Lymphocytosis,HP:0030782 Abnormal serum interleukin level,HP:0002850 Decreased circulating total IgM,HP:0001880 Eosinophilia,HP:0001890 Autoimmune hemolytic anemia,HP:0005528 Bone marrow hypocellularity,HP:0002848 Decreased specific anti-polysaccharide antibody level,HP:0001973 Autoimmune thrombocytopenia,HP:0001888 Lymphopenia,HP:0002240 Hepatomegaly,HP:0031393 Abnormal proportion of CD8-positive T cells,HP:0031392 Abnormal proportion of CD4-positive T cells,HP:0004844 Coombs-positive hemolytic anemia,HP:0012490 Panniculitis,HP:0001369 Arthritis,HP:0005404 Increased B cell count,HP:0001402 Hepatocellular carcinoma,HP:0003261 Increased circulating IgA level,HP:0004315 Decreased circulating IgG level,HP:0003237 Increased circulating IgG level,HP:0003212 Increased circulating IgE level,HP:0010702 Increased circulating antibody level,HP:0100646 Thyroiditis,HP:0002730 Chronic noninfectious lymphadenopathy,HP:0005407 Decreased proportion of CD4-positive helper T cells,HP:0001923 Reticulocytosis,HP:0000099 Glomerulonephritis,HP:0002583 Colitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "41.3",
            "diseaseModelAvgRaw": "0.95",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.6",
            "diseaseModelMaxNorm": "81.3",
            "markerNumModels": "9",
            "diseaseTerm": "Autoimmune Lymphoproliferative Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:139090",
            "phenodigmScore": 43.684999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0011872 Impaired thrombin-induced platelet aggregation,HP:0012528 Abnormal number of alpha granules,HP:0001744 Splenomegaly,HP:0008320 Impaired collagen-induced platelet aggregation,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.05",
            "diseaseModelAvgRaw": "0.44",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "68.32",
            "markerNumModels": "9",
            "diseaseTerm": "Gray Platelet Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:601457",
            "phenodigmScore": 69.375,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010976 B lymphocytopenia,HP:0005390 Recurrent opportunistic infections,HP:0002090 Pneumonia,HP:0008866 Failure to thrive secondary to recurrent infections,HP:0001369 Arthritis,HP:0001287 Meningitis,HP:0003139 Panhypogammaglobulinemia,HP:0000388 Otitis media,HP:0005403 T lymphocytopenia,HP:0040334 Purulent rhinitis,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "56.9",
            "diseaseModelAvgRaw": "1.27",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "81.85",
            "markerNumModels": "9",
            "diseaseTerm": "Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Negative, Nk Cell-Positive",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:2442",
            "phenodigmScore": 65.92,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0002037 Inflammation of the large intestine,HP:0002716 Lymphadenopathy,HP:0004313 Decreased circulating antibody level,HP:0001744 Splenomegaly,HP:0040219 Absent natural killer cells,HP:0002961 Dysgammaglobulinemia,HP:0003281 Increased circulating ferritin concentration,HP:0001433 Hepatosplenomegaly,HP:0100827 Lymphocytosis,HP:0002850 Decreased circulating total IgM,HP:0001876 Pancytopenia,HP:0002205 Recurrent respiratory infections,HP:0002955 Granulomatosis,HP:0030812 Enlarged tonsils,HP:0100727 Histiocytosis,HP:0010976 B lymphocytopenia,HP:0005528 Bone marrow hypocellularity,HP:0040218 Reduced natural killer cell count,HP:0002155 Hypertriglyceridemia,HP:0031408 Increased proportion of CD25+ mast cells,HP:0005403 T lymphocytopenia,HP:0002720 Decreased circulating IgA level,HP:0000123 Nephritis,HP:0004787 Fulminant hepatitis,HP:0002605 Hepatic necrosis,HP:0003496 Increased circulating IgM level,HP:0001915 Aplastic anemia,HP:0012156 Hemophagocytosis,HP:0005404 Increased B cell count,HP:0003261 Increased circulating IgA level,HP:0100828 Increased T cell count,HP:0004315 Decreased circulating IgG level,HP:0031693 Severe Epstein Barr virus infection,HP:0025289 Cervical lymphadenopathy,HP:0002583 Colitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "52.61",
            "diseaseModelAvgRaw": "1.26",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "79.23",
            "markerNumModels": "9",
            "diseaseTerm": "X-Linked Lymphoproliferative Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:612690",
            "phenodigmScore": 42.585,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001744 Splenomegaly,HP:0004444 Spherocytosis,HP:0001923 Reticulocytosis,HP:0001878 Hemolytic anemia,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "16.44",
            "diseaseModelAvgRaw": "0.43",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "68.73",
            "markerNumModels": "9",
            "diseaseTerm": "Spherocytosis, Type 5",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:155950",
            "phenodigmScore": 68.525,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100774 Hyperostosis,HP:0011001 Increased bone mineral density",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "67.52",
            "diseaseModelAvgRaw": "1.83",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.99",
            "diseaseModelMaxNorm": "69.53",
            "markerNumModels": "9",
            "diseaseTerm": "Melorheostosis, Isolated",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "OMIM:603909",
            "phenodigmScore": 68.21000000000001,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002851 Elevated proportion of CD4-negative\\, CD8-negative\\, alpha-beta regulatory T cells,HP:0001904 Neutropenia in presence of anti-neutropil antibodies,HP:0002716 Lymphadenopathy,HP:0001744 Splenomegaly,HP:0001880 Eosinophilia,HP:0001890 Autoimmune hemolytic anemia,HP:0001973 Autoimmune thrombocytopenia,HP:0002729 Follicular hyperplasia,HP:0002240 Hepatomegaly,HP:0002731 Decreased lymphocyte apoptosis,HP:0001891 Iron deficiency anemia,HP:0004844 Coombs-positive hemolytic anemia,HP:0000123 Nephritis,HP:0002972 Reduced delayed hypersensitivity,HP:0025300 Malar rash,HP:0002853 Increased proportion of HLA DR+ T cells,HP:0003496 Increased circulating IgM level,HP:0005404 Increased B cell count,HP:0003261 Increased circulating IgA level,HP:0003237 Increased circulating IgG level,HP:0002730 Chronic noninfectious lymphadenopathy,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "45.42",
            "diseaseModelAvgRaw": "1.07",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "91.0",
            "markerNumModels": "9",
            "diseaseTerm": "Autoimmune Lymphoproliferative Syndrome, Type Iia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:233710",
            "phenodigmScore": 54.415,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002740 Recurrent E. coli infections,HP:0000976 Eczematoid dermatitis,HP:0002240 Hepatomegaly,HP:0002840 Lymphadenitis,HP:0002716 Lymphadenopathy,HP:0007417 Discoid lupus rash,HP:0002754 Osteomyelitis,HP:0001744 Splenomegaly,HP:0002955 Granulomatosis,HP:0003203 Impaired oxidative burst,HP:0002724 Recurrent Aspergillus infections,HP:0006532 Recurrent pneumonia,HP:0005406 Recurrent bacterial skin infections,HP:0002842 Recurrent Burkholderia cepacia infections,HP:0005224 Rectal abscess,HP:0002741 Recurrent Serratia marcescens infections,HP:0002726 Recurrent Staphylococcus aureus infections,HP:0002742 Recurrent Klebsiella infections,HP:0100523 Liver abscess",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "44.7",
            "diseaseModelAvgRaw": "1.04",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "64.13",
            "markerNumModels": "9",
            "diseaseTerm": "Granulomatous Disease, Chronic, Autosomal Recessive, 2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:33355",
            "phenodigmScore": 58.645,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0001882 Leukopenia,HP:0000389 Chronic otitis media,HP:0004313 Decreased circulating antibody level,HP:0001903 Anemia,HP:0000988 Skin rash,HP:0010515 Aplasia/Hypoplasia of the thymus,HP:0002205 Recurrent respiratory infections,HP:0001874 Abnormality of neutrophils",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "44.5",
            "diseaseModelAvgRaw": "0.96",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.01",
            "diseaseModelMaxNorm": "72.79",
            "markerNumModels": "9",
            "diseaseTerm": "Reticular Dysgenesis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:619658",
            "phenodigmScore": 49.355000000000004,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001395 Hepatic fibrosis,HP:0001744 Splenomegaly,HP:0410053 Elevated circulating gamma-aminobutyric acid concentration,HP:0001396 Cholestasis,HP:0002901 Hypocalcemia,HP:0012852 Hepatic bridging fibrosis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.01",
            "diseaseModelAvgRaw": "0.46",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "78.7",
            "markerNumModels": "9",
            "diseaseTerm": "Cholestasis, Progressive Familial Intrahepatic, 7, With Or Without Hearing Loss",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:222700",
            "phenodigmScore": 43.675,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001882 Leukopenia,HP:0001903 Anemia,HP:0001733 Pancreatitis,HP:0001744 Splenomegaly,HP:0001987 Hyperammonemia,HP:0003281 Increased circulating ferritin concentration,HP:0001873 Thrombocytopenia,HP:0012156 Hemophagocytosis,HP:0006517 Intraalveolar phospholipid accumulation",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "22.02",
            "diseaseModelAvgRaw": "0.5",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "65.33",
            "markerNumModels": "9",
            "diseaseTerm": "Lysinuric Protein Intolerance",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:231222",
            "phenodigmScore": 46.260000000000005,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0011031 Abnormality of iron homeostasis,HP:0002240 Hepatomegaly,HP:0012465 Elevated hepatic iron concentration,HP:0001402 Hepatocellular carcinoma,HP:0012132 Erythroid hyperplasia,HP:0001081 Cholelithiasis,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0011904 Persistence of hemoglobin F,HP:0001433 Hepatosplenomegaly,HP:0001392 Abnormality of the liver,HP:0001978 Extramedullary hematopoiesis,HP:0010972 Anemia of inadequate production,HP:0025066 Decreased mean corpuscular volume,HP:0045048 Increased HbA2 hemoglobin,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.93",
            "diseaseModelAvgRaw": "0.52",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "70.59",
            "markerNumModels": "9",
            "diseaseTerm": "Beta-Thalassemia Intermedia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:612653",
            "phenodigmScore": 45.92,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002904 Hyperbilirubinemia,HP:0001744 Splenomegaly,HP:0004444 Spherocytosis,HP:0001923 Reticulocytosis,HP:0001878 Hemolytic anemia,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.11",
            "diseaseModelAvgRaw": "0.61",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "68.73",
            "markerNumModels": "9",
            "diseaseTerm": "Spherocytosis, Type 4",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:601708",
            "phenodigmScore": 91.685,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0011989 Ectopic ossification in ligament tissue",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "89.83",
            "diseaseModelAvgRaw": "1.64",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.71",
            "diseaseModelMaxNorm": "93.54",
            "markerNumModels": "9",
            "diseaseTerm": "Superior Transverse Scapular Ligament, Calcification Of, Familial",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "OMIM:259700",
            "phenodigmScore": 45.2,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0002754 Osteomyelitis,HP:0002901 Hypocalcemia,HP:0001876 Pancytopenia,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "17.48",
            "diseaseModelAvgRaw": "0.38",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "72.92",
            "markerNumModels": "9",
            "diseaseTerm": "Osteopetrosis, Autosomal Recessive 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:147060",
            "phenodigmScore": 60.595,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000976 Eczematoid dermatitis,HP:0005425 Recurrent sinopulmonary infections,HP:0002841 Recurrent fungal infections,HP:0002728 Chronic mucocutaneous candidiasis,HP:0003212 Increased circulating IgE level,HP:0006532 Recurrent pneumonia,HP:0000988 Skin rash,HP:0001880 Eosinophilia,HP:0002726 Recurrent Staphylococcus aureus infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "39.91",
            "diseaseModelAvgRaw": "0.86",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "81.28",
            "markerNumModels": "9",
            "diseaseTerm": "Hyper-Ige Recurrent Infection Syndrome 1, Autosomal Dominant",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:183350",
            "phenodigmScore": 61.65,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002965 Cutaneous anergy,HP:0001744 Splenomegaly,HP:0001971 Hypersplenism,HP:0008165 Decreased helper T cell proportion,HP:0001876 Pancytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "42.09",
            "diseaseModelAvgRaw": "0.95",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.21",
            "diseaseModelMaxNorm": "81.21",
            "markerNumModels": "9",
            "diseaseTerm": "Splenomegaly Syndrome With Splenic Germinal Center Hypoplasia And Reduced Circulating T Helper Cells",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615269",
            "phenodigmScore": 68.635,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000939 Osteoporosis,HP:0000938 Osteopenia",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "60.43",
            "diseaseModelAvgRaw": "1.2",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.93",
            "diseaseModelMaxNorm": "76.84",
            "markerNumModels": "9",
            "diseaseTerm": "Hypogonadotropic Hypogonadism 19 With Or Without Anosmia",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "OMIM:618204",
            "phenodigmScore": 70.95,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000403 Recurrent otitis media,HP:0040154 Acne inversa,HP:0002728 Chronic mucocutaneous candidiasis,HP:0005407 Decreased proportion of CD4-positive helper T cells,HP:0005415 Decreased proportion of CD8-positive T cells,HP:0030374 Decreased proportion of memory B cells,HP:0002205 Recurrent respiratory infections,HP:0011108 Recurrent sinusitis,HP:0031292 Cutaneous abscess",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "41.9",
            "diseaseModelAvgRaw": "0.87",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.65",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 15A",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:2912",
            "phenodigmScore": 52.585,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0030813 Absent tonsils,HP:0001287 Meningitis,HP:0002383 Infectious encephalitis,HP:0012486 Myelitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "12.2",
            "diseaseModelAvgRaw": "0.26",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "92.97",
            "markerNumModels": "9",
            "diseaseTerm": "Poliomyelitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618973",
            "phenodigmScore": 65.51,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004315 Decreased circulating IgG level,HP:0001272 Cerebellar atrophy,HP:0002126 Polymicrogyria,HP:0002059 Cerebral atrophy",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "34.13",
            "diseaseModelAvgRaw": "0.64",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0004811 abnormal neuron physiology,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "96.89",
            "markerNumModels": "9",
            "diseaseTerm": "Neurodegeneration, Infantile-Onset, Biotin-Responsive",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:606445",
            "phenodigmScore": 71.79,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002719 Recurrent infections,HP:0001744 Splenomegaly,HP:0100827 Lymphocytosis,HP:0002850 Decreased circulating total IgM",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "58.15",
            "diseaseModelAvgRaw": "1.32",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "85.43",
            "markerNumModels": "9",
            "diseaseTerm": "Persistent Polyclonal B-Cell Lymphocytosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:601220",
            "phenodigmScore": 52.185,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000939 Osteoporosis,HP:0040160 Generalized osteoporosis",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "43.81",
            "diseaseModelAvgRaw": "1.16",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.87",
            "diseaseModelMaxNorm": "60.56",
            "markerNumModels": "9",
            "diseaseTerm": "Osteoporosis And Oculocutaneous Hypopigmentation Syndrome",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "ORPHA:79324",
            "phenodigmScore": 51.6,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0002902 Hyponatremia,HP:0010976 B lymphocytopenia,HP:0410018 Recurrent ear infections,HP:0410295 Complete or near-complete absence of specific antibody response to tetanus vaccine,HP:0410305 Partial absence of specific antibody response to Haemophilus influenzae type b (Hib) vaccine,HP:0002257 Chronic rhinitis,HP:0003146 Hypocholesterolemia,HP:0001302 Pachygyria,HP:0410240 Abnormal circulating IgA level,HP:0006532 Recurrent pneumonia,HP:0003073 Hypoalbuminemia,HP:0100776 Recurrent pharyngitis,HP:0001873 Thrombocytopenia,HP:0002205 Recurrent respiratory infections,HP:0410242 Abnormal circulating IgG level,HP:0410243 Abnormal circulating IgM level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "24.28",
            "diseaseModelAvgRaw": "0.51",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0004811 abnormal neuron physiology,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.36",
            "diseaseModelMaxNorm": "78.92",
            "markerNumModels": "9",
            "diseaseTerm": "Alg12-Cdg",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:616278",
            "phenodigmScore": 48.95,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001395 Hepatic fibrosis,HP:0006580 Portal fibrosis,HP:0001891 Iron deficiency anemia,HP:0002904 Hyperbilirubinemia,HP:0001744 Splenomegaly,HP:0000952 Jaundice,HP:0012202 Increased serum bile acid concentration,HP:0001409 Portal hypertension,HP:0025196 Increased total iron binding capacity",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.89",
            "diseaseModelAvgRaw": "0.56",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "74.01",
            "markerNumModels": "9",
            "diseaseTerm": "Bile Acid Synthesis Defect, Congenital, 5",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:449563",
            "phenodigmScore": 51.21,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0030151 Cholangitis,HP:0000024 Prostatitis,HP:0002716 Lymphadenopathy,HP:0005200 Retroperitoneal fibrosis,HP:0032300 Increased circulating IgG4 level,HP:0001733 Pancreatitis,HP:0000491 Keratitis,HP:0003212 Increased circulating IgE level,HP:0100646 Thyroiditis,HP:0100796 Orchitis,HP:0001880 Eosinophilia,HP:0011227 Elevated circulating C-reactive protein concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "28.36",
            "diseaseModelAvgRaw": "0.66",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.52",
            "diseaseModelMaxNorm": "74.06",
            "markerNumModels": "9",
            "diseaseTerm": "Igg4-Related Ophthalmic Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613506",
            "phenodigmScore": 67.605,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004432 Agammaglobulinemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "45.71",
            "diseaseModelAvgRaw": "0.92",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.03",
            "diseaseModelMaxNorm": "89.5",
            "markerNumModels": "9",
            "diseaseTerm": "Agammaglobulinemia 5, Autosomal Dominant",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:293987",
            "phenodigmScore": 48.445,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002902 Hyponatremia,HP:0002383 Infectious encephalitis,HP:0003077 Hyperlipidemia,HP:0002783 Recurrent lower respiratory tract infections,HP:0002788 Recurrent upper respiratory tract infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "11.24",
            "diseaseModelAvgRaw": "0.25",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "85.65",
            "markerNumModels": "9",
            "diseaseTerm": "Rapid-Onset Childhood Obesity-Hypothalamic Dysfunction-Hypoventilation-Autonomic Dysregulation Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:152800",
            "phenodigmScore": 61.195,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002593 Intestinal lymphangiectasia,HP:0004315 Decreased circulating IgG level,HP:0001888 Lymphopenia,HP:0008360 Neonatal hypoproteinemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "42.78",
            "diseaseModelAvgRaw": "0.93",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "79.61",
            "markerNumModels": "9",
            "diseaseTerm": "Lymphangiectasia, Intestinal",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:242860",
            "phenodigmScore": 62.67999999999999,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0002090 Pneumonia,HP:0002110 Bronchiectasis,HP:0002720 Decreased circulating IgA level,HP:0040218 Reduced natural killer cell count,HP:0003496 Increased circulating IgM level,HP:0005403 T lymphocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "35.12",
            "diseaseModelAvgRaw": "0.79",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "90.24",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:150550",
            "phenodigmScore": 55.010000000000005,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0031394 Abnormal CD4:CD8 ratio,HP:0010976 B lymphocytopenia,HP:0001875 Neutropenia,HP:0002110 Bronchiectasis,HP:0002716 Lymphadenopathy,HP:0009098 Chronic oral candidiasis,HP:0025615 Abscess,HP:0002719 Recurrent infections,HP:0001744 Splenomegaly,HP:0004854 Intermittent thrombocytopenia,HP:0006532 Recurrent pneumonia,HP:0011107 Recurrent aphthous stomatitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "36.12",
            "diseaseModelAvgRaw": "0.83",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "73.9",
            "markerNumModels": "9",
            "diseaseTerm": "Periodic Fever, Immunodeficiency, And Thrombocytopenia Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:48435",
            "phenodigmScore": 53.2,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0032170 Severe varicella zoster infection,HP:0005401 Recurrent candida infections,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0011123 Inflammatory abnormality of the skin,HP:0100778 Cryoglobulinemia,HP:0012649 Increased inflammatory response,HP:0020180 Elevated haptoglobin level,HP:0011274 Recurrent mycobacterial infections,HP:0020101 Invasive fungal infection,HP:0005366 Recurrent streptococcus pneumoniae infections,HP:0020114 Persistent human papillomavirus infection,HP:0002090 Pneumonia,HP:0001369 Arthritis,HP:0031692 Severe cytomegalovirus infection,HP:0000793 Membranoproliferative glomerulonephritis,HP:0100796 Orchitis,HP:0006562 Viral hepatitis,HP:0002726 Recurrent Staphylococcus aureus infections,HP:0005368 Abnormality of humoral immunity,HP:0006689 Bacterial endocarditis,HP:0003261 Increased circulating IgA level,HP:0010702 Increased circulating antibody level,HP:0031691 Severe viral infection,HP:0031693 Severe Epstein Barr virus infection,HP:0004386 Gastrointestinal inflammation,HP:0010876 Abnormal circulating protein concentration,HP:0000099 Glomerulonephritis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "37.98",
            "diseaseModelAvgRaw": "0.77",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "68.42",
            "markerNumModels": "9",
            "diseaseTerm": "Postinfectious Vasculitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:766",
            "phenodigmScore": 52.675,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003452 Increased serum iron,HP:0004804 Congenital hemolytic anemia,HP:0025109 Reduced red cell pyruvate kinase level,HP:0008282 Unconjugated hyperbilirubinemia,HP:0001903 Anemia,HP:0012463 Elevated transferrin saturation,HP:0001744 Splenomegaly,HP:0003281 Increased circulating ferritin concentration,HP:0011273 Anisocytosis,HP:0004447 Poikilocytosis,HP:0004870 Chronic hemolytic anemia,HP:0001923 Reticulocytosis,HP:0006579 Prolonged neonatal jaundice,HP:0001877 Abnormal erythrocyte morphology",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "29.57",
            "diseaseModelAvgRaw": "0.72",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "75.78",
            "markerNumModels": "9",
            "diseaseTerm": "Hemolytic Anemia Due To Red Cell Pyruvate Kinase Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:137050",
            "phenodigmScore": 67.785,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002720 Decreased circulating IgA level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "54.52",
            "diseaseModelAvgRaw": "1.2",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "81.05",
            "markerNumModels": "9",
            "diseaseTerm": "Gamma-A-Globulin, Defect In Assembly Of",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:264580",
            "phenodigmScore": 45.675,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0006580 Portal fibrosis,HP:0001395 Hepatic fibrosis,HP:0003236 Elevated circulating creatine kinase concentration,HP:0002719 Recurrent infections,HP:0012028 Hepatocellular adenoma,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0003124 Hypercholesterolemia,HP:0001394 Cirrhosis,HP:0001397 Hepatic steatosis,HP:0002155 Hypertriglyceridemia,HP:0001396 Cholestasis,HP:0030272 Abnormal erythrocyte enzyme level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.03",
            "diseaseModelAvgRaw": "0.45",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "71.32",
            "markerNumModels": "9",
            "diseaseTerm": "Glycogen Storage Disease Due To Liver Phosphorylase Kinase Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618116",
            "phenodigmScore": 57.815,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000964 Eczema,HP:0001882 Leukopenia,HP:0004313 Decreased circulating antibody level,HP:0005528 Bone marrow hypocellularity,HP:0001903 Anemia,HP:0001873 Thrombocytopenia,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "46.31",
            "diseaseModelAvgRaw": "0.97",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.01",
            "diseaseModelMaxNorm": "69.32",
            "markerNumModels": "9",
            "diseaseTerm": "Bone Marrow Failure Syndrome 4",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:612692",
            "phenodigmScore": 59.545,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0004432 Agammaglobulinemia,HP:0002837 Recurrent bronchitis,HP:0011109 Chronic sinusitis,HP:0000403 Recurrent otitis media,HP:0006532 Recurrent pneumonia,HP:0002205 Recurrent respiratory infections,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "45.42",
            "diseaseModelAvgRaw": "0.99",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "1.98",
            "diseaseModelMaxNorm": "73.67",
            "markerNumModels": "9",
            "diseaseTerm": "Agammaglobulinemia 6, Autosomal Recessive",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:616860",
            "phenodigmScore": 50.33,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0032231 Hypochromia,HP:0012465 Elevated hepatic iron concentration,HP:0012132 Erythroid hyperplasia,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0003281 Increased circulating ferritin concentration,HP:0001433 Hepatosplenomegaly,HP:0002908 Conjugated hyperbilirubinemia,HP:0011273 Anisocytosis,HP:0025066 Decreased mean corpuscular volume,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "30.07",
            "diseaseModelAvgRaw": "0.7",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "70.59",
            "markerNumModels": "9",
            "diseaseTerm": "Anemia, Sideroblastic, 3, Pyridoxine-Refractory",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:300972",
            "phenodigmScore": 55.21,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004313 Decreased circulating antibody level,HP:0002719 Recurrent infections,HP:0001744 Splenomegaly,HP:0001747 Accessory spleen,HP:0002850 Decreased circulating total IgM,HP:0006579 Prolonged neonatal jaundice,HP:0001395 Hepatic fibrosis,HP:0001394 Cirrhosis,HP:0001397 Hepatic steatosis,HP:0001396 Cholestasis,HP:0001738 Exocrine pancreatic insufficiency,HP:0011967 Decreased circulating copper concentration,HP:0012852 Hepatic bridging fibrosis,HP:0002240 Hepatomegaly,HP:0003460 Decreased circulating total IgA,HP:0001897 Normocytic anemia,HP:0002718 Recurrent bacterial infections,HP:0032132 Decreased circulating total IgG,HP:0001882 Leukopenia,HP:0003124 Hypercholesterolemia,HP:0001873 Thrombocytopenia,HP:0032134 Chronic decreased circulating total IgG",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "38.64",
            "diseaseModelAvgRaw": "0.91",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "71.78",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 47",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:343",
            "phenodigmScore": 50.129999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002586 Peritonitis,HP:0003261 Increased circulating IgA level,HP:0002716 Lymphadenopathy,HP:0001369 Arthritis,HP:0011107 Recurrent aphthous stomatitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "26.49",
            "diseaseModelAvgRaw": "0.59",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "73.77",
            "markerNumModels": "9",
            "diseaseTerm": "Hyperimmunoglobulinemia D With Periodic Fever",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615767",
            "phenodigmScore": 66.17999999999999,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002037 Inflammation of the large intestine,HP:0030388 Decreased proportion of class-switched memory B cells,HP:0004315 Decreased circulating IgG level,HP:0003212 Increased circulating IgE level,HP:0100280 Crohn's disease,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "48.98",
            "diseaseModelAvgRaw": "1.02",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "83.38",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency, Common Variable, 11",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:99745",
            "phenodigmScore": 59.865,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002383 Infectious encephalitis,HP:0000988 Skin rash,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.73",
            "diseaseModelAvgRaw": "0.42",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Typhoid",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:911",
            "phenodigmScore": 66.47,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0005390 Recurrent opportunistic infections,HP:0010280 Stomatitis,HP:0002716 Lymphadenopathy,HP:0200117 Recurrent upper and lower respiratory tract infections,HP:0005422 Absence of CD8-positive T cells,HP:0001433 Hepatosplenomegaly,HP:0100827 Lymphocytosis,HP:0001880 Eosinophilia,HP:0001890 Autoimmune hemolytic anemia,HP:0002840 Lymphadenitis,HP:0001973 Autoimmune thrombocytopenia,HP:0000988 Skin rash,HP:0011274 Recurrent mycobacterial infections,HP:0005415 Decreased proportion of CD8-positive T cells,HP:0002090 Pneumonia,HP:0009098 Chronic oral candidiasis,HP:0031381 Decreased lymphocyte proliferation in response to mitogen,HP:0002728 Chronic mucocutaneous candidiasis,HP:0005406 Recurrent bacterial skin infections,HP:0002718 Recurrent bacterial infections,HP:0004798 Recurrent infection of the gastrointestinal tract,HP:0004429 Recurrent viral infections,HP:0002733 Abnormality of the lymph nodes,HP:0002583 Colitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "47.15",
            "diseaseModelAvgRaw": "1.03",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.65",
            "diseaseModelMaxNorm": "85.79",
            "markerNumModels": "9",
            "diseaseTerm": "Combined Immunodeficiency Due To Zap70 Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:249100",
            "phenodigmScore": 50.099999999999994,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0002240 Hepatomegaly,HP:0001701 Pericarditis,HP:0002586 Peritonitis,HP:0033332 Elevated circulating amyloid A,HP:0001369 Arthritis,HP:0001744 Splenomegaly,HP:0100280 Crohn's disease,HP:0001287 Meningitis,HP:0011897 Neutrophilia,HP:0100796 Orchitis,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0001055 Erysipelas",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "32.46",
            "diseaseModelAvgRaw": "0.73",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "67.74",
            "markerNumModels": "9",
            "diseaseTerm": "Familial Mediterranean Fever",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:222800",
            "phenodigmScore": 45.125,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001897 Normocytic anemia,HP:0001901 Polycythemia,HP:0001895 Normochromic anemia,HP:0001081 Cholelithiasis,HP:0001744 Splenomegaly,HP:0001930 Nonspherocytic hemolytic anemia,HP:0001082 Cholecystitis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.96",
            "diseaseModelAvgRaw": "0.56",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "69.29",
            "markerNumModels": "9",
            "diseaseTerm": "Erythrocytosis, Familial, 8",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618892",
            "phenodigmScore": 49.57,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0003265 Neonatal hyperbilirubinemia,HP:0001744 Splenomegaly,HP:0003281 Increased circulating ferritin concentration,HP:0001923 Reticulocytosis,HP:0006579 Prolonged neonatal jaundice,HP:0001878 Hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "24.67",
            "diseaseModelAvgRaw": "0.57",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "74.47",
            "markerNumModels": "9",
            "diseaseTerm": "Harderoporphyria",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:308230",
            "phenodigmScore": 71.78,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0001875 Neutropenia,HP:0010280 Stomatitis,HP:0012115 Hepatitis,HP:0001744 Splenomegaly,HP:0002961 Dysgammaglobulinemia,HP:0001878 Hemolytic anemia,HP:0030812 Enlarged tonsils,HP:0002783 Recurrent lower respiratory tract infections,HP:0001394 Cirrhosis,HP:0002959 Impaired Ig class switch recombination,HP:0005419 Decreased T cell activation,HP:0005479 Decreased circulating IgE,HP:0002849 Absence of lymph node germinal center,HP:0002240 Hepatomegaly,HP:0002720 Decreased circulating IgA level,HP:0002847 Impaired memory B cell generation,HP:0003496 Increased circulating IgM level,HP:0200123 Chronic hepatitis,HP:0030991 Sclerosing cholangitis,HP:0002718 Recurrent bacterial infections,HP:0004315 Decreased circulating IgG level,HP:0001287 Meningitis,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "55.95",
            "diseaseModelAvgRaw": "1.32",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "87.61",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency With Hyper-Igm, Type 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:266200",
            "phenodigmScore": 47.215,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0008282 Unconjugated hyperbilirubinemia,HP:0001081 Cholelithiasis,HP:0001744 Splenomegaly,HP:0004870 Chronic hemolytic anemia,HP:0001082 Cholecystitis,HP:0001923 Reticulocytosis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "25.14",
            "diseaseModelAvgRaw": "0.62",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "69.29",
            "markerNumModels": "9",
            "diseaseTerm": "Pyruvate Kinase Deficiency Of Red Cells",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618534",
            "phenodigmScore": 78.17500000000001,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0031394 Abnormal CD4:CD8 ratio,HP:0030253 Defective T cell proliferation,HP:0100721 Mediastinal lymphadenopathy,HP:0002110 Bronchiectasis,HP:0003261 Increased circulating IgA level,HP:0002716 Lymphadenopathy,HP:0004315 Decreased circulating IgG level,HP:0031381 Decreased lymphocyte proliferation in response to mitogen,HP:0002719 Recurrent infections,HP:0003237 Increased circulating IgG level,HP:0002783 Recurrent lower respiratory tract infections,HP:0001744 Splenomegaly,HP:0033207 Increased proportion autoreactive unresponsive CD21-/low B cells,HP:0001433 Hepatosplenomegaly,HP:0001973 Autoimmune thrombocytopenia,HP:0003496 Increased circulating IgM level,HP:0032218 Decreased proportion of CD4-positive T cells,HP:0025289 Cervical lymphadenopathy,HP:0001890 Autoimmune hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "61.7",
            "diseaseModelAvgRaw": "1.33",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "94.65",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 64",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:214900",
            "phenodigmScore": 51.55,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0003077 Hyperlipidemia,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0002908 Conjugated hyperbilirubinemia,HP:0006566 Neonatal cholestatic liver disease,HP:0001055 Erysipelas,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "25.13",
            "diseaseModelAvgRaw": "0.6",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "77.97",
            "markerNumModels": "9",
            "diseaseTerm": "Cholestasis-Lymphedema Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:617050",
            "phenodigmScore": 44.645,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001875 Neutropenia,HP:0001744 Splenomegaly,HP:0002059 Cerebral atrophy,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.0",
            "diseaseModelAvgRaw": "0.41",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "70.29",
            "markerNumModels": "9",
            "diseaseTerm": "Hermansky-Pudlak Syndrome 10",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:619183",
            "phenodigmScore": 43.635000000000005,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0100614 Myositis,HP:0002716 Lymphadenopathy,HP:0012490 Panniculitis,HP:0001744 Splenomegaly,HP:0001890 Autoimmune hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.4",
            "diseaseModelAvgRaw": "0.45",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "67.87",
            "markerNumModels": "9",
            "diseaseTerm": "Proteasome-Associated Autoinflammatory Syndrome 4",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:363558",
            "phenodigmScore": 60.945,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002283 Global brain atrophy,HP:0002383 Infectious encephalitis,HP:0030782 Abnormal serum interleukin level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.89",
            "diseaseModelAvgRaw": "0.44",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "New-Onset Refractory Status Epilepticus",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:42642",
            "phenodigmScore": 65.43,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002383 Infectious encephalitis,HP:0002716 Lymphadenopathy,HP:0001369 Arthritis,HP:0001744 Splenomegaly,HP:0100776 Recurrent pharyngitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "30.86",
            "diseaseModelAvgRaw": "0.62",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Pfapa Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:600903",
            "phenodigmScore": 58.19,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0002971 Absent microvilli on the surface of peripheral blood lymphocytes,HP:0000964 Eczema,HP:0002037 Inflammation of the large intestine,HP:0002090 Pneumonia,HP:0003261 Increased circulating IgA level,HP:0001891 Iron deficiency anemia,HP:0005537 Decreased mean platelet volume,HP:0002963 Abnormal delayed hypersensitivity skin test,HP:0002848 Decreased specific anti-polysaccharide antibody level,HP:0002783 Recurrent lower respiratory tract infections,HP:0003212 Increased circulating IgE level,HP:0001287 Meningitis,HP:0000388 Otitis media,HP:0002788 Recurrent upper respiratory tract infections,HP:0001888 Lymphopenia,HP:0002850 Decreased circulating total IgM,HP:0001873 Thrombocytopenia,HP:0001878 Hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "48.29",
            "diseaseModelAvgRaw": "1.14",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "68.09",
            "markerNumModels": "9",
            "diseaseTerm": "Wiskott-Aldrich Syndrome, Autosomal Dominant",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "DECIPHER:76",
            "phenodigmScore": 69.975,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010739 Osteopoikilosis",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "62.07",
            "diseaseModelAvgRaw": "1.33",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.93",
            "diseaseModelMaxNorm": "77.88",
            "markerNumModels": "9",
            "diseaseTerm": "12q14 microdeletion syndrome",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "ORPHA:90037",
            "phenodigmScore": 44.730000000000004,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001890 Autoimmune hemolytic anemia,HP:0003573 Increased total bilirubin,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "17.35",
            "diseaseModelAvgRaw": "0.42",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "72.11",
            "markerNumModels": "9",
            "diseaseTerm": "Drug-Induced Autoimmune Hemolytic Anemia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:85436",
            "phenodigmScore": 41.335,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0011118 Abnormality of tumor necrosis factor secretion",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Camb>/Mavs<tm1Camb>",
            "diseaseModelAvgNorm": "9.84",
            "diseaseModelAvgRaw": "0.21",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008664 decreased interleukin-12 secretion,MP:0008561 decreased tumor necrosis factor secretion",
            "modelId": "MGI:5308089",
            "diseaseModelMaxRaw": "2.48",
            "diseaseModelMaxNorm": "72.83",
            "markerNumModels": "9",
            "diseaseTerm": "Psoriasis-Related Juvenile Idiopathic Arthritis",
            "modelGeneticBackground": "involves: 129S6/SvEvTac * C57BL/6"
        },
        {
            "diseaseId": "OMIM:608885",
            "phenodigmScore": 45.445,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002153 Hyperkalemia,HP:0002240 Hepatomegaly,HP:0001744 Splenomegaly,HP:0001878 Hemolytic anemia,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.33",
            "diseaseModelAvgRaw": "0.37",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "72.56",
            "markerNumModels": "9",
            "diseaseTerm": "Stomatin-Deficient Cryohydrocytosis With Neurologic Defects",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618261",
            "phenodigmScore": 65.25,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0032170 Severe varicella zoster infection,HP:0002716 Lymphadenopathy,HP:0004313 Decreased circulating antibody level,HP:0002719 Recurrent infections,HP:0040218 Reduced natural killer cell count,HP:0001433 Hepatosplenomegaly,HP:0410297 Partial absence of specific antibody response to tetanus vaccine",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "59.49",
            "diseaseModelAvgRaw": "1.2",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.01",
            "diseaseModelMaxNorm": "71.01",
            "markerNumModels": "9",
            "diseaseTerm": "Lymphoproliferative Syndrome 3",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:500150",
            "phenodigmScore": 40.769999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004433 Secretory IgA deficiency,HP:0004315 Decreased circulating IgG level,HP:0002283 Global brain atrophy,HP:0002719 Recurrent infections,HP:0009879 Simplified gyral pattern,HP:0011467 Absent gallbladder,HP:0002126 Polymicrogyria",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "12.63",
            "diseaseModelAvgRaw": "0.28",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0004811 abnormal neuron physiology,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "68.91",
            "markerNumModels": "9",
            "diseaseTerm": "Brain Malformations-Musculoskeletal Abnormalities-Facial Dysmorphism-Intellectual Disability Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618213",
            "phenodigmScore": 59.58500000000001,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0001894 Thrombocytosis,HP:0032170 Severe varicella zoster infection,HP:0030253 Defective T cell proliferation,HP:0003237 Increased circulating IgG level,HP:0001931 Hypochromic anemia,HP:0410151 Eosinophilic infiltration of the esophagus,HP:0003212 Increased circulating IgE level,HP:0009789 Perianal abscess,HP:0033256 Pancolitis,HP:0005419 Decreased T cell activation,HP:0002059 Cerebral atrophy,HP:0002205 Recurrent respiratory infections,HP:0033351 Candida esophagitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "46.02",
            "diseaseModelAvgRaw": "1.02",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.6",
            "diseaseModelMaxNorm": "73.15",
            "markerNumModels": "9",
            "diseaseTerm": "Inflammatory Bowel Disease, Immunodeficiency, And Encephalopathy",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:284227",
            "phenodigmScore": 57.385000000000005,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001901 Polycythemia,HP:0001899 Increased hematocrit,HP:0003237 Increased circulating IgG level,HP:0001541 Ascites",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "29.51",
            "diseaseModelAvgRaw": "0.74",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.6",
            "diseaseModelMaxNorm": "85.26",
            "markerNumModels": "9",
            "diseaseTerm": "Tempi Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:102700",
            "phenodigmScore": 61.19499999999999,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0002718 Recurrent bacterial infections,HP:0010976 B lymphocytopenia,HP:0002240 Hepatomegaly,HP:0002090 Pneumonia,HP:0002720 Decreased circulating IgA level,HP:0002841 Recurrent fungal infections,HP:0004429 Recurrent viral infections,HP:0030273 Reduced red cell adenosine deaminase level,HP:0001744 Splenomegaly,HP:0005359 Aplasia of the thymus,HP:0003212 Increased circulating IgE level,HP:0001973 Autoimmune thrombocytopenia,HP:0005365 Severe B lymphocytopenia,HP:0005424 Absent specific antibody response,HP:0002850 Decreased circulating total IgM,HP:0001888 Lymphopenia,HP:0001880 Eosinophilia,HP:0008348 Decreased circulating IgG2 level,HP:0001890 Autoimmune hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "50.62",
            "diseaseModelAvgRaw": "1.16",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "71.77",
            "markerNumModels": "9",
            "diseaseTerm": "Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Negative, Nk Cell-Negative, Due To Adenosine Deaminase Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615271",
            "phenodigmScore": 71.74000000000001,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000939 Osteoporosis,HP:0000938 Osteopenia",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "66.64",
            "diseaseModelAvgRaw": "1.44",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.93",
            "diseaseModelMaxNorm": "76.84",
            "markerNumModels": "9",
            "diseaseTerm": "Hypogonadotropic Hypogonadism 21 With Or Without Anosmia",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "DECIPHER:45",
            "phenodigmScore": 50.629999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002720 Decreased circulating IgA level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.21",
            "diseaseModelAvgRaw": "0.41",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "81.05",
            "markerNumModels": "9",
            "diseaseTerm": "Xq28 (MECP2) duplication",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:147050",
            "phenodigmScore": 58.855000000000004,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003212 Increased circulating IgE level,HP:0000964 Eczema,HP:0003193 Allergic rhinitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "36.43",
            "diseaseModelAvgRaw": "0.85",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "81.28",
            "markerNumModels": "9",
            "diseaseTerm": "Ige Responsiveness, Atopic",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:617006",
            "phenodigmScore": 60.489999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0033221 Increased CD4:CD8 ratio,HP:0003347 Impaired lymphocyte transformation with phytohemagglutinin,HP:0012476 Decreased specific pneumococcal antibody level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "44.38",
            "diseaseModelAvgRaw": "0.99",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.04",
            "diseaseModelMaxNorm": "76.6",
            "markerNumModels": "9",
            "diseaseTerm": "Autoimmune Disease, Multisystem, Infantile-Onset, 2",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:137100",
            "phenodigmScore": 61.489999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002720 Decreased circulating IgA level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "41.93",
            "diseaseModelAvgRaw": "0.9",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "81.05",
            "markerNumModels": "9",
            "diseaseTerm": "Immunoglobulin A Deficiency 1",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:109270",
            "phenodigmScore": 44.97,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001878 Hemolytic anemia,HP:0001927 Acanthocytosis,HP:0004446 Stomatocytosis,HP:0002904 Hyperbilirubinemia,HP:0001744 Splenomegaly,HP:0000952 Jaundice,HP:0001923 Reticulocytosis,HP:0004444 Spherocytosis,HP:0004445 Elliptocytosis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "22.79",
            "diseaseModelAvgRaw": "0.64",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "67.15",
            "markerNumModels": "9",
            "diseaseTerm": "Solute carrier family 4 (anion exchanger), member 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615561",
            "phenodigmScore": 53.17,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0002090 Pneumonia,HP:0002586 Peritonitis,HP:0005416 Decreased serum complement factor B,HP:0001287 Meningitis,HP:0005381 Recurrent meningococcal disease",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "32.32",
            "diseaseModelAvgRaw": "0.72",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0002493 increased IgG level,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "74.02",
            "markerNumModels": "9",
            "diseaseTerm": "Complement Factor B Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:166710",
            "phenodigmScore": 71.57,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000939 Osteoporosis",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "68.59",
            "diseaseModelAvgRaw": "1.72",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.87",
            "diseaseModelMaxNorm": "74.55",
            "markerNumModels": "9",
            "diseaseTerm": "Osteoporosis",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "OMIM:300908",
            "phenodigmScore": 48.03,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0008282 Unconjugated hyperbilirubinemia,HP:0410179 Decreased glucose-6-phosphate dehydrogenase level in blood,HP:0020082 Heinz bodies,HP:0001744 Splenomegaly,HP:0004814 Fava bean-induced hemolytic anemia,HP:0011273 Anisocytosis,HP:0004447 Poikilocytosis,HP:0001923 Reticulocytosis,HP:0006579 Prolonged neonatal jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "29.46",
            "diseaseModelAvgRaw": "0.7",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "66.6",
            "markerNumModels": "9",
            "diseaseTerm": "Anemia, Nonspherocytic Hemolytic, Due To G6Pd Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:169079",
            "phenodigmScore": 64.52,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0010976 B lymphocytopenia,HP:0004429 Recurrent viral infections,HP:0004313 Decreased circulating antibody level,HP:0001903 Anemia,HP:0001888 Lymphopenia,HP:0001873 Thrombocytopenia,HP:0005403 T lymphocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "52.72",
            "diseaseModelAvgRaw": "1.07",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.08",
            "diseaseModelMaxNorm": "76.32",
            "markerNumModels": "9",
            "diseaseTerm": "Cernunnos-Xlf Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:606843",
            "phenodigmScore": 77.155,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0001875 Neutropenia,HP:0002720 Decreased circulating IgA level,HP:0002847 Impaired memory B cell generation,HP:0004315 Decreased circulating IgG level,HP:0003496 Increased circulating IgM level,HP:0002959 Impaired Ig class switch recombination,HP:0005479 Decreased circulating IgE,HP:0002849 Absence of lymph node germinal center",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "57.28",
            "diseaseModelAvgRaw": "1.39",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "97.03",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency With Hyper-Igm, Type 3",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:75234",
            "phenodigmScore": 48.33,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001744 Splenomegaly,HP:0003124 Hypercholesterolemia,HP:0001394 Cirrhosis,HP:0002155 Hypertriglyceridemia,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.71",
            "diseaseModelAvgRaw": "0.44",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "77.95",
            "markerNumModels": "9",
            "diseaseTerm": "Cholesteryl Ester Storage Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:391487",
            "phenodigmScore": 60.875,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0011123 Inflammatory abnormality of the skin,HP:0010976 B lymphocytopenia,HP:0000964 Eczema,HP:0002383 Infectious encephalitis,HP:0005353 Recurrent herpes,HP:0002110 Bronchiectasis,HP:0001904 Neutropenia in presence of anti-neutropil antibodies,HP:0012115 Hepatitis,HP:0002719 Recurrent infections,HP:0002728 Chronic mucocutaneous candidiasis,HP:0030355 Abnormal serum interferon-gamma level,HP:0002788 Recurrent upper respiratory tract infections,HP:0002724 Recurrent Aspergillus infections,HP:0100646 Thyroiditis,HP:0001433 Hepatosplenomegaly,HP:0001973 Autoimmune thrombocytopenia,HP:0004387 Enterocolitis,HP:0001888 Lymphopenia,HP:0001873 Thrombocytopenia,HP:0001890 Autoimmune hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "36.16",
            "diseaseModelAvgRaw": "0.8",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "85.59",
            "markerNumModels": "9",
            "diseaseTerm": "Autoimmune Enteropathy And Endocrinopathy-Susceptibility To Chronic Infections Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:178610",
            "phenodigmScore": 53.769999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010702 Increased circulating antibody level,HP:0001370 Rheumatoid arthritis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "33.97",
            "diseaseModelAvgRaw": "0.72",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "73.57",
            "markerNumModels": "9",
            "diseaseTerm": "Pulmonary Nodular Lymphoid Hyperplasia, Familial",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:614480",
            "phenodigmScore": 51.59,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001395 Hepatic fibrosis,HP:0001744 Splenomegaly,HP:0001397 Hepatic steatosis,HP:0002155 Hypertriglyceridemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "22.14",
            "diseaseModelAvgRaw": "0.51",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "81.04",
            "markerNumModels": "9",
            "diseaseTerm": "Hypertriglyceridemia, Transient Infantile",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:123880",
            "phenodigmScore": 91.58500000000001,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002833 Cystic angiomatosis of bone",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "90.59",
            "diseaseModelAvgRaw": "1.58",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.61",
            "diseaseModelMaxNorm": "92.58",
            "markerNumModels": "9",
            "diseaseTerm": "Cystic Angiomatosis Of Bone, Diffuse",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "ORPHA:99827",
            "phenodigmScore": 53.405,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0002716 Lymphadenopathy,HP:0011850 Parotitis,HP:0001744 Splenomegaly,HP:0001735 Acute pancreatitis,HP:0001876 Pancytopenia,HP:0012282 Morbilliform rash,HP:0000952 Jaundice,HP:0000509 Conjunctivitis,HP:0001974 Leukocytosis,HP:0000031 Epididymitis,HP:0001082 Cholecystitis,HP:0012219 Erythema nodosum,HP:0002240 Hepatomegaly,HP:0003236 Elevated circulating creatine kinase concentration,HP:0011897 Neutrophilia,HP:0003496 Increased circulating IgM level,HP:0100796 Orchitis,HP:0001541 Ascites,HP:0001882 Leukopenia,HP:0003237 Increased circulating IgG level,HP:0011854 Hemoperitoneum,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "25.68",
            "diseaseModelAvgRaw": "0.6",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "81.13",
            "markerNumModels": "9",
            "diseaseTerm": "Crimean-Congo Hemorrhagic Fever",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:617062",
            "phenodigmScore": 53.82,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002720 Decreased circulating IgA level,HP:0004315 Decreased circulating IgG level,HP:0004313 Decreased circulating antibody level,HP:0009879 Simplified gyral pattern,HP:0001302 Pachygyria",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "24.8",
            "diseaseModelAvgRaw": "0.5",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0004811 abnormal neuron physiology,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "82.84",
            "markerNumModels": "9",
            "diseaseTerm": "Okur-Chung Neurodevelopmental Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:562639",
            "phenodigmScore": 57.3,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0011040 Abnormality of the intrahepatic bile duct,HP:0002037 Inflammation of the large intestine,HP:0032220 Interface hepatitis,HP:0030988 Granulomatous cholangitis,HP:0003237 Increased circulating IgG level,HP:0002904 Hyperbilirubinemia,HP:0002611 Cholestatic liver disease,HP:0001394 Cirrhosis,HP:0003496 Increased circulating IgM level,HP:0100889 Abnormality of the ductus choledochus,HP:0001396 Cholestasis,HP:0032252 Granuloma,HP:0025344 Interlobular bile duct destruction,HP:0030991 Sclerosing cholangitis,HP:0100279 Ulcerative colitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "33.43",
            "diseaseModelAvgRaw": "0.8",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "81.17",
            "markerNumModels": "9",
            "diseaseTerm": "Primary Biliary Cholangitis/Primary Sclerosing Cholangitis And Autoimmune Hepatitis Overlap Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:108",
            "phenodigmScore": 50.809999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001882 Leukopenia,HP:0002719 Recurrent infections,HP:0001744 Splenomegaly,HP:0100776 Recurrent pharyngitis,HP:0001873 Thrombocytopenia,HP:0001878 Hemolytic anemia,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.63",
            "diseaseModelAvgRaw": "0.44",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "79.99",
            "markerNumModels": "9",
            "diseaseTerm": "Babesiosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:707",
            "phenodigmScore": 41.655,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0025043 Enlarged mesenteric lymph node,HP:0002037 Inflammation of the large intestine,HP:0002240 Hepatomegaly,HP:0100584 Endocarditis,HP:0002840 Lymphadenitis,HP:0040181 Chapped lip,HP:0001369 Arthritis,HP:0001744 Splenomegaly,HP:0001287 Meningitis,HP:0100533 Inflammatory abnormality of the eye,HP:0000988 Skin rash,HP:0011949 Acute infectious pneumonia,HP:0004387 Enterocolitis,HP:0012219 Erythema nodosum",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.47",
            "diseaseModelAvgRaw": "0.43",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "63.84",
            "markerNumModels": "9",
            "diseaseTerm": "Plague",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:505248",
            "phenodigmScore": 57.045,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0001882 Leukopenia,HP:0004315 Decreased circulating IgG level,HP:0005528 Bone marrow hypocellularity,HP:0001903 Anemia,HP:0000105 Enlarged kidney,HP:0001433 Hepatosplenomegaly,HP:0012444 Brain atrophy,HP:0003496 Increased circulating IgM level,HP:0003073 Hypoalbuminemia,HP:0001873 Thrombocytopenia,HP:0002205 Recurrent respiratory infections,HP:0031123 Recurrent gastroenteritis,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "26.64",
            "diseaseModelAvgRaw": "0.59",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "87.45",
            "markerNumModels": "9",
            "diseaseTerm": "Mucopolysaccharidosis-Like Syndrome With Congenital Heart Defects And Hematopoietic Disorders",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:617900",
            "phenodigmScore": 60.36,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012302 Herpes simplex encephalitis,HP:0001287 Meningitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.72",
            "diseaseModelAvgRaw": "0.43",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0006082 CNS inflammation",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.7",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Encephalopathy, Acute, Infection-Induced (Herpes-Specific), Susceptibility To, 8",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:1560",
            "phenodigmScore": 55.485,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010702 Increased circulating antibody level,HP:0002383 Infectious encephalitis,HP:0001094 Iridocyclitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "25.31",
            "diseaseModelAvgRaw": "0.5",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "85.66",
            "markerNumModels": "9",
            "diseaseTerm": "Cysticercosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:139417",
            "phenodigmScore": 41.055,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0025615 Abscess,HP:0001287 Meningitis,HP:0031691 Severe viral infection,HP:0032283 Disseminated nontuberculous mycobacterial infection,HP:0032271 Extrapulmonary tuberculosis,HP:0031700 Invasive parasitic infection,HP:0011967 Decreased circulating copper concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "13.67",
            "diseaseModelAvgRaw": "0.29",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "68.44",
            "markerNumModels": "9",
            "diseaseTerm": "Acute Transverse Myelitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:614470",
            "phenodigmScore": 67.645,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001875 Neutropenia,HP:0002731 Decreased lymphocyte apoptosis,HP:0001909 Leukemia,HP:0012311 Monocytosis,HP:0002719 Recurrent infections,HP:0001744 Splenomegaly,HP:0010702 Increased circulating antibody level,HP:0001973 Autoimmune thrombocytopenia,HP:0100827 Lymphocytosis,HP:0001876 Pancytopenia,HP:0002205 Recurrent respiratory infections,HP:0001878 Hemolytic anemia,HP:0002729 Follicular hyperplasia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "54.93",
            "diseaseModelAvgRaw": "1.21",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "80.36",
            "markerNumModels": "9",
            "diseaseTerm": "Ras-Associated Autoimmune Leukoproliferative Disorder",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:31202",
            "phenodigmScore": 47.96,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0030049 Brain abscess,HP:0100806 Sepsis,HP:0001743 Abnormality of the spleen,HP:0032162 Unusual skin infection,HP:0025059 Splenic abscess,HP:0002090 Pneumonia,HP:0000024 Prostatitis,HP:0025044 Lung abscess,HP:0012115 Hepatitis,HP:0003095 Septic arthritis,HP:0011850 Parotitis,HP:0011949 Acute infectious pneumonia,HP:0002758 Osteoarthritis,HP:0001886 Foot osteomyelitis,HP:0031292 Cutaneous abscess,HP:0100523 Liver abscess",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "31.03",
            "diseaseModelAvgRaw": "0.73",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.13",
            "diseaseModelMaxNorm": "64.89",
            "markerNumModels": "9",
            "diseaseTerm": "Melioidosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:314000",
            "phenodigmScore": 58.775,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003261 Increased circulating IgA level,HP:0001873 Thrombocytopenia,HP:0000099 Glomerulonephritis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "38.78",
            "diseaseModelAvgRaw": "0.92",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "78.77",
            "markerNumModels": "9",
            "diseaseTerm": "Thrombocytopenia With Elevated Serum Iga And Renal Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:634",
            "phenodigmScore": 51.769999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000964 Eczema,HP:0001019 Erythroderma,HP:0004313 Decreased circulating antibody level,HP:0002719 Recurrent infections,HP:0003212 Increased circulating IgE level,HP:0000988 Skin rash,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "28.55",
            "diseaseModelAvgRaw": "0.63",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "74.99",
            "markerNumModels": "9",
            "diseaseTerm": "Netherton Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:276700",
            "phenodigmScore": 41.69,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001402 Hepatocellular carcinoma,HP:0001541 Ascites,HP:0003231 Hypertyrosinemia,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0004510 Pancreatic islet-cell hyperplasia,HP:0006254 Elevated alpha-fetoprotein,HP:0003235 Hypermethioninemia,HP:0004912 Hypophosphatemic rickets,HP:0000105 Enlarged kidney",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.81",
            "diseaseModelAvgRaw": "0.44",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "64.57",
            "markerNumModels": "9",
            "diseaseTerm": "Tyrosinemia, Type I",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:269650",
            "phenodigmScore": 67.035,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004433 Secretory IgA deficiency",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Camb>/Mavs<tm1Camb>",
            "diseaseModelAvgNorm": "42.84",
            "diseaseModelAvgRaw": "0.85",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0002459 abnormal B cell physiology,MP:0005093 decreased B cell proliferation",
            "modelId": "MGI:5308089",
            "diseaseModelMaxRaw": "2.05",
            "diseaseModelMaxNorm": "91.23",
            "markerNumModels": "9",
            "diseaseTerm": "Secretory Component Deficiency",
            "modelGeneticBackground": "involves: 129S6/SvEvTac * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:79139",
            "phenodigmScore": 57.775,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002902 Hyponatremia,HP:0002383 Infectious encephalitis,HP:0001287 Meningitis,HP:0010702 Increased circulating antibody level,HP:0011897 Neutrophilia,HP:0003496 Increased circulating IgM level,HP:0007277 Paucity of anterior horn motor neurons",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.88",
            "diseaseModelAvgRaw": "0.45",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "93.67",
            "markerNumModels": "9",
            "diseaseTerm": "Japanese Encephalitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:259720",
            "phenodigmScore": 47.11,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001541 Ascites,HP:0001903 Anemia,HP:0002904 Hyperbilirubinemia,HP:0030328 Decreased osteoclast count,HP:0001744 Splenomegaly,HP:0001978 Extramedullary hematopoiesis,HP:0002901 Hypocalcemia,HP:0001876 Pancytopenia,HP:0001873 Thrombocytopenia,HP:0002059 Cerebral atrophy",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.3",
            "diseaseModelAvgRaw": "0.46",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "72.92",
            "markerNumModels": "9",
            "diseaseTerm": "Osteopetrosis, Autosomal Recessive 5",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:521",
            "phenodigmScore": 45.57,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0001912 Abnormal basophil morphology,HP:0001974 Leukocytosis,HP:0001911 Abnormal granulocyte morphology,HP:0001744 Splenomegaly,HP:0005547 Myeloproliferative disorder,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.28",
            "diseaseModelAvgRaw": "0.55",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "67.86",
            "markerNumModels": "9",
            "diseaseTerm": "Chronic Myeloid Leukemia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:609981",
            "phenodigmScore": 49.98,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002716 Lymphadenopathy,HP:0004429 Recurrent viral infections,HP:0001744 Splenomegaly,HP:0040218 Reduced natural killer cell count,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "24.25",
            "diseaseModelAvgRaw": "0.52",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "75.71",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 54",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:616689",
            "phenodigmScore": 47.815,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0004823 Anisopoikilocytosis,HP:0005518 Increased mean corpuscular volume,HP:0001927 Acanthocytosis,HP:0002904 Hyperbilirubinemia,HP:0001744 Splenomegaly,HP:0025548 Increased mean corpuscular hemoglobin concentration,HP:0001923 Reticulocytosis,HP:0020122 Bite cells,HP:0001878 Hemolytic anemia,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "25.8",
            "diseaseModelAvgRaw": "0.67",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "69.83",
            "markerNumModels": "9",
            "diseaseTerm": "Dehydrated Hereditary Stomatocytosis 2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:85443",
            "phenodigmScore": 46.495,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001903 Anemia,HP:0001392 Abnormality of the liver,HP:0031185 Increased circulating NT-proBNP concentration,HP:0010702 Increased circulating antibody level,HP:0032550 Howell-Jolly bodies,HP:0003073 Hypoalbuminemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.38",
            "diseaseModelAvgRaw": "0.43",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "73.61",
            "markerNumModels": "9",
            "diseaseTerm": "Al Amyloidosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:301045",
            "phenodigmScore": 59.230000000000004,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001541 Ascites,HP:0004313 Decreased circulating antibody level,HP:0002719 Recurrent infections,HP:0001413 Micronodular cirrhosis,HP:0001397 Hepatic steatosis,HP:0032218 Decreased proportion of CD4-positive T cells,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "42.6",
            "diseaseModelAvgRaw": "0.96",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.04",
            "diseaseModelMaxNorm": "75.86",
            "markerNumModels": "9",
            "diseaseTerm": "Congenital Disorder Of Glycosylation, Type Iir",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:616873",
            "phenodigmScore": 59.739999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001876 Pancytopenia,HP:0010976 B lymphocytopenia,HP:0006721 Acute lymphoblastic leukemia,HP:0004313 Decreased circulating antibody level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "45.87",
            "diseaseModelAvgRaw": "1.11",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.07",
            "diseaseModelMaxNorm": "73.61",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency, Common Variable, 13",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:100025",
            "phenodigmScore": 57.89,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001541 Ascites,HP:0002716 Lymphadenopathy,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0002961 Dysgammaglobulinemia,HP:0002901 Hypocalcemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "37.08",
            "diseaseModelAvgRaw": "0.78",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "78.7",
            "markerNumModels": "9",
            "diseaseTerm": "Alpha-Heavy Chain Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613101",
            "phenodigmScore": 65.595,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002716 Lymphadenopathy,HP:0004313 Decreased circulating antibody level,HP:0001903 Anemia,HP:0012177 Abnormal natural killer cell physiology,HP:0001744 Splenomegaly,HP:0003281 Increased circulating ferritin concentration,HP:0002788 Recurrent upper respiratory tract infections,HP:0001433 Hepatosplenomegaly,HP:0002155 Hypertriglyceridemia,HP:0001873 Thrombocytopenia,HP:0002583 Colitis,HP:0012156 Hemophagocytosis,HP:0011108 Recurrent sinusitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "52.81",
            "diseaseModelAvgRaw": "1.18",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "78.38",
            "markerNumModels": "9",
            "diseaseTerm": "Hemophagocytic Lymphohistiocytosis, Familial, 5, With Or Without Microvillus Inclusion Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:1858",
            "phenodigmScore": 52.11,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003212 Increased circulating IgE level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "22.94",
            "diseaseModelAvgRaw": "0.48",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "81.28",
            "markerNumModels": "9",
            "diseaseTerm": "Skeletal Dysplasia-Epilepsy-Short Stature Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:616532",
            "phenodigmScore": 60.99,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002383 Infectious encephalitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.98",
            "diseaseModelAvgRaw": "0.43",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0006082 CNS inflammation",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Encephalopathy, Acute, Infection-Induced (Herpes-Specific), Susceptibility To, 7",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:612301",
            "phenodigmScore": 52.605,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002199 Hypocalcemic seizures,HP:0002720 Decreased circulating IgA level,HP:0004315 Decreased circulating IgG level,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0006532 Recurrent pneumonia,HP:0002850 Decreased circulating total IgM",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "37.14",
            "diseaseModelAvgRaw": "0.82",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "68.07",
            "markerNumModels": "9",
            "diseaseTerm": "Osteopetrosis, Autosomal Recessive 7",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:619510",
            "phenodigmScore": 64.715,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000964 Eczema,HP:0001019 Erythroderma,HP:0002720 Decreased circulating IgA level,HP:0040313 Oligoarthritis,HP:0004315 Decreased circulating IgG level,HP:0040218 Reduced natural killer cell count,HP:0005407 Decreased proportion of CD4-positive helper T cells,HP:0001888 Lymphopenia,HP:0002850 Decreased circulating total IgM,HP:0030374 Decreased proportion of memory B cells,HP:0002205 Recurrent respiratory infections,HP:0005403 T lymphocytopenia,HP:0005479 Decreased circulating IgE,HP:0020072 Persistent EBV viremia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "52.04",
            "diseaseModelAvgRaw": "1.19",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "77.39",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 85 And Autoimmunity",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:1163",
            "phenodigmScore": 65.655,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0002383 Infectious encephalitis,HP:0001875 Neutropenia,HP:0002090 Pneumonia,HP:0002110 Bronchiectasis,HP:0012115 Hepatitis,HP:0020103 Invasive pulmonary aspergillosis,HP:0002754 Osteomyelitis,HP:0000491 Keratitis,HP:0003212 Increased circulating IgE level,HP:0001287 Meningitis,HP:0011450 Unusual CNS infection,HP:0001880 Eosinophilia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "31.88",
            "diseaseModelAvgRaw": "0.68",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "99.43",
            "markerNumModels": "9",
            "diseaseTerm": "Aspergillosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:90970",
            "phenodigmScore": 43.465,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003077 Hyperlipidemia,HP:0001733 Pancreatitis,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0001397 Hepatic steatosis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "16.6",
            "diseaseModelAvgRaw": "0.4",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "70.33",
            "markerNumModels": "9",
            "diseaseTerm": "Primary Lipodystrophy",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:83453",
            "phenodigmScore": 52.96,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0011118 Abnormality of tumor necrosis factor secretion",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Camb>/Mavs<tm1Camb>",
            "diseaseModelAvgNorm": "21.52",
            "diseaseModelAvgRaw": "0.46",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008664 decreased interleukin-12 secretion,MP:0008561 decreased tumor necrosis factor secretion",
            "modelId": "MGI:5308089",
            "diseaseModelMaxRaw": "2.48",
            "diseaseModelMaxNorm": "84.4",
            "markerNumModels": "9",
            "diseaseTerm": "Vulvovaginal Gingival Syndrome",
            "modelGeneticBackground": "involves: 129S6/SvEvTac * C57BL/6"
        },
        {
            "diseaseId": "OMIM:617303",
            "phenodigmScore": 62.0,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0002240 Hepatomegaly,HP:0001875 Neutropenia,HP:0001882 Leukopenia,HP:0006538 Recurrent bronchopulmonary infections,HP:0000123 Nephritis,HP:0005528 Bone marrow hypocellularity,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0001403 Macrovesicular hepatic steatosis,HP:0012444 Brain atrophy,HP:0003496 Increased circulating IgM level,HP:0006532 Recurrent pneumonia,HP:0003073 Hypoalbuminemia,HP:0001873 Thrombocytopenia,HP:0002205 Recurrent respiratory infections,HP:0000105 Enlarged kidney",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "31.68",
            "diseaseModelAvgRaw": "0.67",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "92.32",
            "markerNumModels": "9",
            "diseaseTerm": "Mucopolysaccharidosis-Plus Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:171442",
            "phenodigmScore": 52.32,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0031047 Paraproteinemia,HP:0008180 Mildly elevated creatine kinase",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.66",
            "diseaseModelAvgRaw": "0.43",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "82.98",
            "markerNumModels": "9",
            "diseaseTerm": "Adult-Onset Nemaline Myopathy",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:30",
            "phenodigmScore": 46.825,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001903 Anemia,HP:0002205 Recurrent respiratory infections,HP:0001744 Splenomegaly,HP:0005435 Impaired T cell function",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "28.32",
            "diseaseModelAvgRaw": "0.62",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "65.33",
            "markerNumModels": "9",
            "diseaseTerm": "Hereditary Orotic Aciduria",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:178320",
            "phenodigmScore": 55.49,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0011112 Abnormality of serum cytokine level,HP:0032094 Increased circulating surfactant protein level,HP:0030783 Increased circulating interleukin 6,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0011118 Abnormality of tumor necrosis factor secretion",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "38.06",
            "diseaseModelAvgRaw": "0.87",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008565 decreased interferon-beta secretion,MP:0005025 abnormal response to infection,MP:0020937 increased susceptibility to Picornaviridae infection,MP:0008706 decreased interleukin-6 secretion,MP:0008563 decreased interferon-alpha secretion,MP:0003009 abnormal cytokine secretion",
            "modelId": "MGI:3773164",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "72.92",
            "markerNumModels": "9",
            "diseaseTerm": "Acute Lung Injury",
            "modelGeneticBackground": "Not Specified"
        },
        {
            "diseaseId": "OMIM:614328",
            "phenodigmScore": 51.519999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003212 Increased circulating IgE level,HP:0000498 Blepharitis,HP:0001019 Erythroderma,HP:0200039 Pustule",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "28.05",
            "diseaseModelAvgRaw": "0.65",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "74.99",
            "markerNumModels": "9",
            "diseaseTerm": "Inflammatory Skin And Bowel Disease, Neonatal, 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:207750",
            "phenodigmScore": 46.415,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001733 Pancreatitis,HP:0001744 Splenomegaly,HP:0003124 Hypercholesterolemia,HP:0002155 Hypertriglyceridemia,HP:0033983 Decreased circulating apolipoprotein C-II concentration,HP:0012238 Increased circulating chylomicron concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "30.27",
            "diseaseModelAvgRaw": "0.71",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "62.56",
            "markerNumModels": "9",
            "diseaseTerm": "Apolipoprotein C-Ii Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:254500",
            "phenodigmScore": 58.980000000000004,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0031047 Paraproteinemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "48.35",
            "diseaseModelAvgRaw": "1.06",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.03",
            "diseaseModelMaxNorm": "69.61",
            "markerNumModels": "9",
            "diseaseTerm": "Myeloma, Multiple",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613179",
            "phenodigmScore": 60.07,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0005390 Recurrent opportunistic infections,HP:0001904 Neutropenia in presence of anti-neutropil antibodies,HP:0001744 Splenomegaly,HP:0001890 Autoimmune hemolytic anemia,HP:0002732 Lymph node hypoplasia,HP:0002783 Recurrent lower respiratory tract infections,HP:0000010 Recurrent urinary tract infections,HP:0001973 Autoimmune thrombocytopenia,HP:0001888 Lymphopenia,HP:0005372 Abnormality of B cell physiology,HP:0003537 Hypouricemia,HP:0002090 Pneumonia,HP:0033339 Increased circulating inosine concentration,HP:0031381 Decreased lymphocyte proliferation in response to mitogen,HP:0000388 Otitis media,HP:0002718 Recurrent bacterial infections,HP:0005435 Impaired T cell function,HP:0004429 Recurrent viral infections,HP:0012410 Pure red cell aplasia,HP:0002788 Recurrent upper respiratory tract infections,HP:0033340 Increased circulating guanosine concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "50.83",
            "diseaseModelAvgRaw": "1.06",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "69.31",
            "markerNumModels": "9",
            "diseaseTerm": "Purine Nucleoside Phosphorylase Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:139406",
            "phenodigmScore": 53.685,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002205 Recurrent respiratory infections,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.33",
            "diseaseModelAvgRaw": "0.42",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "87.04",
            "markerNumModels": "9",
            "diseaseTerm": "Encephalopathy Due To Prosaposin Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:231214",
            "phenodigmScore": 45.3,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0031035 Chronic infection,HP:0004823 Anisopoikilocytosis,HP:0011031 Abnormality of iron homeostasis,HP:0001395 Hepatic fibrosis,HP:0004840 Hypochromic microcytic anemia,HP:0001402 Hepatocellular carcinoma,HP:0001744 Splenomegaly,HP:0011904 Persistence of hemoglobin F,HP:0001394 Cirrhosis,HP:0001433 Hepatosplenomegaly,HP:0001971 Hypersplenism,HP:0001978 Extramedullary hematopoiesis,HP:0011905 Reduced hemoglobin A,HP:0010972 Anemia of inadequate production,HP:0025066 Decreased mean corpuscular volume,HP:0025547 Decreased mean corpuscular hemoglobin concentration,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.77",
            "diseaseModelAvgRaw": "0.46",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "69.83",
            "markerNumModels": "9",
            "diseaseTerm": "Beta-Thalassemia Major",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:208910",
            "phenodigmScore": 49.160000000000004,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002720 Decreased circulating IgA level,HP:0006254 Elevated alpha-fetoprotein,HP:0001909 Leukemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "28.87",
            "diseaseModelAvgRaw": "0.69",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "69.45",
            "markerNumModels": "9",
            "diseaseTerm": "Ataxia-Telangiectasia With Generalized Skin Pigmentation And Early Death",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:300988",
            "phenodigmScore": 68.72,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000964 Eczema,HP:0001875 Neutropenia,HP:0004313 Decreased circulating antibody level,HP:0000010 Recurrent urinary tract infections,HP:0001888 Lymphopenia,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "58.42",
            "diseaseModelAvgRaw": "1.28",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.01",
            "diseaseModelMaxNorm": "79.02",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 50",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618309",
            "phenodigmScore": 48.935,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0020114 Persistent human papillomavirus infection,HP:0032160 Cryptococcal meningitis,HP:0001888 Lymphopenia,HP:0005403 T lymphocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "30.9",
            "diseaseModelAvgRaw": "0.69",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.13",
            "diseaseModelMaxNorm": "66.97",
            "markerNumModels": "9",
            "diseaseTerm": "Epidermodysplasia Verruciformis, Susceptibility To, 5",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:619164",
            "phenodigmScore": 56.97500000000001,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010976 B lymphocytopenia,HP:0002716 Lymphadenopathy,HP:0005403 T lymphocytopenia,HP:0001744 Splenomegaly,HP:0006532 Recurrent pneumonia,HP:0001888 Lymphopenia,HP:0100501 Recurrent bronchiolitis,HP:0002583 Colitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "36.77",
            "diseaseModelAvgRaw": "0.76",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "77.18",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 76",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:601859",
            "phenodigmScore": 70.575,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002851 Elevated proportion of CD4-negative\\, CD8-negative\\, alpha-beta regulatory T cells,HP:0002729 Follicular hyperplasia,HP:0002731 Decreased lymphocyte apoptosis,HP:0003261 Increased circulating IgA level,HP:0001904 Neutropenia in presence of anti-neutropil antibodies,HP:0001891 Iron deficiency anemia,HP:0004844 Coombs-positive hemolytic anemia,HP:0003237 Increased circulating IgG level,HP:0001744 Splenomegaly,HP:0002972 Reduced delayed hypersensitivity,HP:0001973 Autoimmune thrombocytopenia,HP:0002853 Increased proportion of HLA DR+ T cells,HP:0003496 Increased circulating IgM level,HP:0002730 Chronic noninfectious lymphadenopathy,HP:0001880 Eosinophilia,HP:0001890 Autoimmune hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "46.5",
            "diseaseModelAvgRaw": "1.08",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "94.65",
            "markerNumModels": "9",
            "diseaseTerm": "Autoimmune Lymphoproliferative Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:85414",
            "phenodigmScore": 50.345,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001701 Pericarditis,HP:0002716 Lymphadenopathy,HP:0012122 Anterior uveitis,HP:0001744 Splenomegaly,HP:0005681 Juvenile rheumatoid arthritis,HP:0000988 Skin rash,HP:0011227 Elevated circulating C-reactive protein concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "28.65",
            "diseaseModelAvgRaw": "0.66",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "72.04",
            "markerNumModels": "9",
            "diseaseTerm": "Systemic-Onset Juvenile Idiopathic Arthritis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:602668",
            "phenodigmScore": 53.495,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003236 Elevated circulating creatine kinase concentration,HP:0004315 Decreased circulating IgG level,HP:0002850 Decreased circulating total IgM",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "31.83",
            "diseaseModelAvgRaw": "0.71",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "75.16",
            "markerNumModels": "9",
            "diseaseTerm": "Myotonic Dystrophy 2",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618986",
            "phenodigmScore": 65.475,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0032170 Severe varicella zoster infection,HP:0001875 Neutropenia,HP:0001433 Hepatosplenomegaly,HP:0001876 Pancytopenia,HP:0012312 Monocytopenia,HP:0002205 Recurrent respiratory infections,HP:0010976 B lymphocytopenia,HP:0410305 Partial absence of specific antibody response to Haemophilus influenzae type b (Hib) vaccine,HP:0002840 Lymphadenitis,HP:0002783 Recurrent lower respiratory tract infections,HP:0006532 Recurrent pneumonia,HP:0001888 Lymphopenia,HP:0005403 T lymphocytopenia,HP:0031382 Decreased lymphocyte proliferation in response to anti-CD3,HP:0008940 Generalized lymphadenopathy,HP:0040238 Impaired neutrophil chemotaxis,HP:0001882 Leukopenia,HP:0002110 Bronchiectasis,HP:0004315 Decreased circulating IgG level,HP:0000403 Recurrent otitis media,HP:0031545 Abnormally low T cell receptor excision circle level,HP:0011108 Recurrent sinusitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "56.94",
            "diseaseModelAvgRaw": "1.28",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "74.01",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 73B With Defective Neutrophil Chemotaxis And Lymphopenia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:64744",
            "phenodigmScore": 50.81,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0005200 Retroperitoneal fibrosis,HP:0032300 Increased circulating IgG4 level,HP:0100646 Thyroiditis,HP:0002901 Hypocalcemia,HP:0000872 Hashimoto thyroiditis,HP:0100732 Pancreatic fibrosis,HP:0030991 Sclerosing cholangitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.44",
            "diseaseModelAvgRaw": "0.6",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.52",
            "diseaseModelMaxNorm": "78.18",
            "markerNumModels": "9",
            "diseaseTerm": "Igg4-Related Thyroid Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:158029",
            "phenodigmScore": 47.11,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0100721 Mediastinal lymphadenopathy,HP:0001744 Splenomegaly,HP:0001873 Thrombocytopenia,HP:0000498 Blepharitis,HP:0001982 Sea-blue histiocytosis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.16",
            "diseaseModelAvgRaw": "0.46",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "73.06",
            "markerNumModels": "9",
            "diseaseTerm": "Sea-Blue Histiocytosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:2968",
            "phenodigmScore": 50.185,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0100806 Sepsis,HP:0007499 Recurrent staphylococcal infections,HP:0002059 Cerebral atrophy,HP:0003540 Impaired platelet aggregation,HP:0000509 Conjunctivitis,HP:0001974 Leukocytosis,HP:0001901 Polycythemia,HP:0002841 Recurrent fungal infections,HP:0005528 Bone marrow hypocellularity,HP:0030683 Vaginitis,HP:0002754 Osteomyelitis,HP:0000010 Recurrent urinary tract infections,HP:0004808 Acute myeloid leukemia,HP:0011110 Recurrent tonsillitis,HP:0002090 Pneumonia,HP:0009098 Chronic oral candidiasis,HP:0009789 Perianal abscess,HP:0000166 Severe periodontitis,HP:0000388 Otitis media,HP:0040238 Impaired neutrophil chemotaxis,HP:0002718 Recurrent bacterial infections,HP:0001894 Thrombocytosis,HP:0006527 Lymphocytic interstitial pneumonia,HP:0020087 BCGosis,HP:0002110 Bronchiectasis,HP:0002586 Peritonitis,HP:0000099 Glomerulonephritis,HP:0001287 Meningitis,HP:0001581 Recurrent skin infections,HP:0011990 Abnormality of neutrophil physiology,HP:0011107 Recurrent aphthous stomatitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "37.35",
            "diseaseModelAvgRaw": "0.87",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "63.02",
            "markerNumModels": "9",
            "diseaseTerm": "Leukocyte Adhesion Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:90363",
            "phenodigmScore": 52.465,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002563 Constrictive pericarditis,HP:0031085 Decreased prealbumin level,HP:0002720 Decreased circulating IgA level,HP:0032387 Reduced circulating transferrin concentration,HP:0003146 Hypocholesterolemia,HP:0004313 Decreased circulating antibody level,HP:0002719 Recurrent infections,HP:0001394 Cirrhosis,HP:0032136 Decreased circulating IgG1 level,HP:0001888 Lymphopenia,HP:0002850 Decreased circulating total IgM,HP:0003073 Hypoalbuminemia,HP:0012281 Chylous ascites",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "34.85",
            "diseaseModelAvgRaw": "0.8",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "70.08",
            "markerNumModels": "9",
            "diseaseTerm": "Secondary Intestinal Lymphangiectasia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:619441",
            "phenodigmScore": 59.095,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0033993 Viral encephalitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.19",
            "diseaseModelAvgRaw": "0.44",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0006082 CNS inflammation",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.77",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Encephalitis, Acute, Infection (Viral)-Induced, Susceptibility To, 11",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:2902",
            "phenodigmScore": 53.535,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001047 Atopic dermatitis,HP:0001974 Leukocytosis,HP:0003212 Increased circulating IgE level,HP:0032061 Hypereosinophilia,HP:0011227 Elevated circulating C-reactive protein concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "31.97",
            "diseaseModelAvgRaw": "0.68",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "75.1",
            "markerNumModels": "9",
            "diseaseTerm": "Idiopathic Chronic Eosinophilic Pneumonia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:607616",
            "phenodigmScore": 58.230000000000004,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0003233 Decreased HDL cholesterol concentration,HP:0003141 Increased LDL cholesterol concentration,HP:0004333 Bone-marrow foam cells,HP:0001744 Splenomegaly,HP:0002155 Hypertriglyceridemia,HP:0002205 Recurrent respiratory infections,HP:0001982 Sea-blue histiocytosis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "33.96",
            "diseaseModelAvgRaw": "0.72",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "82.5",
            "markerNumModels": "9",
            "diseaseTerm": "Niemann-Pick Disease, Type B",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:210900",
            "phenodigmScore": 52.425000000000004,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002110 Bronchiectasis,HP:0002720 Decreased circulating IgA level,HP:0001909 Leukemia,HP:0004315 Decreased circulating IgG level,HP:0025300 Malar rash,HP:0002788 Recurrent upper respiratory tract infections,HP:0002850 Decreased circulating total IgM",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "27.92",
            "diseaseModelAvgRaw": "0.61",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "76.93",
            "markerNumModels": "9",
            "diseaseTerm": "Bloom Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:619313",
            "phenodigmScore": 52.995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010976 B lymphocytopenia,HP:0003347 Impaired lymphocyte transformation with phytohemagglutinin,HP:0000778 Hypoplasia of the thymus,HP:0031382 Decreased lymphocyte proliferation in response to anti-CD3,HP:0031692 Severe cytomegalovirus infection,HP:0003281 Increased circulating ferritin concentration,HP:0040218 Reduced natural killer cell count,HP:0002155 Hypertriglyceridemia,HP:0005403 T lymphocytopenia,HP:0006270 Hypoplastic spleen",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "40.3",
            "diseaseModelAvgRaw": "0.91",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.08",
            "diseaseModelMaxNorm": "65.69",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 80 With Or Without Congenital Cardiomyopathy",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:276",
            "phenodigmScore": 73.275,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0005390 Recurrent opportunistic infections,HP:0005353 Recurrent herpes,HP:0005428 Severe recurrent varicella,HP:0045080 Decreased proportion of CD3-positive T cells,HP:0000952 Jaundice,HP:0030813 Absent tonsils,HP:0002732 Lymph node hypoplasia,HP:0040218 Reduced natural killer cell count,HP:0005376 Recurrent Haemophilus influenzae infections,HP:0000988 Skin rash,HP:0001888 Lymphopenia,HP:0002240 Hepatomegaly,HP:0031397 Decreased proportion of naive T cells,HP:0002090 Pneumonia,HP:0002720 Decreased circulating IgA level,HP:0010701 Abnormal immunoglobulin level,HP:0009098 Chronic oral candidiasis,HP:0031381 Decreased lymphocyte proliferation in response to mitogen,HP:0002728 Chronic mucocutaneous candidiasis,HP:0005406 Recurrent bacterial skin infections,HP:0002718 Recurrent bacterial infections,HP:0004315 Decreased circulating IgG level,HP:0003237 Increased circulating IgG level,HP:0031545 Abnormally low T cell receptor excision circle level,HP:0011370 Recurrent cutaneous fungal infections,HP:0005407 Decreased proportion of CD4-positive helper T cells",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "60.79",
            "diseaseModelAvgRaw": "1.31",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.6",
            "diseaseModelMaxNorm": "85.76",
            "markerNumModels": "9",
            "diseaseTerm": "T-B+ Severe Combined Immunodeficiency Due To Gamma Chain Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:809",
            "phenodigmScore": 48.43,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0001097 Keratoconjunctivitis sicca,HP:0002240 Hepatomegaly,HP:0001701 Pericarditis,HP:0100721 Mediastinal lymphadenopathy,HP:0001882 Leukopenia,HP:0100614 Myositis,HP:0002716 Lymphadenopathy,HP:0001369 Arthritis,HP:0001744 Splenomegaly,HP:0005263 Gastritis,HP:0001287 Meningitis,HP:0000988 Skin rash,HP:0001878 Hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "22.26",
            "diseaseModelAvgRaw": "0.52",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "74.6",
            "markerNumModels": "9",
            "diseaseTerm": "Mixed Connective Tissue Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:275350",
            "phenodigmScore": 54.24,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001972 Macrocytic anemia,HP:0001875 Neutropenia,HP:0002720 Decreased circulating IgA level,HP:0004315 Decreased circulating IgG level,HP:0001896 Reticulocytopenia,HP:0002850 Decreased circulating total IgM,HP:0001876 Pancytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "37.75",
            "diseaseModelAvgRaw": "0.88",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "70.73",
            "markerNumModels": "9",
            "diseaseTerm": "Transcobalamin Ii Deficiency",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:230350",
            "phenodigmScore": 50.985,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000952 Jaundice,HP:0002240 Hepatomegaly,HP:0012024 Hypergalactosemia,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.89",
            "diseaseModelAvgRaw": "0.41",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "82.08",
            "markerNumModels": "9",
            "diseaseTerm": "Galactosemia Iii",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:99825",
            "phenodigmScore": 58.135,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100776 Recurrent pharyngitis,HP:0002383 Infectious encephalitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "16.27",
            "diseaseModelAvgRaw": "0.32",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0006082 CNS inflammation",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Nipah Virus Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:228312",
            "phenodigmScore": 49.815,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001878 Hemolytic anemia,HP:0001881 Abnormal leukocyte morphology,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "16.66",
            "diseaseModelAvgRaw": "0.37",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "82.97",
            "markerNumModels": "9",
            "diseaseTerm": "Autoimmune Hemolytic Anemia, Cold Type",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:1304",
            "phenodigmScore": 62.64,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0002716 Lymphadenopathy,HP:0005086 Knee osteoarthritis,HP:0003095 Septic arthritis,HP:0001744 Splenomegaly,HP:0001971 Hypersplenism,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0100523 Liver abscess,HP:0001974 Leukocytosis,HP:0001701 Pericarditis,HP:0002383 Infectious encephalitis,HP:0025044 Lung abscess,HP:0000031 Epididymitis,HP:0012317 Sacroiliac arthritis,HP:0002754 Osteomyelitis,HP:0012122 Anterior uveitis,HP:0012089 Arteritis,HP:0002240 Hepatomegaly,HP:0002090 Pneumonia,HP:0100584 Endocarditis,HP:0001369 Arthritis,HP:0001392 Abnormality of the liver,HP:0003496 Increased circulating IgM level,HP:0100796 Orchitis,HP:0001894 Thrombocytosis,HP:0008843 Hip osteoarthritis,HP:0001882 Leukopenia,HP:0001903 Anemia,HP:0003237 Increased circulating IgG level,HP:0032252 Granuloma,HP:0001873 Thrombocytopenia,HP:0000099 Glomerulonephritis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "39.24",
            "diseaseModelAvgRaw": "0.86",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "86.04",
            "markerNumModels": "9",
            "diseaseTerm": "Brucellosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:779",
            "phenodigmScore": 55.975,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001097 Keratoconjunctivitis sicca,HP:0002240 Hepatomegaly,HP:0002383 Infectious encephalitis,HP:0001541 Ascites,HP:0001369 Arthritis,HP:0001394 Cirrhosis,HP:0000988 Skin rash,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "17.2",
            "diseaseModelAvgRaw": "0.41",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "94.75",
            "markerNumModels": "9",
            "diseaseTerm": "Reynolds Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:617514",
            "phenodigmScore": 69.73,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002110 Bronchiectasis,HP:0002716 Lymphadenopathy,HP:0004844 Coombs-positive hemolytic anemia,HP:0500270 Increased proportion of gamma-delta T cells,HP:0004313 Decreased circulating antibody level,HP:0002719 Recurrent infections,HP:0001744 Splenomegaly,HP:0001973 Autoimmune thrombocytopenia,HP:0006532 Recurrent pneumonia,HP:0032247 Persistent CMV viremia,HP:0001888 Lymphopenia,HP:0032218 Decreased proportion of CD4-positive T cells,HP:0020072 Persistent EBV viremia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "60.76",
            "diseaseModelAvgRaw": "1.23",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "78.7",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 52",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:83597",
            "phenodigmScore": 52.205,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012302 Herpes simplex encephalitis,HP:0100653 Optic neuritis,HP:0031696 Disseminated viral infection,HP:0031693 Severe Epstein Barr virus infection,HP:0031695 Severe parainfluenza infection,HP:0012486 Myelitis,HP:0006562 Viral hepatitis,HP:0020089 Post-vaccination rubella,HP:0020088 Post-vaccination measles",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "15.32",
            "diseaseModelAvgRaw": "0.29",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.7",
            "diseaseModelMaxNorm": "89.09",
            "markerNumModels": "9",
            "diseaseTerm": "Acute Disseminated Encephalomyelitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:179700",
            "phenodigmScore": 51.165,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001923 Reticulocytosis,HP:0001046 Intermittent jaundice,HP:0002904 Hyperbilirubinemia,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.34",
            "diseaseModelAvgRaw": "0.59",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "78.99",
            "markerNumModels": "9",
            "diseaseTerm": "Red Cell Phospholipid Defect With Hemolysis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:118900",
            "phenodigmScore": 60.1,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001394 Cirrhosis,HP:0200120 Chronic active hepatitis,HP:0010702 Increased circulating antibody level,HP:0012115 Hepatitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "36.7",
            "diseaseModelAvgRaw": "0.92",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "83.5",
            "markerNumModels": "9",
            "diseaseTerm": "Cirrhosis, Familial",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:616638",
            "phenodigmScore": 48.32,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002720 Decreased circulating IgA level,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "17.94",
            "diseaseModelAvgRaw": "0.36",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "78.7",
            "markerNumModels": "9",
            "diseaseTerm": "Smith-Kingsmore Syndrome",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:863",
            "phenodigmScore": 45.165,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003212 Increased circulating IgE level,HP:0001287 Meningitis,HP:0000988 Skin rash,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.03",
            "diseaseModelAvgRaw": "0.45",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "69.3",
            "markerNumModels": "9",
            "diseaseTerm": "Trichinellosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:464370",
            "phenodigmScore": 49.665000000000006,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0002090 Pneumonia,HP:0001904 Neutropenia in presence of anti-neutropil antibodies,HP:0001287 Meningitis,HP:0032169 Severe infection,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "24.65",
            "diseaseModelAvgRaw": "0.56",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "74.68",
            "markerNumModels": "9",
            "diseaseTerm": "Neonatal Alloimmune Neutropenia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:2116",
            "phenodigmScore": 53.655,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002383 Infectious encephalitis,HP:0000988 Skin rash",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "12.8",
            "diseaseModelAvgRaw": "0.27",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0006082 CNS inflammation",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "94.51",
            "markerNumModels": "9",
            "diseaseTerm": "Hartnup Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:614892",
            "phenodigmScore": 58.35,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012302 Herpes simplex encephalitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "16.7",
            "diseaseModelAvgRaw": "0.45",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0006082 CNS inflammation",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.7",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 31A",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:77259",
            "phenodigmScore": 52.705,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001541 Ascites,HP:0001882 Leukopenia,HP:0005230 Biliary tract obstruction,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0001971 Hypersplenism,HP:0010702 Increased circulating antibody level,HP:0001876 Pancytopenia,HP:0001873 Thrombocytopenia,HP:0002758 Osteoarthritis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "32.12",
            "diseaseModelAvgRaw": "0.71",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "73.29",
            "markerNumModels": "9",
            "diseaseTerm": "Gaucher Disease Type 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:619463",
            "phenodigmScore": 47.985,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001541 Ascites,HP:0001402 Hepatocellular carcinoma,HP:0002719 Recurrent infections,HP:0011954 Nodular regenerative hyperplasia of liver,HP:0001744 Splenomegaly,HP:0001873 Thrombocytopenia,HP:0001409 Portal hypertension",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "22.34",
            "diseaseModelAvgRaw": "0.52",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "73.63",
            "markerNumModels": "9",
            "diseaseTerm": "Portal Hypertension, Noncirrhotic, 2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:606367",
            "phenodigmScore": 61.519999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000964 Eczema,HP:0032170 Severe varicella zoster infection,HP:0002716 Lymphadenopathy,HP:0001433 Hepatosplenomegaly,HP:0002205 Recurrent respiratory infections,HP:0001878 Hemolytic anemia,HP:0030812 Enlarged tonsils,HP:0001890 Autoimmune hemolytic anemia,HP:0010976 B lymphocytopenia,HP:0001019 Erythroderma,HP:0002841 Recurrent fungal infections,HP:0002848 Decreased specific anti-polysaccharide antibody level,HP:0005403 T lymphocytopenia,HP:0002720 Decreased circulating IgA level,HP:0009098 Chronic oral candidiasis,HP:0031382 Decreased lymphocyte proliferation in response to anti-CD3,HP:0002718 Recurrent bacterial infections,HP:0003765 Psoriasiform dermatitis,HP:0004429 Recurrent viral infections,HP:0020113 Decreased proportion of CD4+CD25+ regulatory T cells,HP:0003212 Increased circulating IgE level,HP:0100646 Thyroiditis,HP:0033222 Decreased CD4:CD8 ratio",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "48.88",
            "diseaseModelAvgRaw": "1.11",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "74.16",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 41 With Lymphoproliferation And Autoimmunity",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:221700",
            "phenodigmScore": 58.019999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0007573 Late onset atopic dermatitis,HP:0003212 Increased circulating IgE level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "34.76",
            "diseaseModelAvgRaw": "0.84",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "81.28",
            "markerNumModels": "9",
            "diseaseTerm": "Deafness, Neural, With Atypical Atopic Dermatitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:205",
            "phenodigmScore": 59.215,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001392 Abnormality of the liver,HP:0002383 Infectious encephalitis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.43",
            "diseaseModelAvgRaw": "0.39",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Crigler-Najjar Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:47612",
            "phenodigmScore": 54.555,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0100806 Sepsis,HP:0001875 Neutropenia,HP:0000389 Chronic otitis media,HP:0002716 Lymphadenopathy,HP:0002719 Recurrent infections,HP:0001744 Splenomegaly,HP:0002205 Recurrent respiratory infections,HP:0001701 Pericarditis,HP:0005528 Bone marrow hypocellularity,HP:0000010 Recurrent urinary tract infections,HP:0006532 Recurrent pneumonia,HP:0100776 Recurrent pharyngitis,HP:0002240 Hepatomegaly,HP:0100534 Episcleritis,HP:0100769 Synovitis,HP:0012384 Rhinitis,HP:0004332 Abnormal lymphocyte morphology,HP:0001369 Arthritis,HP:0001903 Anemia,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "35.67",
            "diseaseModelAvgRaw": "0.77",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "73.44",
            "markerNumModels": "9",
            "diseaseTerm": "Felty Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:79240",
            "phenodigmScore": 45.464999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001395 Hepatic fibrosis,HP:0001402 Hepatocellular carcinoma,HP:0003236 Elevated circulating creatine kinase concentration,HP:0002719 Recurrent infections,HP:0012028 Hepatocellular adenoma,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0003124 Hypercholesterolemia,HP:0001394 Cirrhosis,HP:0002155 Hypertriglyceridemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.61",
            "diseaseModelAvgRaw": "0.45",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "71.32",
            "markerNumModels": "9",
            "diseaseTerm": "Glycogen Storage Disease Due To Liver And Muscle Phosphorylase Kinase Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:75565",
            "phenodigmScore": 38.3,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0030783 Increased circulating interleukin 6,HP:0001541 Ascites,HP:0001640 Cardiomegaly,HP:0001744 Splenomegaly,HP:0003073 Hypoalbuminemia,HP:0001880 Eosinophilia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "15.52",
            "diseaseModelAvgRaw": "0.37",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "61.08",
            "markerNumModels": "9",
            "diseaseTerm": "Tropical Endomyocardial Fibrosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:373",
            "phenodigmScore": 41.1,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002884 Hepatoblastoma,HP:0001744 Splenomegaly,HP:0004510 Pancreatic islet-cell hyperplasia,HP:0003212 Increased circulating IgE level,HP:0001748 Polysplenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "12.67",
            "diseaseModelAvgRaw": "0.29",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "69.53",
            "markerNumModels": "9",
            "diseaseTerm": "Simpson-Golabi-Behmel Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613495",
            "phenodigmScore": 68.065,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0032134 Chronic decreased circulating total IgG,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "44.12",
            "diseaseModelAvgRaw": "0.94",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "92.01",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency, Common Variable, 5",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:616098",
            "phenodigmScore": 80.87,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0410388 Decreased proportion of central memory CD4-positive\\, alpha-beta T cells,HP:0002383 Infectious encephalitis,HP:0004313 Decreased circulating antibody level,HP:0002719 Recurrent infections,HP:0002583 Colitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "61.74",
            "diseaseModelAvgRaw": "1.36",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 37",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:2905",
            "phenodigmScore": 46.945,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0001541 Ascites,HP:0002716 Lymphadenopathy,HP:0001901 Polycythemia,HP:0010702 Increased circulating antibody level,HP:0003271 Visceromegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.7",
            "diseaseModelAvgRaw": "0.43",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "74.19",
            "markerNumModels": "9",
            "diseaseTerm": "Poems Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:603902",
            "phenodigmScore": 48.425,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001744 Splenomegaly,HP:0011904 Persistence of hemoglobin F,HP:0001935 Microcytic anemia,HP:0020080 Erythrocyte inclusion bodies,HP:0025547 Decreased mean corpuscular hemoglobin concentration,HP:0045048 Increased HbA2 hemoglobin",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.32",
            "diseaseModelAvgRaw": "0.46",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "76.53",
            "markerNumModels": "9",
            "diseaseTerm": "Beta-Thalassemia, Dominant Inclusion Body Type",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:605258",
            "phenodigmScore": 68.535,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004798 Recurrent infection of the gastrointestinal tract,HP:0002718 Recurrent bacterial infections,HP:0002720 Decreased circulating IgA level,HP:0002716 Lymphadenopathy,HP:0004315 Decreased circulating IgG level,HP:0200117 Recurrent upper and lower respiratory tract infections,HP:0002959 Impaired Ig class switch recombination,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "54.23",
            "diseaseModelAvgRaw": "1.15",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "82.84",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency With Hyper-Igm, Type 2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:118830",
            "phenodigmScore": 55.629999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010980 Hyperlipoproteinemia,HP:0100027 Recurrent pancreatitis,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "27.85",
            "diseaseModelAvgRaw": "0.59",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "83.41",
            "markerNumModels": "9",
            "diseaseTerm": "Chylomicronemia, Familial, Due To Circulating Inhibitor Of Lipoprotein Lipase",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:270300",
            "phenodigmScore": 50.555,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003212 Increased circulating IgE level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "24.19",
            "diseaseModelAvgRaw": "0.55",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "76.92",
            "markerNumModels": "9",
            "diseaseTerm": "Peeling Skin Syndrome 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:284",
            "phenodigmScore": 48.75,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0030151 Cholangitis,HP:0002613 Biliary cirrhosis,HP:0001737 Pancreatic cysts,HP:0100016 Abnormality of mesentery morphology,HP:0001407 Hepatic cysts,HP:0001903 Anemia,HP:0025408 Abnormal spleen morphology,HP:0100523 Liver abscess,HP:0010702 Increased circulating antibody level,HP:0001880 Eosinophilia,HP:0001409 Portal hypertension,HP:0031292 Cutaneous abscess,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "26.07",
            "diseaseModelAvgRaw": "0.56",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "71.43",
            "markerNumModels": "9",
            "diseaseTerm": "Alveolar Echinococcosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:66661",
            "phenodigmScore": 51.565,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0100721 Mediastinal lymphadenopathy,HP:0002716 Lymphadenopathy,HP:0001744 Splenomegaly,HP:0100495 Mastocytosis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "26.68",
            "diseaseModelAvgRaw": "0.62",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "76.45",
            "markerNumModels": "9",
            "diseaseTerm": "Mast Cell Sarcoma",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:91139",
            "phenodigmScore": 58.205,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0006562 Viral hepatitis,HP:0005550 Chronic lymphatic leukemia,HP:0001701 Pericarditis,HP:0005508 Monoclonal immunoglobulin M proteinemia,HP:0000123 Nephritis,HP:0001369 Arthritis,HP:0004431 Complement deficiency,HP:0031047 Paraproteinemia,HP:0003496 Increased circulating IgM level,HP:0032290 Monoclonal elevation of IgG,HP:0000793 Membranoproliferative glomerulonephritis,HP:0032335 Monoclonal elevation of circulating IgA",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "29.11",
            "diseaseModelAvgRaw": "0.62",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "87.3",
            "markerNumModels": "9",
            "diseaseTerm": "Simple Cryoglobulinemia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:90159",
            "phenodigmScore": 56.81,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010701 Abnormal immunoglobulin level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "34.24",
            "diseaseModelAvgRaw": "0.74",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.1",
            "diseaseModelMaxNorm": "79.38",
            "markerNumModels": "9",
            "diseaseTerm": "Panniculitis-Induced Localized Lipodystrophy",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:66628",
            "phenodigmScore": 49.845,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002788 Recurrent upper respiratory tract infections,HP:0005419 Decreased T cell activation,HP:0002155 Hypertriglyceridemia,HP:0005407 Decreased proportion of CD4-positive helper T cells",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "29.44",
            "diseaseModelAvgRaw": "0.65",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.15",
            "diseaseModelMaxNorm": "70.25",
            "markerNumModels": "9",
            "diseaseTerm": "Obesity Due To Congenital Leptin Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:221139",
            "phenodigmScore": 55.0,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0003765 Psoriasiform dermatitis,HP:0010976 B lymphocytopenia,HP:0003460 Decreased circulating total IgA,HP:0032140 Decreased specific antibody response to vaccination,HP:0032132 Decreased circulating total IgG,HP:0002100 Recurrent aspiration pneumonia,HP:0410018 Recurrent ear infections,HP:0002841 Recurrent fungal infections,HP:0009098 Chronic oral candidiasis,HP:0031381 Decreased lymphocyte proliferation in response to mitogen,HP:0004313 Decreased circulating antibody level,HP:0031382 Decreased lymphocyte proliferation in response to anti-CD3,HP:0001369 Arthritis,HP:0004429 Recurrent viral infections,HP:0000010 Recurrent urinary tract infections,HP:0040218 Reduced natural killer cell count,HP:0005407 Decreased proportion of CD4-positive helper T cells,HP:0002850 Decreased circulating total IgM,HP:0025540 Abnormal T cell subset distribution",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "33.47",
            "diseaseModelAvgRaw": "0.71",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "76.53",
            "markerNumModels": "9",
            "diseaseTerm": "Combined Immunodeficiency With Faciooculoskeletal Anomalies",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:319218",
            "phenodigmScore": 54.465,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0001882 Leukopenia,HP:0012115 Hepatitis,HP:0010702 Increased circulating antibody level,HP:0001735 Acute pancreatitis,HP:0040186 Maculopapular exanthema,HP:0001888 Lymphopenia,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "36.73",
            "diseaseModelAvgRaw": "0.79",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "72.2",
            "markerNumModels": "9",
            "diseaseTerm": "Ebola Hemorrhagic Fever",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:3386",
            "phenodigmScore": 58.879999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0002240 Hepatomegaly,HP:0002383 Infectious encephalitis,HP:0002716 Lymphadenopathy,HP:0001744 Splenomegaly,HP:0000988 Skin rash",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "21.91",
            "diseaseModelAvgRaw": "0.49",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "95.85",
            "markerNumModels": "9",
            "diseaseTerm": "American Trypanosomiasis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:482",
            "phenodigmScore": 58.05500000000001,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002716 Lymphadenopathy,HP:0003212 Increased circulating IgE level,HP:0001880 Eosinophilia,HP:0002729 Follicular hyperplasia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "37.13",
            "diseaseModelAvgRaw": "0.96",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "78.98",
            "markerNumModels": "9",
            "diseaseTerm": "Kimura Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:1310",
            "phenodigmScore": 51.32,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010702 Increased circulating antibody level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "24.69",
            "diseaseModelAvgRaw": "0.5",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "77.95",
            "markerNumModels": "9",
            "diseaseTerm": "Caffey Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:448237",
            "phenodigmScore": 64.925,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002383 Infectious encephalitis,HP:0001369 Arthritis,HP:0001287 Meningitis,HP:0003496 Increased circulating IgM level,HP:0040186 Maculopapular exanthema,HP:0000988 Skin rash,HP:0012486 Myelitis,HP:0001873 Thrombocytopenia,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "35.0",
            "diseaseModelAvgRaw": "0.74",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "94.85",
            "markerNumModels": "9",
            "diseaseTerm": "Zika Virus Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:619175",
            "phenodigmScore": 56.73,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001744 Splenomegaly,HP:0000988 Skin rash,HP:0002155 Hypertriglyceridemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "28.25",
            "diseaseModelAvgRaw": "0.6",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "85.21",
            "markerNumModels": "9",
            "diseaseTerm": "Proteasome-Associated Autoinflammatory Syndrome 5",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:187950",
            "phenodigmScore": 49.845,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0008148 Impaired epinephrine-induced platelet aggregation,HP:0001744 Splenomegaly,HP:0008320 Impaired collagen-induced platelet aggregation,HP:0004866 Impaired ADP-induced platelet aggregation",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "22.61",
            "diseaseModelAvgRaw": "0.59",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "77.08",
            "markerNumModels": "9",
            "diseaseTerm": "Thrombocythemia 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:586",
            "phenodigmScore": 50.1,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0004313 Decreased circulating antibody level,HP:0001738 Exocrine pancreatic insufficiency,HP:0002205 Recurrent respiratory infections,HP:0002613 Biliary cirrhosis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "36.82",
            "diseaseModelAvgRaw": "0.9",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.01",
            "diseaseModelMaxNorm": "63.38",
            "markerNumModels": "9",
            "diseaseTerm": "Cystic Fibrosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:619437",
            "phenodigmScore": 57.480000000000004,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0010976 B lymphocytopenia,HP:0001744 Splenomegaly,HP:0009789 Perianal abscess,HP:0020072 Persistent EBV viremia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "35.34",
            "diseaseModelAvgRaw": "0.72",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "79.62",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 84",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:616005",
            "phenodigmScore": 61.04,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0005550 Chronic lymphatic leukemia,HP:0002110 Bronchiectasis,HP:0004313 Decreased circulating antibody level,HP:0001744 Splenomegaly,HP:0001888 Lymphopenia,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "51.45",
            "diseaseModelAvgRaw": "1.15",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "70.63",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 36",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:411593",
            "phenodigmScore": 56.835,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0005059 Arthralgia/arthritis,HP:0010702 Increased circulating antibody level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "25.64",
            "diseaseModelAvgRaw": "0.59",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "88.03",
            "markerNumModels": "9",
            "diseaseTerm": "Insulin Autoimmune Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:846",
            "phenodigmScore": 46.584999999999994,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001903 Anemia,HP:0001081 Cholelithiasis,HP:0011902 Abnormal hemoglobin,HP:0001744 Splenomegaly,HP:0001971 Hypersplenism,HP:0001935 Microcytic anemia,HP:0001878 Hemolytic anemia,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.4",
            "diseaseModelAvgRaw": "0.43",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "74.77",
            "markerNumModels": "9",
            "diseaseTerm": "Alpha-Thalassemia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613027",
            "phenodigmScore": 44.339999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0006568 Increased hepatic glycogen content,HP:0001408 Bile duct proliferation,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0002155 Hypertriglyceridemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.86",
            "diseaseModelAvgRaw": "0.42",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "69.82",
            "markerNumModels": "9",
            "diseaseTerm": "Glycogen Storage Disease Ixc",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:2136",
            "phenodigmScore": 46.89,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0006521 Pulmonary lymphangiectasia,HP:0001541 Ascites,HP:0002716 Lymphadenopathy,HP:0100764 Lymphangioma,HP:0004313 Decreased circulating antibody level,HP:0001744 Splenomegaly,HP:0001302 Pachygyria,HP:0001888 Lymphopenia,HP:0002901 Hypocalcemia,HP:0002205 Recurrent respiratory infections,HP:0001055 Erysipelas",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "27.18",
            "diseaseModelAvgRaw": "0.61",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0004811 abnormal neuron physiology,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "66.6",
            "markerNumModels": "9",
            "diseaseTerm": "Hennekam Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:186",
            "phenodigmScore": 59.045,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0011040 Abnormality of the intrahepatic bile duct,HP:0001395 Hepatic fibrosis,HP:0001402 Hepatocellular carcinoma,HP:0001541 Ascites,HP:0003261 Increased circulating IgA level,HP:0002841 Recurrent fungal infections,HP:0003119 Abnormal circulating lipid concentration,HP:0012115 Hepatitis,HP:0012203 Onychomycosis,HP:0001394 Cirrhosis,HP:0002908 Conjugated hyperbilirubinemia,HP:0003496 Increased circulating IgM level,HP:0004386 Gastrointestinal inflammation,HP:0003073 Hypoalbuminemia,HP:0002613 Biliary cirrhosis,HP:0001409 Portal hypertension,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "33.4",
            "diseaseModelAvgRaw": "0.8",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "84.69",
            "markerNumModels": "9",
            "diseaseTerm": "Primary Biliary Cholangitis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:619375",
            "phenodigmScore": 52.415,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0030388 Decreased proportion of class-switched memory B cells,HP:0000099 Glomerulonephritis,HP:0030384 Decreased proportion of marginal zone B cells,HP:0002716 Lymphadenopathy,HP:0004844 Coombs-positive hemolytic anemia,HP:0001744 Splenomegaly,HP:0001973 Autoimmune thrombocytopenia,HP:0100646 Thyroiditis,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "30.51",
            "diseaseModelAvgRaw": "0.65",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "74.32",
            "markerNumModels": "9",
            "diseaseTerm": "Autoinflammatory Syndrome, Familial, With Or Without Immunodeficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:99826",
            "phenodigmScore": 48.205,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002716 Lymphadenopathy,HP:0410257 Neutrophilia in presence of infection,HP:0001987 Hyperammonemia,HP:0000554 Uveitis,HP:0040186 Maculopapular exanthema,HP:0000952 Jaundice,HP:0410288 Hyperamylasemia,HP:0001701 Pericarditis,HP:0000988 Skin rash,HP:0001888 Lymphopenia,HP:0003073 Hypoalbuminemia,HP:0002900 Hypokalemia,HP:0003236 Elevated circulating creatine kinase concentration,HP:0004332 Abnormal lymphocyte morphology,HP:0001369 Arthritis,HP:0100796 Orchitis,HP:0032169 Severe infection,HP:0001882 Leukopenia,HP:0003259 Elevated circulating creatinine concentration,HP:0001733 Pancreatitis,HP:0010702 Increased circulating antibody level,HP:0001923 Reticulocytosis,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "27.99",
            "diseaseModelAvgRaw": "0.62",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "68.42",
            "markerNumModels": "9",
            "diseaseTerm": "Marburg Hemorrhagic Fever",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:256040",
            "phenodigmScore": 54.58,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002716 Lymphadenopathy,HP:0033178 Increased circulating interleukin 8,HP:0011850 Parotitis,HP:0001744 Splenomegaly,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0000509 Conjunctivitis,HP:0003233 Decreased HDL cholesterol concentration,HP:0000031 Epididymitis,HP:0002155 Hypertriglyceridemia,HP:0030356 Increased serum interferon-gamma level,HP:0012219 Erythema nodosum,HP:0002240 Hepatomegaly,HP:0030783 Increased circulating interleukin 6,HP:0100534 Episcleritis,HP:0012490 Panniculitis,HP:0001935 Microcytic anemia,HP:0003261 Increased circulating IgA level,HP:0000403 Recurrent otitis media,HP:0001640 Cardiomegaly,HP:0003237 Increased circulating IgG level,HP:0010702 Increased circulating antibody level,HP:0002788 Recurrent upper respiratory tract infections,HP:0001873 Thrombocytopenia,HP:0011108 Recurrent sinusitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "30.17",
            "diseaseModelAvgRaw": "0.65",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.6",
            "diseaseModelMaxNorm": "78.99",
            "markerNumModels": "9",
            "diseaseTerm": "Proteasome-Associated Autoinflammatory Syndrome 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:848",
            "phenodigmScore": 48.925,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0011031 Abnormality of iron homeostasis,HP:0012115 Hepatitis,HP:0011902 Abnormal hemoglobin,HP:0001903 Anemia,HP:0001081 Cholelithiasis,HP:0001744 Splenomegaly,HP:0001935 Microcytic anemia,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.08",
            "diseaseModelAvgRaw": "0.54",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "74.77",
            "markerNumModels": "9",
            "diseaseTerm": "Beta-Thalassemia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:235900",
            "phenodigmScore": 78.245,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010702 Increased circulating antibody level,HP:0002719 Recurrent infections,HP:0005413 Increased alpha-globulin,HP:0100727 Histiocytosis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "59.39",
            "diseaseModelAvgRaw": "1.2",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "97.1",
            "markerNumModels": "9",
            "diseaseTerm": "Histiocytosis, Familial Lipochrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:167",
            "phenodigmScore": 51.54,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001875 Neutropenia,HP:0011869 Abnormal platelet function,HP:0002716 Lymphadenopathy,HP:0002719 Recurrent infections,HP:0001744 Splenomegaly,HP:0000704 Periodontitis,HP:0003281 Increased circulating ferritin concentration,HP:0001433 Hepatosplenomegaly,HP:0007499 Recurrent staphylococcal infections,HP:0006827 Atrophy of the spinal cord,HP:0001876 Pancytopenia,HP:0002205 Recurrent respiratory infections,HP:0000952 Jaundice,HP:0002902 Hyponatremia,HP:0001922 Vacuolated lymphocytes,HP:0012444 Brain atrophy,HP:0000988 Skin rash,HP:0020096 Recurrent streptococcal infections,HP:0002155 Hypertriglyceridemia,HP:0031408 Increased proportion of CD25+ mast cells,HP:0003075 Hypoproteinemia,HP:0005406 Recurrent bacterial skin infections,HP:0012156 Hemophagocytosis,HP:0001881 Abnormal leukocyte morphology,HP:0002718 Recurrent bacterial infections,HP:0012176 Abnormal natural killer cell morphology,HP:0001272 Cerebellar atrophy,HP:0001903 Anemia,HP:0011990 Abnormality of neutrophil physiology,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "33.41",
            "diseaseModelAvgRaw": "0.74",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "69.67",
            "markerNumModels": "9",
            "diseaseTerm": "Chédiak-Higashi Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:228123",
            "phenodigmScore": 57.04,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002716 Lymphadenopathy,HP:0011450 Unusual CNS infection,HP:0001880 Eosinophilia,HP:0012282 Morbilliform rash,HP:0001701 Pericarditis,HP:0025084 Folliculitis,HP:0002754 Osteomyelitis,HP:0000988 Skin rash,HP:0020101 Invasive fungal infection,HP:0012219 Erythema nodosum,HP:0001743 Abnormality of the spleen,HP:0100721 Mediastinal lymphadenopathy,HP:0002090 Pneumonia,HP:0025615 Abscess,HP:0012490 Panniculitis,HP:0001369 Arthritis,HP:0001392 Abnormality of the liver,HP:0003496 Increased circulating IgM level,HP:0002586 Peritonitis,HP:0003237 Increased circulating IgG level,HP:0001733 Pancreatitis,HP:0032252 Granuloma,HP:0032161 Coccidioidal meningitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "30.19",
            "diseaseModelAvgRaw": "0.65",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "83.89",
            "markerNumModels": "9",
            "diseaseTerm": "Coccidioidomycosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:211600",
            "phenodigmScore": 44.86,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001081 Cholelithiasis,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0006575 Intrahepatic cholestasis with episodic jaundice,HP:0002908 Conjugated hyperbilirubinemia,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "17.43",
            "diseaseModelAvgRaw": "0.42",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "72.29",
            "markerNumModels": "9",
            "diseaseTerm": "Cholestasis, Progressive Familial Intrahepatic, 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613471",
            "phenodigmScore": 39.405,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0003761 Calcinosis,HP:0002904 Hyperbilirubinemia,HP:0001744 Splenomegaly,HP:0002613 Biliary cirrhosis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "16.31",
            "diseaseModelAvgRaw": "0.4",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "62.5",
            "markerNumModels": "9",
            "diseaseTerm": "Reynolds Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:300400",
            "phenodigmScore": 71.85,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0003347 Impaired lymphocyte transformation with phytohemagglutinin,HP:0004432 Agammaglobulinemia,HP:0002090 Pneumonia,HP:0002720 Decreased circulating IgA level,HP:0002841 Recurrent fungal infections,HP:0012178 Reduced natural killer cell activity,HP:0004315 Decreased circulating IgG level,HP:0009098 Chronic oral candidiasis,HP:0000778 Hypoplasia of the thymus,HP:0007274 Recurrent bacterial meningitis,HP:0006532 Recurrent pneumonia,HP:0000988 Skin rash,HP:0002850 Decreased circulating total IgM,HP:0005403 T lymphocytopenia,HP:0005479 Decreased circulating IgE",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "61.78",
            "diseaseModelAvgRaw": "1.43",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "81.92",
            "markerNumModels": "9",
            "diseaseTerm": "Severe Combined Immunodeficiency, X-Linked",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615673",
            "phenodigmScore": 47.6,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0002240 Hepatomegaly,HP:0012650 Perisylvian polymicrogyria,HP:0003236 Elevated circulating creatine kinase concentration,HP:0010910 Hypervalinemia,HP:0030235 Extremely elevated creatine kinase,HP:0001744 Splenomegaly,HP:0002161 Hyperlysinemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.48",
            "diseaseModelAvgRaw": "0.37",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0004811 abnormal neuron physiology,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "76.72",
            "markerNumModels": "9",
            "diseaseTerm": "Myopathy With Extrapyramidal Signs",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:58",
            "phenodigmScore": 48.905,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002383 Infectious encephalitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "6.31",
            "diseaseModelAvgRaw": "0.13",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0006082 CNS inflammation",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "91.5",
            "markerNumModels": "9",
            "diseaseTerm": "Alexander Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:611804",
            "phenodigmScore": 40.620000000000005,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000952 Jaundice,HP:0001878 Hemolytic anemia,HP:0004445 Elliptocytosis,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "14.09",
            "diseaseModelAvgRaw": "0.37",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "67.15",
            "markerNumModels": "9",
            "diseaseTerm": "Elliptocytosis 1",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:617591",
            "phenodigmScore": 58.64,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0002240 Hepatomegaly,HP:0100614 Myositis,HP:0002716 Lymphadenopathy,HP:0012490 Panniculitis,HP:0002719 Recurrent infections,HP:0001369 Arthritis,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0010702 Increased circulating antibody level,HP:0000988 Skin rash,HP:0002155 Hypertriglyceridemia,HP:0001888 Lymphopenia,HP:0001873 Thrombocytopenia,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "46.54",
            "diseaseModelAvgRaw": "1.05",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "70.74",
            "markerNumModels": "9",
            "diseaseTerm": "Proteasome-Associated Autoinflammatory Syndrome 3",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:614699",
            "phenodigmScore": 68.625,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012476 Decreased specific pneumococcal antibody level,HP:0032132 Decreased circulating total IgG,HP:0032139 Reduced isohemagglutinin level,HP:0002720 Decreased circulating IgA level,HP:0002719 Recurrent infections,HP:0001744 Splenomegaly,HP:0000010 Recurrent urinary tract infections,HP:0002205 Recurrent respiratory infections,HP:0041059 Chronic (near) absent circulating IgG4,HP:0041070 Chronic partially decreased circulating IgG1",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "56.93",
            "diseaseModelAvgRaw": "1.2",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "80.32",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency, Common Variable, 7",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618985",
            "phenodigmScore": 58.32,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003212 Increased circulating IgE level,HP:0000964 Eczema,HP:0100646 Thyroiditis,HP:0002719 Recurrent infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "40.2",
            "diseaseModelAvgRaw": "0.82",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "76.44",
            "markerNumModels": "9",
            "diseaseTerm": "Growth Hormone Insensitivity Syndrome With Immune Dysregulation 2, Autosomal Dominant",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:614850",
            "phenodigmScore": 58.35,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012302 Herpes simplex encephalitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "16.7",
            "diseaseModelAvgRaw": "0.45",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0006082 CNS inflammation",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.7",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Encephalopathy, Acute, Infection-Induced (Herpes-Specific), Susceptibility To, 6",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:614576",
            "phenodigmScore": 54.19500000000001,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002536 Abnormal cortical gyration,HP:0002240 Hepatomegaly,HP:0002037 Inflammation of the large intestine,HP:0001272 Cerebellar atrophy,HP:0005435 Impaired T cell function,HP:0003236 Elevated circulating creatine kinase concentration,HP:0002719 Recurrent infections,HP:0002848 Decreased specific anti-polysaccharide antibody level,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0001396 Cholestasis,HP:0002059 Cerebral atrophy,HP:0001876 Pancytopenia,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "31.21",
            "diseaseModelAvgRaw": "0.69",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0004811 abnormal neuron physiology,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "77.18",
            "markerNumModels": "9",
            "diseaseTerm": "Congenital Disorder Of Glycosylation, Type Iil",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:612840",
            "phenodigmScore": 52.36,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0100806 Sepsis,HP:0002240 Hepatomegaly,HP:0001974 Leukocytosis,HP:0001903 Anemia,HP:0002733 Abnormality of the lymph nodes,HP:0001744 Splenomegaly,HP:0001433 Hepatosplenomegaly,HP:0001581 Recurrent skin infections,HP:0001978 Extramedullary hematopoiesis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "31.8",
            "diseaseModelAvgRaw": "0.72",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "72.92",
            "markerNumModels": "9",
            "diseaseTerm": "Leukocyte Adhesion Deficiency, Type Iii",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:447788",
            "phenodigmScore": 57.004999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0007009 Central nervous system degeneration,HP:0002383 Infectious encephalitis,HP:0002180 Neurodegeneration,HP:0001287 Meningitis,HP:0011450 Unusual CNS infection",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.74",
            "diseaseModelAvgRaw": "0.39",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0006082 CNS inflammation,MP:0003224 neuron degeneration,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "95.27",
            "markerNumModels": "9",
            "diseaseTerm": "Cerebral Visual Impairment",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:212065",
            "phenodigmScore": 48.51,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001894 Thrombocytosis,HP:0001395 Hepatic fibrosis,HP:0002720 Decreased circulating IgA level,HP:0003146 Hypocholesterolemia,HP:0004315 Decreased circulating IgG level,HP:0001397 Hepatic steatosis,HP:0003073 Hypoalbuminemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.58",
            "diseaseModelAvgRaw": "0.44",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "76.44",
            "markerNumModels": "9",
            "diseaseTerm": "Congenital Disorder Of Glycosylation, Type Ia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:370",
            "phenodigmScore": 44.095,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0006580 Portal fibrosis,HP:0001395 Hepatic fibrosis,HP:0001402 Hepatocellular carcinoma,HP:0003236 Elevated circulating creatine kinase concentration,HP:0012028 Hepatocellular adenoma,HP:0001744 Splenomegaly,HP:0003124 Hypercholesterolemia,HP:0001394 Cirrhosis,HP:0001397 Hepatic steatosis,HP:0002155 Hypertriglyceridemia,HP:0001396 Cholestasis,HP:0030272 Abnormal erythrocyte enzyme level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "16.87",
            "diseaseModelAvgRaw": "0.37",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "71.32",
            "markerNumModels": "9",
            "diseaseTerm": "Glycogen Storage Disease Due To Phosphorylase Kinase Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:64743",
            "phenodigmScore": 51.58,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001402 Hepatocellular carcinoma,HP:0001541 Ascites,HP:0001882 Leukopenia,HP:0002719 Recurrent infections,HP:0002904 Hyperbilirubinemia,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0011954 Nodular regenerative hyperplasia of liver,HP:0030146 Abnormal liver parenchyma morphology,HP:0001971 Hypersplenism,HP:0006707 Abnormality of the hepatic vasculature,HP:0031015 Intrahepatic portal vein sclerosis,HP:0003073 Hypoalbuminemia,HP:0001873 Thrombocytopenia,HP:0001409 Portal hypertension,HP:0001405 Periportal fibrosis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "30.71",
            "diseaseModelAvgRaw": "0.71",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "72.45",
            "markerNumModels": "9",
            "diseaseTerm": "Hepatoportal Sclerosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:98848",
            "phenodigmScore": 53.165,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002716 Lymphadenopathy,HP:0100494 Abnormal mast cell morphology,HP:0001744 Splenomegaly,HP:0000988 Skin rash,HP:0040186 Maculopapular exanthema,HP:0031408 Increased proportion of CD25+ mast cells,HP:0100495 Mastocytosis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "31.26",
            "diseaseModelAvgRaw": "0.65",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "75.07",
            "markerNumModels": "9",
            "diseaseTerm": "Indolent Systemic Mastocytosis",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:166260",
            "phenodigmScore": 60.730000000000004,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002659 Increased susceptibility to fractures,HP:0000938 Osteopenia,HP:0005045 Diaphyseal cortical sclerosis,HP:0002754 Osteomyelitis",
            "type": "disease_model_summary",
            "modelSource": "IMPC",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<em1(IMPC)Mbp> hom early",
            "diseaseModelAvgNorm": "54.09",
            "diseaseModelAvgRaw": "1.28",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0010124 decreased bone mineral content",
            "modelId": "MGI:6276904#hom#early",
            "diseaseModelMaxRaw": "1.93",
            "diseaseModelMaxNorm": "67.37",
            "markerNumModels": "9",
            "diseaseTerm": "Gnathodiaphyseal Dysplasia",
            "modelGeneticBackground": "C57BL/6NCrl"
        },
        {
            "diseaseId": "ORPHA:3392",
            "phenodigmScore": 61.91,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0030049 Brain abscess,HP:0001974 Leukocytosis,HP:0100721 Mediastinal lymphadenopathy,HP:0001873 Thrombocytopenia,HP:0002090 Pneumonia,HP:0002716 Lymphadenopathy,HP:0001903 Anemia,HP:0001287 Meningitis,HP:0010702 Increased circulating antibody level,HP:0000388 Otitis media,HP:0100533 Inflammatory abnormality of the eye,HP:0000988 Skin rash,HP:0025289 Cervical lymphadenopathy,HP:3000033 Abnormal nasopharyngeal adenoid morphology,HP:0012219 Erythema nodosum,HP:0031292 Cutaneous abscess,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "43.26",
            "diseaseModelAvgRaw": "0.88",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "80.56",
            "markerNumModels": "9",
            "diseaseTerm": "Tularemia",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:95159",
            "phenodigmScore": 40.989999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001878 Hemolytic anemia,HP:0500046 Seborrhoeic blepharitis,HP:0012132 Erythroid hyperplasia,HP:0001744 Splenomegaly,HP:0005406 Recurrent bacterial skin infections,HP:0100532 Scleritis,HP:0001096 Keratoconjunctivitis,HP:0010472 Abnormal circulating porphyrin concentration",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "17.41",
            "diseaseModelAvgRaw": "0.39",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "64.57",
            "markerNumModels": "9",
            "diseaseTerm": "Hepatoerythropoietic Porphyria",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:608233",
            "phenodigmScore": 51.28,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002718 Recurrent bacterial infections,HP:0002240 Hepatomegaly,HP:0001875 Neutropenia,HP:0012178 Reduced natural killer cell activity,HP:0009098 Chronic oral candidiasis,HP:0000403 Recurrent otitis media,HP:0033264 Enlarged platelet dense granules,HP:0033263 Absent platelet dense granules,HP:0001744 Splenomegaly,HP:0000704 Periodontitis,HP:0040218 Reduced natural killer cell count,HP:0002722 Recurrent abscess formation,HP:0001433 Hepatosplenomegaly,HP:0006532 Recurrent pneumonia,HP:0004866 Impaired ADP-induced platelet aggregation,HP:0033222 Decreased CD4:CD8 ratio,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "32.27",
            "diseaseModelAvgRaw": "0.71",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "70.29",
            "markerNumModels": "9",
            "diseaseTerm": "Hermansky-Pudlak Syndrome 2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618641",
            "phenodigmScore": 44.18,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001744 Splenomegaly,HP:0001987 Hyperammonemia,HP:0001397 Hepatic steatosis,HP:0001396 Cholestasis,HP:0012852 Hepatic bridging fibrosis,HP:0000952 Jaundice",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "16.91",
            "diseaseModelAvgRaw": "0.39",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "71.45",
            "markerNumModels": "9",
            "diseaseTerm": "Infantile Liver Failure Syndrome 3",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:565612",
            "phenodigmScore": 43.1,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0011123 Inflammatory abnormality of the skin,HP:0002240 Hepatomegaly,HP:0003077 Hyperlipidemia,HP:0003236 Elevated circulating creatine kinase concentration,HP:0001922 Vacuolated lymphocytes,HP:0001733 Pancreatitis,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.06",
            "diseaseModelAvgRaw": "0.51",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "63.14",
            "markerNumModels": "9",
            "diseaseTerm": "Triglyceride Deposit Cardiomyovasculopathy",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:83313",
            "phenodigmScore": 64.295,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001882 Leukopenia,HP:0002716 Lymphadenopathy,HP:0003237 Increased circulating IgG level,HP:0003496 Increased circulating IgM level,HP:0040186 Maculopapular exanthema,HP:0000988 Skin rash,HP:0025289 Cervical lymphadenopathy,HP:0001873 Thrombocytopenia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "37.59",
            "diseaseModelAvgRaw": "0.79",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "91.0",
            "markerNumModels": "9",
            "diseaseTerm": "Boutonneuse Fever",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:79292",
            "phenodigmScore": 45.14,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002716 Lymphadenopathy,HP:0002240 Hepatomegaly,HP:0003233 Decreased HDL cholesterol concentration,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.95",
            "diseaseModelAvgRaw": "0.47",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "70.33",
            "markerNumModels": "9",
            "diseaseTerm": "Fish-Eye Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:619220",
            "phenodigmScore": 79.335,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0006268 Fluctuating splenomegaly,HP:0002110 Bronchiectasis,HP:0001904 Neutropenia in presence of anti-neutropil antibodies,HP:0410028 Recurrent oral herpes,HP:0002716 Lymphadenopathy,HP:0000403 Recurrent otitis media,HP:0003237 Increased circulating IgG level,HP:0002783 Recurrent lower respiratory tract infections,HP:0001973 Autoimmune thrombocytopenia,HP:0003496 Increased circulating IgM level,HP:0032247 Persistent CMV viremia,HP:0001890 Autoimmune hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "61.4",
            "diseaseModelAvgRaw": "1.29",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "97.27",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 78 With Autoimmunity And Developmental Delay",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:117",
            "phenodigmScore": 53.265,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001097 Keratoconjunctivitis sicca,HP:0002383 Infectious encephalitis,HP:0001701 Pericarditis,HP:0100584 Endocarditis,HP:0100654 Retrobulbar optic neuritis,HP:0100614 Myositis,HP:0002716 Lymphadenopathy,HP:0001061 Acne,HP:0001369 Arthritis,HP:0001733 Pancreatitis,HP:0100653 Optic neuritis,HP:0012649 Increased inflammatory response,HP:0001287 Meningitis,HP:0001744 Splenomegaly,HP:0100796 Orchitis,HP:0011107 Recurrent aphthous stomatitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.49",
            "diseaseModelAvgRaw": "0.43",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "86.04",
            "markerNumModels": "9",
            "diseaseTerm": "Behçet Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:2584",
            "phenodigmScore": 49.81,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0000964 Eczema,HP:0002716 Lymphadenopathy,HP:0004332 Abnormal lymphocyte morphology,HP:0001744 Splenomegaly,HP:0000988 Skin rash",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.46",
            "diseaseModelAvgRaw": "0.41",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "80.16",
            "markerNumModels": "9",
            "diseaseTerm": "Classic Mycosis Fungoides",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:256500",
            "phenodigmScore": 55.97,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003193 Allergic rhinitis,HP:0001019 Erythroderma,HP:0004315 Decreased circulating IgG level,HP:0002719 Recurrent infections,HP:0003212 Increased circulating IgE level,HP:0032061 Hypereosinophilia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "35.0",
            "diseaseModelAvgRaw": "0.81",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.29",
            "diseaseModelMaxNorm": "76.94",
            "markerNumModels": "9",
            "diseaseTerm": "Netherton Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613489",
            "phenodigmScore": 48.84,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004798 Recurrent infection of the gastrointestinal tract,HP:0002240 Hepatomegaly,HP:0001744 Splenomegaly,HP:0001394 Cirrhosis,HP:0002059 Cerebral atrophy,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.5",
            "diseaseModelAvgRaw": "0.41",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "77.18",
            "markerNumModels": "9",
            "diseaseTerm": "Congenital Disorder Of Glycosylation, Type Iij",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:2643",
            "phenodigmScore": 61.115,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004315 Decreased circulating IgG level,HP:0002205 Recurrent respiratory infections,HP:0001875 Neutropenia,HP:0002850 Decreased circulating total IgM",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "37.78",
            "diseaseModelAvgRaw": "0.8",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "84.45",
            "markerNumModels": "9",
            "diseaseTerm": "Microcephalic Primordial Dwarfism, Toriello Type",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618398",
            "phenodigmScore": 50.225,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012490 Panniculitis,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0003281 Increased circulating ferritin concentration,HP:0002155 Hypertriglyceridemia,HP:0001876 Pancytopenia,HP:0012156 Hemophagocytosis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "32.58",
            "diseaseModelAvgRaw": "0.74",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "67.87",
            "markerNumModels": "9",
            "diseaseTerm": "T-Cell Lymphoma, Subcutaneous Panniculitis-Like",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:1929",
            "phenodigmScore": 47.7,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0003460 Decreased circulating total IgA",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "14.29",
            "diseaseModelAvgRaw": "0.28",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.21",
            "diseaseModelMaxNorm": "81.11",
            "markerNumModels": "9",
            "diseaseTerm": "Rasmussen Subacute Encephalitis",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:300076",
            "phenodigmScore": 54.910000000000004,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0008348 Decreased circulating IgG2 level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "25.84",
            "diseaseModelAvgRaw": "0.56",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0002451 abnormal macrophage physiology,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.23",
            "diseaseModelMaxNorm": "83.98",
            "markerNumModels": "9",
            "diseaseTerm": "Immunoneurologic Disorder, X-Linked",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:232300",
            "phenodigmScore": 44.975,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0003236 Elevated circulating creatine kinase concentration,HP:0001640 Cardiomegaly,HP:0001744 Splenomegaly,HP:0002205 Recurrent respiratory infections",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.34",
            "diseaseModelAvgRaw": "0.49",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "66.61",
            "markerNumModels": "9",
            "diseaseTerm": "Glycogen Storage Disease Ii",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:139402",
            "phenodigmScore": 59.004999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0002383 Infectious encephalitis,HP:0001019 Erythroderma,HP:0001970 Tubulointerstitial nephritis,HP:0200039 Pustule,HP:0006515 Interstitial pneumonitis,HP:0002716 Lymphadenopathy,HP:0012115 Hepatitis,HP:0100646 Thyroiditis,HP:0100827 Lymphocytosis,HP:0000988 Skin rash,HP:0001880 Eosinophilia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "26.29",
            "diseaseModelAvgRaw": "0.63",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "91.72",
            "markerNumModels": "9",
            "diseaseTerm": "Drug Reaction With Eosinophilia And Systemic Symptoms",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:251260",
            "phenodigmScore": 50.769999999999996,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000246 Sinusitis,HP:0004798 Recurrent infection of the gastrointestinal tract,HP:0010976 B lymphocytopenia,HP:0002110 Bronchiectasis,HP:0002837 Recurrent bronchitis,HP:0002180 Neurodegeneration,HP:0000010 Recurrent urinary tract infections,HP:0002961 Dysgammaglobulinemia,HP:0000388 Otitis media,HP:0006532 Recurrent pneumonia,HP:0001873 Thrombocytopenia,HP:0005403 T lymphocytopenia,HP:0001890 Autoimmune hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "34.72",
            "diseaseModelAvgRaw": "0.8",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.12",
            "diseaseModelMaxNorm": "66.82",
            "markerNumModels": "9",
            "diseaseTerm": "Nijmegen Breakage Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:309854",
            "phenodigmScore": 42.88,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0012343 Decreased circulating ferritin concentration,HP:0001901 Polycythemia,HP:0001413 Micronodular cirrhosis,HP:0010927 Abnormal blood inorganic cation concentration,HP:0002154 Hyperglycinemia,HP:0040135 Abnormal transferrin saturation,HP:0001744 Splenomegaly,HP:0000952 Jaundice,HP:0001392 Abnormality of the liver,HP:0001409 Portal hypertension,HP:0025196 Increased total iron binding capacity",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "18.33",
            "diseaseModelAvgRaw": "0.41",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "67.43",
            "markerNumModels": "9",
            "diseaseTerm": "Cirrhosis-Dystonia-Polycythemia-Hypermanganesemia Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:614379",
            "phenodigmScore": 60.364999999999995,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001287 Meningitis,HP:0045044 Decreased serum complement C4b,HP:0200120 Chronic active hepatitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "29.99",
            "diseaseModelAvgRaw": "0.58",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002494 increased IgM level,MP:0002493 increased IgG level,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "90.74",
            "markerNumModels": "9",
            "diseaseTerm": "Complement Component 4B Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:201100",
            "phenodigmScore": 51.385,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001744 Splenomegaly,HP:0005401 Recurrent candida infections,HP:0005435 Impaired T cell function",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "26.47",
            "diseaseModelAvgRaw": "0.55",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "76.3",
            "markerNumModels": "9",
            "diseaseTerm": "Acrodermatitis Enteropathica, Zinc-Deficiency Type",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:46532",
            "phenodigmScore": 51.68,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001903 Anemia,HP:0011904 Persistence of hemoglobin F,HP:0001744 Splenomegaly",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "16.89",
            "diseaseModelAvgRaw": "0.38",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008126 increased dendritic cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "86.47",
            "markerNumModels": "9",
            "diseaseTerm": "Hereditary Persistence Of Fetal Hemoglobin-Beta-Thalassemia Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:324625",
            "phenodigmScore": 50.205,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002383 Infectious encephalitis,HP:0100769 Synovitis,HP:0002716 Lymphadenopathy,HP:0001369 Arthritis,HP:0040186 Maculopapular exanthema,HP:0000988 Skin rash,HP:0025289 Cervical lymphadenopathy,HP:0007473 Crusting erythematous dermatitis,HP:0012219 Erythema nodosum",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "14.74",
            "diseaseModelAvgRaw": "0.31",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "85.67",
            "markerNumModels": "9",
            "diseaseTerm": "Chikungunya",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:615513",
            "phenodigmScore": 82.03999999999999,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012476 Decreased specific pneumococcal antibody level,HP:0030381 Increased proportion of transitional B cells,HP:0030388 Decreased proportion of class-switched memory B cells,HP:0410018 Recurrent ear infections,HP:0002110 Bronchiectasis,HP:0002716 Lymphadenopathy,HP:0005425 Recurrent sinopulmonary infections,HP:0001744 Splenomegaly,HP:0003496 Increased circulating IgM level,HP:0002205 Recurrent respiratory infections,HP:0005403 T lymphocytopenia,HP:0008348 Decreased circulating IgG2 level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "66.81",
            "diseaseModelAvgRaw": "1.44",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "97.27",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 14A, Autosomal Dominant",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:100024",
            "phenodigmScore": 61.650000000000006,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0010975 Abnormal B cell count,HP:0002716 Lymphadenopathy,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0010702 Increased circulating antibody level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "40.54",
            "diseaseModelAvgRaw": "0.9",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "82.76",
            "markerNumModels": "9",
            "diseaseTerm": "Mu-Heavy Chain Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:759",
            "phenodigmScore": 46.82,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001287 Meningitis,HP:0001061 Acne",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "12.14",
            "diseaseModelAvgRaw": "0.26",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0006082 CNS inflammation",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.24",
            "diseaseModelMaxNorm": "81.5",
            "markerNumModels": "9",
            "diseaseTerm": "Central Precocious Puberty",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:99965",
            "phenodigmScore": 55.89,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010702 Increased circulating antibody level,HP:0001880 Eosinophilia,HP:0006827 Atrophy of the spinal cord",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "39.17",
            "diseaseModelAvgRaw": "0.81",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.26",
            "diseaseModelMaxNorm": "72.61",
            "markerNumModels": "9",
            "diseaseTerm": "O'Sullivan-Mcleod Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:79124",
            "phenodigmScore": 57.035,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0030355 Abnormal serum interferon-gamma level,HP:0001433 Hepatosplenomegaly,HP:0030782 Abnormal serum interleukin level,HP:0001876 Pancytopenia,HP:0002205 Recurrent respiratory infections,HP:0001409 Portal hypertension,HP:0000952 Jaundice,HP:0002100 Recurrent aspiration pneumonia,HP:0002722 Recurrent abscess formation,HP:0030374 Decreased proportion of memory B cells,HP:0005403 T lymphocytopenia,HP:0002849 Absence of lymph node germinal center,HP:0002240 Hepatomegaly,HP:0410018 Recurrent ear infections,HP:0002728 Chronic mucocutaneous candidiasis,HP:0003139 Panhypogammaglobulinemia,HP:0002743 Recurrent enteroviral infections,HP:0031123 Recurrent gastroenteritis,HP:0001541 Ascites,HP:0004429 Recurrent viral infections,HP:0001903 Anemia,HP:0001873 Thrombocytopenia,HP:0040089 Abnormal natural killer cell count,HP:0040088 Abnormal lymphocyte count",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "46.36",
            "diseaseModelAvgRaw": "1.02",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.08",
            "diseaseModelMaxNorm": "67.71",
            "markerNumModels": "9",
            "diseaseTerm": "Hepatic Veno-Occlusive Disease-Immunodeficiency Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:83617",
            "phenodigmScore": 46.0,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0010976 B lymphocytopenia,HP:0000964 Eczema,HP:0002240 Hepatomegaly,HP:0002594 Pancreatic hypoplasia,HP:0031190 Superficial dermal perivascular inflammatory infiltrate,HP:0001051 Seborrheic dermatitis,HP:0001081 Cholelithiasis,HP:0006560 Biliary hyperplasia,HP:0005365 Severe B lymphocytopenia,HP:0012444 Brain atrophy,HP:0002850 Decreased circulating total IgM,HP:0002506 Diffuse cerebral atrophy",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "23.04",
            "diseaseModelAvgRaw": "0.54",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.3",
            "diseaseModelMaxNorm": "68.96",
            "markerNumModels": "9",
            "diseaseTerm": "Agammaglobulinemia-Microcephaly-Craniosynostosis-Severe Dermatitis Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:91546",
            "phenodigmScore": 56.72,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001287 Meningitis,HP:0000554 Uveitis,HP:0002383 Infectious encephalitis,HP:0001369 Arthritis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "16.77",
            "diseaseModelAvgRaw": "0.36",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0006082 CNS inflammation",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.84",
            "diseaseModelMaxNorm": "96.67",
            "markerNumModels": "9",
            "diseaseTerm": "Lyme Disease",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:391",
            "phenodigmScore": 47.755,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002716 Lymphadenopathy,HP:0005528 Bone marrow hypocellularity,HP:0001744 Splenomegaly,HP:0000988 Skin rash",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "20.56",
            "diseaseModelAvgRaw": "0.42",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "74.95",
            "markerNumModels": "9",
            "diseaseTerm": "Classic Hodgkin Lymphoma",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:613002",
            "phenodigmScore": 59.705,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0012302 Herpes simplex encephalitis,HP:0001287 Meningitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.41",
            "diseaseModelAvgRaw": "0.41",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0006082 CNS inflammation",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.7",
            "diseaseModelMaxNorm": "100.0",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency 83, Susceptibility To Viral Infections",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:610199",
            "phenodigmScore": 42.87,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002594 Pancreatic hypoplasia,HP:0001395 Hepatic fibrosis,HP:0001737 Pancreatic cysts,HP:0030423 Splenic cyst,HP:0012115 Hepatitis,HP:0002719 Recurrent infections,HP:0001744 Splenomegaly,HP:0001396 Cholestasis,HP:0001409 Portal hypertension",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "17.63",
            "diseaseModelAvgRaw": "0.42",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "68.11",
            "markerNumModels": "9",
            "diseaseTerm": "Diabetes Mellitus, Neonatal, With Congenital Hypothyroidism",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:611926",
            "phenodigmScore": 69.88,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002720 Decreased circulating IgA level,HP:0004315 Decreased circulating IgG level,HP:0005407 Decreased proportion of CD4-positive helper T cells,HP:0005415 Decreased proportion of CD8-positive T cells,HP:0002850 Decreased circulating total IgM",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "53.04",
            "diseaseModelAvgRaw": "1.25",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.65",
            "diseaseModelMaxNorm": "86.72",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency, Ovarian Dysgenesis, And Pulmonary Fibrosis",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "OMIM:616911",
            "phenodigmScore": 68.42,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0004313 Decreased circulating antibody level,HP:0004432 Agammaglobulinemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "47.3",
            "diseaseModelAvgRaw": "1.0",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008495 decreased IgG1 level,MP:0008565 decreased interferon-beta secretion,MP:0008576 decreased circulating interferon-beta level,MP:0008578 decreased circulating interferon-gamma level,MP:0001805 decreased IgG level,MP:0008574 decreased circulating interferon-alpha level,MP:0008496 decreased IgG2a level,MP:0008670 decreased interleukin-12b secretion",
            "modelId": "MGI:3773253",
            "diseaseModelMaxRaw": "2.07",
            "diseaseModelMaxNorm": "89.54",
            "markerNumModels": "9",
            "diseaseTerm": "Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome 4",
            "modelGeneticBackground": "involves: 129P2/OlaHsd * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:70578",
            "phenodigmScore": 53.245000000000005,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0100806 Sepsis,HP:0030783 Increased circulating interleukin 6,HP:0011118 Abnormality of tumor necrosis factor secretion,HP:0030782 Abnormal serum interleukin level",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "33.57",
            "diseaseModelAvgRaw": "0.82",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008597 decreased circulating interleukin-6 level,MP:0008565 decreased interferon-beta secretion,MP:0005025 abnormal response to infection,MP:0020937 increased susceptibility to Picornaviridae infection,MP:0008706 decreased interleukin-6 secretion,MP:0008563 decreased interferon-alpha secretion,MP:0003009 abnormal cytokine secretion",
            "modelId": "MGI:3773164",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "72.92",
            "markerNumModels": "9",
            "diseaseTerm": "Adult Acute Respiratory Distress Syndrome",
            "modelGeneticBackground": "Not Specified"
        },
        {
            "diseaseId": "OMIM:617241",
            "phenodigmScore": 71.105,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0000964 Eczema,HP:0000778 Hypoplasia of the thymus,HP:0031402 Reduced antigen-specific T cell proliferation,HP:0002972 Reduced delayed hypersensitivity,HP:0003212 Increased circulating IgE level,HP:0003496 Increased circulating IgM level,HP:0005415 Decreased proportion of CD8-positive T cells,HP:0005407 Decreased proportion of CD4-positive helper T cells",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "47.1",
            "diseaseModelAvgRaw": "1.04",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.68",
            "diseaseModelMaxNorm": "95.11",
            "markerNumModels": "9",
            "diseaseTerm": "Lung Disease, Immunodeficiency, And Chromosome Breakage Syndrome",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:398124",
            "phenodigmScore": 46.56,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001875 Neutropenia,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0001392 Abnormality of the liver,HP:0025300 Malar rash,HP:0001915 Aplastic anemia,HP:0040186 Maculopapular exanthema,HP:0000988 Skin rash,HP:0001876 Pancytopenia,HP:0001873 Thrombocytopenia,HP:0001878 Hemolytic anemia",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.36",
            "diseaseModelAvgRaw": "0.43",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "73.76",
            "markerNumModels": "9",
            "diseaseTerm": "Neonatal Lupus Erythematosus",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:607625",
            "phenodigmScore": 43.76,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0001791 Fetal ascites,HP:0002240 Hepatomegaly,HP:0003107 Abnormal circulating cholesterol concentration,HP:0004333 Bone-marrow foam cells,HP:0001744 Splenomegaly,HP:0006579 Prolonged neonatal jaundice,HP:0001982 Sea-blue histiocytosis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "19.42",
            "diseaseModelAvgRaw": "0.42",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0000691 enlarged spleen,MP:0008596 increased circulating interleukin-6 level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "68.1",
            "markerNumModels": "9",
            "diseaseTerm": "Niemann-Pick Disease, Type C2",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:253260",
            "phenodigmScore": 45.625,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0001051 Seborrheic dermatitis,HP:0100275 Diffuse cerebellar atrophy,HP:0001987 Hyperammonemia,HP:0001744 Splenomegaly,HP:0001581 Recurrent skin infections,HP:0000988 Skin rash,HP:0002506 Diffuse cerebral atrophy,HP:0000509 Conjunctivitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "22.53",
            "diseaseModelAvgRaw": "0.5",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0008548 abnormal circulating interferon level,MP:0008553 increased circulating tumor necrosis factor level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0008596 increased circulating interleukin-6 level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "68.72",
            "markerNumModels": "9",
            "diseaseTerm": "Biotinidase Deficiency",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "ORPHA:99843",
            "phenodigmScore": 49.540000000000006,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0410292 Abnormal isohemagglutinin level,HP:0001974 Leukocytosis,HP:0002240 Hepatomegaly,HP:0007041 Chronic lymphocytic meningitis,HP:0000403 Recurrent otitis media,HP:0002719 Recurrent infections,HP:0001903 Anemia,HP:0000491 Keratitis,HP:0000010 Recurrent urinary tract infections,HP:0011897 Neutrophilia,HP:0000166 Severe periodontitis,HP:0001935 Microcytic anemia,HP:0006532 Recurrent pneumonia,HP:0002059 Cerebral atrophy,HP:0031123 Recurrent gastroenteritis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "29.68",
            "diseaseModelAvgRaw": "0.62",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0008500 increased IgG2a level,MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0008565 decreased interferon-beta secretion,MP:0008553 increased circulating tumor necrosis factor level,MP:0008548 abnormal circulating interferon level,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0000691 enlarged spleen,MP:0006082 CNS inflammation,MP:0002451 abnormal macrophage physiology,MP:0002494 increased IgM level,MP:0008596 increased circulating interleukin-6 level,MP:0002376 abnormal dendritic cell physiology,MP:0002493 increased IgG level,MP:0003224 neuron degeneration,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number,MP:0008577 increased circulating interferon-gamma level",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.18",
            "diseaseModelMaxNorm": "69.4",
            "markerNumModels": "9",
            "diseaseTerm": "Leukocyte Adhesion Deficiency Type Ii",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        },
        {
            "diseaseId": "OMIM:618852",
            "phenodigmScore": 50.375,
            "associationCurated": "false",
            "diseaseMatchedPhenotypes": "HP:0002240 Hepatomegaly,HP:0002716 Lymphadenopathy,HP:0001744 Splenomegaly,HP:0001935 Microcytic anemia,HP:0011110 Recurrent tonsillitis",
            "type": "disease_model_summary",
            "modelSource": "MGI",
            "markerSymbol": "Mavs",
            "modelDescription": "Mavs<tm1Aki>/Mavs<tm1Aki>",
            "diseaseModelAvgNorm": "24.22",
            "diseaseModelAvgRaw": "0.5",
            "markerLocus": "2:131075983-131089945",
            "modelMatchedPhenotypes": "MP:0001847 brain inflammation,MP:0020943 increased susceptibility to Flaviviridae infection,MP:0000691 enlarged spleen,MP:0008079 decreased CD8-positive\\, alpha-beta T cell number,MP:0008126 increased dendritic cell number,MP:0031044 increased susceptibility to Flaviviridae infection induced morbidity/mortality,MP:0008075 decreased CD4-positive\\, alpha beta T cell number",
            "modelId": "MGI:5313730",
            "diseaseModelMaxRaw": "2.17",
            "diseaseModelMaxNorm": "76.53",
            "markerNumModels": "9",
            "diseaseTerm": "Autoinflammation With Episodic Fever And Lymphadenopathy",
            "modelGeneticBackground": "involves: 129S/SvEv * C57BL/6"
        }
    ]
}